The Australian Corneal Graft Registry 2007 Report by Williams, Keryn Anne et al.
 
 
 
 
THE AUSTRALIAN 
 CORNEAL GRAFT REGISTRY 
 
 
 
 
2007  REPORT 
 
This report was published with assistance from 
The Commonwealth Department of Health and Ageing 
 
 
 
THE AUSTRALIAN 
 CORNEAL GRAFT REGISTRY 
 
2007 REPORT 
 
 
 
 
Edited by:   KA Williams,  MT Lowe,  CM Bartlett,  L Kelly and  DJ Coster 
 
 
 
 
All rights reserved.  No part of this publication may be reproduced, stored in a retrieval system or 
transmitted, in any form or by any means, electronic, mechanical, photocopying or otherwise without 
prior permission. 
 
Adelaide: Flinders University Press 2007 
 
ACKNOWLEDGEMENTS 
 
 
 
 
 
We appreciate the co-operation of the following eye banks: 
Eye Bank of South Australia 
Lions New South Wales Eye Bank 
Lions Eye Bank of Western Australia 
Lions Eye Donation Service, Melbourne 
Queensland Eye Bank 
Donor Tissue Bank of Victoria 
 
 
 
 
CONTACT ADDRESS 
 for the  
AUSTRALIAN CORNEAL GRAFT REGISTRY 
 
Department of Ophthalmology 
Flinders Medical Centre 
BEDFORD PARK  SA  5042 
AUSTRALIA 
 
Telephone:  (618)  8204 5321 
    (618)  8204 4899 
 
FAX:   (618)  8277 0899 
     
 
International FAX: (618)  8277 0899 
 
email:   keryn.williams@flinders.edu.au 
 
Australian Corneal Graft Registry Report  2007  3 
 
TABLE OF CONTENTS 
TABLE OF CONTENTS 
LIST OF CONTRIBUTORS......................................................................................................  6 
 HOW TO READ KAPLAN-MEIER GRAFT SURVIVAL PLOTS................................  8 
 INTRODUCTION.........................................................................................................  9 
1. OVERVIEW AND CONTRIBUTOR INFORMATION ..................................................10 
1.1 Current database.........................................................................................................10 
1.1.1 Synopsis of the current database...................................................................10 
1.1.2 Survival of penetrating, lamellar and limbal grafts .........................................11 
1.2 Grafts registered by state, territory and individual.......................................................13 
1.2.1 Grafts entered by Australian state and territory .............................................13 
1.2.2 Contributors in each state ..............................................................................16 
1.2.3 The centre effect.............................................................................................16 
1.2.4 Outcome: influence of surgeon workload per year.........................................18 
1.2.5 Outcome: according to era .............................................................................21 
1.2.6 Outcome: whether followed by contributing surgeon or another practitioner.23 
1.3 Summary of overview and contributor data.................................................................26 
2. DONORS AND EYE-BANKING..................................................................................27 
2.1 Cause of donor death..................................................................................................27 
2.2 Donor gender...............................................................................................................30 
2.3 Donor age....................................................................................................................30 
2.4 Death-to-enucleation and death-to-graft times............................................................36 
2.5 Corneal storage media ................................................................................................41 
2.5.1 Optisol storage time .......................................................................................44 
2.6 Donor procurement source..........................................................................................46 
2.7 Multi-organ donors.......................................................................................................48 
2.7.1 Multi-organ donors vs cadaveric donors.........................................................49 
2.8 Primary non-functioning grafts ....................................................................................51 
2.9 Summary of donor and eye-banking information ........................................................53 
3. RECIPIENTS...............................................................................................................54 
3.1 Recipient age at graft ..................................................................................................54 
 3.1.1 Infant, child and adolescent recipients ...........................................................58 
  3.1.1.1 Congenital abnormalities ..............................................................58 
  3.1.1.2 Paediatric recipients......................................................................59 
 3.1.2 Elderly recipients ............................................................................................61 
3.2 Recipient gender .........................................................................................................64 
3.3 Pre-graft morbidities ....................................................................................................69 
 3.3.1 Vascularisation ...............................................................................................69 
 3.3.2 Inflammation ...................................................................................................71 
 3.3.3 Intraocular pressure (pre-graft or at graft) ......................................................72 
3.4 Main indication for graft ...............................................................................................74 
3.5 Effect of specific indication for graft on graft survival ..................................................79 
 3.5.1 Keratoconus, keratoconus with hydrops, Down syndrome or keratoglobus ..79 
 3.5.2 Bullous keratopathy........................................................................................81 
 3.5.3 Previous failed ipsilateral graft .......................................................................84 
  3.5.3.1 The effect of reason for failure of a previous graft........................86 
 3.5.4 Corneal dystrophy ..........................................................................................89 
 3.5.5 Herpes simplex virus infection........................................................................92 
 3.5.6 Non-herpetic infections...................................................................................94 
 3.5.7 Burns and trauma...........................................................................................96 
 3.5.9 Descemetocoele.............................................................................................98 
3.6 Summary of recipient-related factors........................................................................ 100 
4  Australian Corneal Graft Registry Report 2007 
TABLE OF CONTENTS 
 
TABLE OF CONTENTS 
 
4. PROCEDURES AT TIME OF GRAFT AND INFLUENCE OF IOLs........................101 
4.1 Operative procedures at graft...................................................................................101 
 4.1.1 Host bed size of graft...................................................................................101 
 4.1.2 Accompanying procedures at graft..............................................................105 
 4.1.3 Influence of vitrectomy.................................................................................106 
 4.1.4 Lens insertion ..............................................................................................108 
  4.1.4.1 Triple and staged procedures ..................................................110 
4.2 Summary of effect of operative procedures at time of graft and influence of IOLs..112 
5. POST-GRAFT EVENTS...........................................................................................114 
5.1 Reasons for graft failure ...........................................................................................114 
5.2 Time to suture removal.............................................................................................116 
5.3 Post-graft complications ...........................................................................................119 
 5.3.1 Microbial keratitis/stitch abscess .................................................................119 
 5.3.2 Uveitis ..........................................................................................................120 
 5.3.3 Synechiae....................................................................................................121 
 5.3.4 Post-graft vascularisation ............................................................................123 
 5.3.5 Post operative rise in intraocular pressure ..................................................124 
  5.3.5.1 Effect of post-operative rise in intraocular pressure ................125 
  5.3.5.2 Post-graft operative procedures for glaucoma.........................126 
 5.3.6 Rejection episodes since graft.....................................................................127 
5.4 Post-graft operative procedures ...............................................................................129 
 5.4.1 Refractive surgery .......................................................................................130 
5.5 Summary of post-graft events ..................................................................................132 
6. VISUAL OUTCOME...............................................................................................  133 
6.1 Desired outcome ...............................................................................................  133 
 6.1.1 Desired outcome and actual outcome achieved .......................................  134 
6.2 Overall visual acuity ...............................................................................................  135 
 6.2.1 Comparison where post-graft visual acuity is ≥6/18 or < 6/18 ..................  136 
 6.2.2 Post-graft changes in visual acuity............................................................  137 
6.3 Visual outcome related to presenting disease .......................................................  139 
 6.3.1 Keratoconus ..............................................................................................  140 
 6.3.2 Fuchs' dystrophy..........................................................................................141 
 6.3.3 Aphakic bullous keratopathy........................................................................142 
 6.3.4 Pseudophakic bullous keratopathy ..............................................................143 
 6.3.5 Previous failed graft .....................................................................................144 
 6.3.6 Herpetic infection .........................................................................................145 
6.4 Factors affecting visual potential of the grafted eye ...............................................  146 
6.5 Astigmatism.............................................................................................................  147 
6.6 Refractive surgery...................................................................................................  148 
 6.6.1 Correction following refractive surgery ......................................................148 
 6.6.2 Has refractive surgery improved visual acuity? .........................................149 
6.7 Triple procedures….. ..............................................................................................  151 
 6.7.1 Snellen acuity.............................................................................................151 
 6.7.2 Visual improvement after graft: triple procedure........................................152 
6.8 Post-graft correction................................................................................................  153 
6.9 Summary of visual outcome after corneal transplantation......................................  154 
 
 
Australian Corneal Graft Registry Report  2007  5 
 
TABLE OF CONTENTS 
TABLE OF CONTENTS 
 
7. LAMELLAR AND LIMBAL GRAFTS.....................................................................156 
7.1 Survival of lamellar and limbal grafts ......................................................................156 
7.2 Desired outcome….. ...............................................................................................158 
7.3 Overall visual acuity ................................................................................................159 
7.4 Effect of surgeon workload .....................................................................................160 
 7.4.1 Outcome: number of grafts performed ...................................................160 
 7.4.2 Outcome: followup surgeon....................................................................161 
7.5 Lamellar grafts……… .............................................................................................163 
7.6 Limbal grafts  ................................................................................................169 
7.7 Summary of factors relating to lamellar and limbal grafts.......................................171 
MULTIVARIATE ANALYSIS, SUMMARY AND METHODS ..............................................173 
8. COX PROPORTIONATE HAZARDS REGRESSION ANALYSIS.........................174 
8.1 Methods ..................................................................................................................174 
8.2 Final model..............................................................................................................175 
 8.2.1 Model 1… ...............................................................................................176 
 7.2.2 Model 2….. .............................................................................................178 
8.3 Transformation of variables ....................................................................................180 
8.4 Interpretation of the model ......................................................................................181 
9. SUMMARY..............................................................................................................182 
9.1 Grafts, contributors and era ....................................................................................182 
9.2 Corneal donors and eye banking............................................................................182 
9.3 Corneal graft recipients...........................................................................................183 
9.4 Operative procedures .............................................................................................183 
9.5 Causes of graft failure.............................................................................................183 
9.6 Visual outcome after corneal transplantation..........................................................183 
9.7 Lamellar and limbal grafts.......................................................................................185 
9.8 Risk factors for failure of penetrating grafts ............................................................185 
10. METHODS AND DEFINITIONS .............................................................................186 
10.1 Entry and follow-up .................................................................................................186 
10.2 Definition of risk factors...........................................................................................186 
10.3 Definition of graft failure, rejection and complications ............................................187 
10.4 Statistical analyses .................................................................................................187 
10.5 Computer hardware and software ..........................................................................187 
10.6 Corneal graft registration form ................................................................................188 
10.7 Corneal graft followup form.....................................................................................190 
10.8 References..............................................................................................................192 
11. ACGR PUBLICATIONS .........................................................................................193 
11.1 Journal articles........................................................................................................193 
11.2 Reports....................................................................................................................194 
 
6  Australian Corneal Graft Registry Report 2007 
 
CONTRIBUTORS 
 
LIST OF CONTRIBUTORS 
 
 
Aboud, JD 
Achnad, J 
Adler, P 
Agnello, R 
Allan, B 
Ambler, J 
Anderson, IL 
Anderson, PF 
Andersons, V 
Apel, AJG 
Apel, J 
Armstrong, RJ 
Arnold, JJ 
Asimakis, P 
Athanasiou, C 
Atkins, T 
Atkinson, GA 
Austin, CW 
Bailey, C 
Baker, CH 
Bambery, SJ 
Barila, A 
Barker, NH 
Barnes, C 
Barnett, WJ 
Barrett, G 
Bassili, S 
Beaumont, P 
Beckingsale, P 
Benecke, P 
Benjamin, FA 
Bennett, C 
Benson, CJ 
Billson, F 
Binetter, R 
Bolliger, PA 
Booth, F 
Booth-Mason, S 
Boreham, C 
Borger, JP 
Bors, FH 
Both, R 
Bougher, GJ 
Brennan, MH 
Brian, G 
Briner, AM 
Brooks, AMV 
Brown, C 
Brunckhorst, A 
Buckley, CA 
Burgess, F 
Burt, P 
Burvill, MJ 
Byrne, JB 
Cains, SE 
Calthorpe, M 
Campbell, DV 
Campbell, W 
Candy, D 
Carey, TM 
 
 
 
 
Carroll, LA 
Chan, DGW 
Chadha, VB 
Challinor, CJ 
Chan, DGW 
Chandra, J 
Chapman, PJ 
Charawanamuttu, A 
Chau, P 
Chehade, M 
Chelvanayagam, D 
Cher, I 
Cherny, M 
Chester, GH 
Chin, D 
Ch'ng, AC 
Chua, SK 
Clark, B 
Cohen, PRA 
Cohn, GS 
Collie, DM 
Conrad, D 
Constable, IJ 
Conway, RM 
Cooper, PS 
Cooper, RL 
Coote, BD 
Coote, MA 
Cornwell, R 
Coroneo, M 
Cosgrove, JM 
Coster, DJ 
Cottee, LB 
Cranstoun, PD 
Crawford, BA 
Crawford, GJ 
Crayford, BB 
Crock, GW 
Crompton, JL 
Cunningham, F 
Czigler, B 
Dalton, JA 
Dang, V 
Daniell, M 
Da Rin, D 
Davey, JC 
Davies, GA 
Davies, IC 
Davies, RP 
Davis, H 
Davis, JL 
Delaney, MR 
Della, N 
Den, BD 
Denman, DP 
Dethlefs, R 
Diamond, J 
Dickson, D 
Dinihan, I 
D'Mellow, G 
 
 
 
 
Dobinson, J 
Donovan, B 
Douglas, I 
Downie, NA 
Doyle, S 
Duggan, JM 
Duke, PS 
Duncan, M 
Dunlop, A 
Dunlop, C 
Dunlop, I 
Durkin, DT 
du Temple, DJ 
Dyer, JA 
Dyson, C 
Economos, AS 
Elder, JR 
Ellis, MF 
English, FP 
English, KP 
English, M 
Evans, L 
Farinelli, AC 
Farpour, B 
Favilla, I 
Favilla, ML 
Ferguson, M 
Field, A 
Finkelstein, E 
Fitzsimons, SR 
Fleming, R 
Fong, LP 
Foo, K 
Forster, TDC 
Fraenkel, G 
Francis, IC 
Franks, SS 
Frauenfelder, G 
Frumar, KD 
Fullarton, F 
Galbraith, JEK 
Galbraith, JK 
Gaston, G 
Genge, J 
Gibbons, N 
Giblin, ME 
Gibson, AG 
Gibson, AJG 
Gibson, BHL 
Giles, M 
Gillies, M 
Gillies, WE 
Glasson, WJ 
Glastonbury, J 
Gnanaharan, P 
Goddard, SJ 
Godfrey, S 
Goggin, M 
Golchin, B 
Goldberg, I 
 
 
 
 
Gole, G 
Gormley, P 
Greer, DV 
Gregor, DJ 
Gregory, EM 
Grice, MJ 
Griffits, RKS 
Groeneveld, E 
Grover, VK 
Gullifer, KP 
Hall, AJH 
Hall, DR 
Hall, P 
Halley, RM 
Ham, B 
Hammerton, M 
Handley, DE 
Hardy Smith, P 
Harkness, MM 
Harris, A 
Harrisberg, BP 
Harrison, MR 
Hart, DRL 
Hatfield, E 
Hauptman, O 
Haybittel, M 
Hayes, P 
Haymet, BT 
Heery, SE 
Hefferan, W 
Heine, DI 
Heiner, PC 
Heinze, JB 
Henderson, RG 
Henderson, T 
Hennessy, M 
Henry, JG 
Heron, H 
Heyworth, P 
Hill, GO 
Hipwell, GC 
Hirst, L 
Ho, R 
Hobbs, I 
Hodson, T 
Hollows, FC 
Hoole, GA 
Hornbrook, JW 
House, PH 
Howes, F 
Howsam, GN 
Hughes, PH 
Hunter, GT 
Hunyor, A 
Hurley, I 
Hutchinson, B 
Ingham, P 
Irvine, S 
Isbell, G 
Jacobi, L 
 
 
 
 
Jamieson, IW 
Jaross, N 
Johnson, GW 
Jones, S 
Jordan, AS 
Kappagoda, MB 
Karagiannis, A 
Karunaratne, D 
Kaufman, DV 
Kearney, RJ 
Keldoulis, T 
Kelly, AJ 
Kennedy, IH 
Kent, DG 
Kent, R 
Kevin, JBR 
Khannah, G 
King, AC 
Kingston, RA 
Kirkwood, RA 
Kitchen, D 
Knight, J 
Kokak, G 
Kokkinakis, J 
Koniuszko, GA  
Kosmin, A 
Kwong, RNK 
La Nauze, JH 
Lai Kwon, N 
Lam, CM 
Lam, GC 
Lamb, AM 
Landers, JAG 
Lane, MJ 
Lansdell, BJ 
Larkin, P 
Latimer, P 
Law, W 
Lawless, M 
Lawson, DJ  
Leber, GL 
Leckie, TD 
Lee, GA 
Lee, JH 
Lee, V 
Leikin, S 
Le May, M 
Lenton, LM  
Leppard, S 
Leunig, GA 
Liew, S 
Lillicrap, GR 
Lim, ASM 
Lindsay, R 
Lister, J 
Littlewood, KR 
Liu, HA  
Livingstone, E 
Lloyd, D 
Loane, M 
 
 
 
 
Australian Corneal Graft Registry Report  2007  7 
CONTRIBUTORS 
 
LIST OF CONTRIBUTORS 
 
 
Lockerbie, SE 
Lockie, P 
Lones, RI 
Loughnan, MS 
Lowe, DR 
Macken, P 
Mackey, DA 
Maclean, H 
MacRobert, I 
Madhok, P  
Mahmood, M 
Majzoub, U 
Maloof, A 
Mantzioros, N 
Maragoudakis, G 
Markwick, KC 
Martin, FJ 
Martin, PA 
Marton, S 
Materne, M 
McAuliffe, DJ 
McCartney, PJ 
McClellan, KA 
McCluskey, PJ 
McCombe, MF 
McDermott, ND 
McDonald, RA 
McGeorge, PA 
McGovern, RA 
McGovern, ST 
McGree, MD 
McGuinness, EF 
McGuinness, R 
McKay, AL 
McKay, DL 
McKinnies, C 
McLennan, M 
McKnight, D 
McNeil, G 
Meades, K 
Meagher, PJ 
Medownick, M 
Mele, EM 
Mills, R 
Milverton, EJ 
Minogue, MJ 
Moon, ME 
Moore, CE 
Moore, DC 
Moore, GGD 
Moore, MC 
Moran, DJ 
Morgan, MW 
Morgan, WH 
Morlet, GC 
Morlet, N 
Morton, MR 
Moshegov, C 
Mountford, J 
Mulligan, NB 
 
Munchenberg, P 
Munt, PC 
Murrell, I 
Nagle, F 
Nallari, L 
Nanda, U 
Nardi, W 
Nathan, F 
Newland, H 
Newman, J 
Newman, M 
Nicholls, SG 
Nicoll, AM 
Nixon, GK 
Noble, JA 
Noble, M 
North, IM 
Novakovic, P 
O'Brien, DP 
O'Callaghan, GJ 
O'Connor, C 
O'Connor, DM 
O'Connor, PA 
O'Day, J 
O'Donnell, BA 
O’Hagan, S 
Ohlrich, JG 
Ohlrich, S 
O'Leary, BJP 
O'Neill, JC 
Ong, K 
Painter, GT 
Parker, RW 
Pater, JB 
Patrick, RK 
Paul, R 
Pavy, IG 
Peachey, G 
Pearce, B 
Pellew, JH 
Perks, KC 
Perriam, DJ 
Perrin, R 
Peters, J 
Petsoglou, C 
Phillips, AJ 
Pigott, LJ 
Pittar, MR 
Pittar, YA 
Playfair, TJ 
Pluschke, ME 
Pluschke, WEW 
Poon, A 
Porter, GT 
Porter, WT 
Pradhan, JS 
Pyle, JD 
Pyne, RJ 
Quatermass, ME 
Qureshi, S 
Rait, J 
 
Ramani, V 
Ramsay, RJ 
Rathod, CB 
Rawson, LR 
Readshaw, GG 
Reich, JA 
Reich, P 
Renton, R 
Retsas, CW 
Rice, N 
Richards, J 
Richardson, P 
Riddington, L 
Rigg, RW 
Roberts, TV 
Robertson, IF 
Robinson, D 
Robinson, LP 
Robson, M 
Rodan, BA 
Roden, D 
Rogers, CM 
Rogers, JA 
Rose, MJA 
Rose, P 
Rosen, B 
Rosen, PA 
Rosenberg, AM 
Ross, C 
Ross, SM 
Ruddell, TJ 
Runciman, JC 
Russell, LJ 
Saareste, AG 
Sack, M 
Samuel, MV 
Saunders, BG 
Saunders, S 
Scales, WTH 
Scargill, SW 
Schiller, GM 
Scobie, MA 
Seawright, A 
Sebban, A 
Serdiuk, A 
Shanahan, LF 
Sharota, DT 
Sheppard, CL 
Siebert, S 
Silva, M 
Simon, A 
Simpson, MB 
Sindhu, K 
Singh, H 
Singh, I 
Slack, A 
Slade, JH 
Slade, MP 
Smiles, JJ 
Smith, G 
 
Smith, JEH 
Smith, RL 
Snibson, GR 
Somerville, G 
Southgate, D 
Spiro, HP 
Spring, TF 
Starling, D B 
Stasiuk, RM 
Steiner, M 
Steiner, MD 
Stern, H 
Stevens, P 
Stewart, ADH 
Stewart, PA 
Stubbs, GM 
Stuckey, GC 
Sullivan, FP 
Sullivan, L 
Sumich, PM 
Sutton, G 
Sutton, JE 
Tamblyn, DM 
Tang, KC 
Tangas, C 
Taylor, C 
Taylor, GAM 
Taylor, H 
Taylor, RF 
Tester, MP 
Thomas, CS 
Thompson, C 
Thomson, CW 
Thomson, GGB 
Thyer, HW 
Tibbs, GJ 
Tole, D 
Tolmie, N 
Toohey, MG 
Townsend, CL 
Tregenza, P 
Treloar, D 
Treplin, MCW 
Tridgell, DE 
Tye, AA 
Unger, H 
Vajpayee, R 
Vandeleur (Jnr), KW 
Vandeleur (Snr), KW 
Velez, S 
Verma, N 
Vernon, AC 
Versace, P 
Violi, C 
Vojlay, R 
Waite, S 
Waldie, MS 
Walker, A 
Walker, FA 
Walker, TD 
 
Walland, MJ 
Walsh, EM 
Walsh, MA 
Warburton, C 
Ward, WJ 
Watson, S 
Watt, B 
Watts, WH 
Waugh, ML 
Weber, A 
Wechsler, AW 
Weir, P 
Welch, R 
Wenas, H 
Westlake, W 
Westmore, RN 
Whaites, MA 
Whitehouse, CA 
Whitehouse, GM 
Whitford, JD 
Whitford, RF 
Whiting, M 
Whitney, JR 
Wicks, NS 
Wiffen, SJ 
Williams, NB 
Williams, RD 
Williams, W 
Willoughby, JG 
Wilson, BG 
Wilson, RG 
Wilson, T 
Win Law, W 
Windle, PL 
Wingate, RJB 
Wise, GM 
Wolfe, RJB 
Wong-See, J 
Woo, HY 
Wood, RFJ 
Woods, S 
Workman, D 
Worner, CM 
Worsnop, DP 
Worthley, DA 
Wunsh, MR 
Yates, WHB 
Young, SH 
Yow, CS 
Zabell, KW 
 
 
 
 
 
& Medical 
Superintendents of  
various hospitals. 
 
(n=591)
Australian Corneal Graft Registry Report 2007 
HOW TO READ KAPLAN MEIER GRAFT SURVIVAL PLOTS 
8 
 
 
HOW TO READ OUR KAPLAN-MEIER 
GRAFT SURVIVAL PLOTS 
 
 
1. The vertical axis shows the probability of graft survival. 
"Perfect" survival (no failures) equates to a probability of 1.0. 
It may help to think of this as 100% survival. 
 
2. The horizontal axis shows time elapsed since the event being 
considered - in this context, the date of graft.  
 
3. The numbers of recipients "at risk" (ie, being followed) at 
given times after graft are shown below the curves. At time 
zero, all patients in the given cohort are at risk. At the 
furthermost point on the right hand side of any curve, one 
patient in the cohort (the one who has been followed for the 
longest time) is at risk. 
 
 We suggest that you interpret the curves with this in mind. A 
sudden dramatic "dip" in survival at the far right of a given 
curve may merely mean, for example, that one of only two 
grafts that have been followed for this length of time has 
failed. 
 
 When the survival curve drops to zero, the probability of graft 
survival beyond that time is zero. This means that all grafts 
that have reached this time elapsed from graft have failed. It 
does not mean that all grafts in this stratum have failed. 
 
4. The p values shown have been calculated by log-rank 
analysis and reflect a comparison of the behaviour of the 
curves as a whole (taking all available data into 
consideration), rather than at any one time-point. 
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INTRODUCTION 
 
 
The Australian Corneal Graft Registry (ACGR) opened in May 
1985 and thus has now been in operation for over 22 years. 
However, the census date for this report was 01/09/2006. Over the 
years, we have collected data on more than 18,500 corneal grafts. 
The majority of corneal grafts registered have been penetrating, 
but increasing numbers of lamellar and limbal grafts have also 
been registered over recent years, as patterns of surgical practice 
change. 
 
At registration, we seek information on the recipient, the donor, the 
eye bank practices and the operative procedure. Follow-up then 
occurs at approximately yearly intervals for an indefinite period, 
and ceases upon loss of the graft, or the death or loss-to-follow-up 
of the patient. At each round of follow-up, we request information 
on the graft and visual outcome, and upon relevant post-operative 
events and treatments. 
 
The data are entered into an Access database and checked for 
consistency. Descriptive, univariate and multivariate analyses are 
subsequently performed using SPPS and Stata software, and the 
report is eventually collated. 
 
We thank all our many contributors for their tireless efforts on our 
behalf. We hope you enjoy reading this report and that it may be 
useful in your clinical practice. 
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1. OVERVIEW AND CONTRIBUTOR 
INFORMATION 
 
1.1 CURRENT DATABASE 
 
1.1.1 Synopsis of the current database 
 
A synopsis of the current state of the database is shown in Table 1.1.  For the purposes of 
this table, graft recipients who died or who were lost to follow-up with a surviving graft have 
been counted amongst those with surviving grafts.   
 
Table 1.1 Synopsis of the current database (CENSUS DATE 1/9/2006)  
 
 
Graft status 
Whole 
database 
Penetrating Lamellar Limbal 
 No. % No. % No. % No. % 
Number registered 18205 100% 17090 100% 1013 100% 102 100% 
Number followed 14158 78% 13350 78% 720 71% 88 86%
Followed for <1 year 2525 18% 2217 17% 280 24% 28 32%
Followed ≥1 & <2 years 3481 25% 3278 25% 180 27% 23 26%
Followed ≥2 & <4 years 3725 26% 3566 27% 136 29% 23 26%
Followed ≥4 & <6 years 1796 13% 1724 13% 65 10% 7 8%
Followed ≥6 & <8 years 1029 7% 996 7% 29 5% 4 7%
Followed ≥8 & <10 years 635 5% 623 5% 10 1% 2 4%
Followed ≥10 & <12 years 384 3% 375 3% 8 1% 1 1%
Followed ≥12 & <14 years 304 2% 300 3% 4 <1% - -
Followed ≥14 & <16 years 172 1% 167 1% 5 <1% - -
Followed ≥16 & <18 years 75 <1% 73 <1% 2 <1% - -
Followed ≥18 & <20 years 30 <1% 29 <1% 1 <1% - -
Followed ≥20 years 2 <1% 2 <1% - - - -
Recipient deaths 871 5% 835 5% 31 3% 5       5%
Total recipients lost  6174 34% 5779 34% 371 37% 24    24% 
Recipient loss to follow up 
within first year after graft 
1660 9% 1469 9% 178 18% 13 13% 
Lost in Register  1470 8% 1339 8% 121 12% 10 10% 
Grafts not yet followed 1037 6% 888 5% 146 14% 3 3%
Surviving when last seen 11070 78% 10456 78% 561 78% 48 55%
Failed when last seen 3088 22% 2894 22% 159 22% 40 45%
 
 
 
Penetrating grafts   94.0% of total database 
Lamellar grafts      5.5% of total database 
Limbal grafts       0.5% of total database 
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1.1.2 Survival of penetrating, lamellar and limbal grafts 
 
Kaplan-Meier plots of the survival of penetrating, lamellar and limbal corneal grafts are 
presented in Figure 1.1 (Log Rank Statistic=65.41; df=2; p<0.00001).  In these and all 
subsequent survival curves, the number of grafts at risk in each stratum is shown in the 
table immediately below the curves and graft survival at various intervals post graft is 
presented in the following table.  Thus, 13,350 penetrating grafts have been followed for 
periods of between approximately one to about twenty years, 720 lamellar grafts have been 
followed for between one and about eighteen years and 88 limbal grafts for between one 
and about ten years. At ten years post-graft all limbal grafts have failed, although there are 
some limbal grafts surviving at periods less than ten years. 
 
Figure 1.1  Survival of penetrating, lamellar and limbal corneal grafts 
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Number at Risk 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Penetrating 13350 5183 2372 1124 529 167 28 0 
Lamellar 720 162 56 26 11 4 1 n/a 
Limbal 88 21 4 2 n/a n/a n/a n/a 
 
Probability of graft survival  
(at years post-graft) Identity 
No. 
initially at 
risk 1 5 10 15 20 
Penetrating  13350 .865 .733 .615 .505 n/a 
Lamellar 720 .799 .692 .555 n/a n/a 
Limbal 88 .608 .419 .000 n/a n/a 
 
      n/a = not applicable 
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OVERALL CORNEAL GRAFT SURVIVAL 
TYPE OF GRAFT 
Penetrating corneal graft survival:  87% at 1 year 
 Mean Survival 12.41 years   73% at 5 years 
 (SE=0.15; 95% CI: 12.11, 12.72)  62% at 10 years 
 Median Survival approx. 16 years  50% at 15 years 
Lamellar corneal graft survival:   80% at 1 year 
 Mean Survival 11.36 years   69% at 5 years 
 (SE=0.64; 95% CI: 10.12, 12.61)  56% at 10 years 
 Median Survival approx. 14 years  
Limbal corneal graft survival:   61% at 1 year 
 Mean Survival 4.96 years   42% at 5 years 
 (SE=0.60, 95% CI: 3.79, 6.12)  0% at 10 years 
 Median Survival 4 years  
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability
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1.2 GRAFTS REGISTERED BY STATE, 
TERRITORY AND INDIVIDUAL  
 
1.2.1 Grafts entered by Australian state and territory 
 
The number of grafts entered from each state is shown in Table 1.2.  Percentages are 
calculated as proportions of the total number of grafts registered, n=18,205.  For the 
Kaplan-Meier plot, grafts performed in the NT have been included with the grafts for SA, 
and those performed in the ACT have been included in the NSW numbers.  
 
 
Table 1.2 Grafts entered and followed from each Australian state 
 
 TOTAL GRAFTS ENTERED TOTAL GRAFTS FOLLOWED 
State Penetrating Lamellar Limbal Penetrating Lamellar Limbal 
 No. % No. % No. % No. % No. % No. % 
NSW 6302 35% 550 3% 30 <1% 4611 25% 360 2% 21 <1%
VIC 3890 22% 118 <1% 15 <1% 3169 17% 81 <1% 13 <1%
QLD 2570 14% 79 <1% 2 <1% 2091 11% 63 <1% 1 <1%
WA 2052 11% 110 <1% 12 <1% 1385 8% 80 <1% 11 <1%
SA 1877 10% 109 <1% 39 <1% 1740 10% 92 <1% 38 <1%
TAS 383 2% 46 <1% 4 <1% 339 2% 43 <1% 4 <1%
ACT 14 <1% - - - - 14 <1% - - - - 
NT 2 <1% 1 <1% - - 1 <1% 1 <1% - - 
Sub-total 17090 94% 1013 6% 102 <1% 13350 73% 720 4% 88 <1%
TOTAL 18205 14158 
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Figure 1.2 compares the graft survival for each state (Log Rank Statistic=63.86; df=5; 
p<0.00001).  Individual states have been de-identified. 
 
Figure 1.2 Graft survival from each Australian state 
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Number At Risk 
 
Graft survival (at years post-graft) Identity 1 5 10 15 20 
State 1 .863 .728 .600 .490 .218 
State 2 .845 .708 .610 .536 n/a 
State 3 .871 .741 .622 .510 .343 
State 4 .874 .740 .602 .502 .190 
State 5 .870 .754 .661 .510 .359 
State 6 .707 .579 .483 n/a n/a 
 
 
Australian Corneal Graft Registry Report 2007 
OVERVIEW AND CONTRIBUTOR INFORMATION 
15
 
 
 
 
 
 
 
 
 
OVERALL CORNEAL GRAFT SURVIVAL 
BY STATE 
State 1:      86% at 1 year 
 Mean Survival 11.45 years   73% at 5 years 
 (SE= 0.23, 95% CI: 11.01, 11.90)  60% at 10 years 
 Median Survival approx. 14 years  49% at 15 years 
State 2:      85% at 1 year 
 Mean Survival 12.88 years   71% at 5 years 
 (SE = 0.32, 95% CI: 12.26, 13.51)   61% at 10 years 
 Median Survival approx. 17 years  54% at 15 years 
State 3:      87% at 1 year 
 Mean Survival 12.22 years   74% at 5 years 
 (SE= 0.25, 95% CI: 11.73, 12.70)  62% at 10 years 
 Median Survival approx. 16 years  51% at 15 years 
State 4:      87% at 1 year 
 Mean Survival 11.86 years   74% at 5 years 
 (SE = 0.34, 95% CI: 11.19, 12.53)   60% at 10 years 
 Median Survival approx. 16 years  50% at 15 years 
State 5:      87% at 1 year 
 Mean Survival 12.58 years   75% at 5 years 
 (SE = 0.37, 95% CI: 11.87, 13.30)   66% at 10 years 
 Median Survival approx. 16 years  51% at 15 years 
State 6:      71% at 1 year 
 Mean Survival 8.36years   58% at 5 years 
 (SE =0.46, 95% CI: 7.45, 9.26)   48% at 10 years 
 Median Survival approx. 9 years   
   
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability  
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1.2.2 Contributors in each state 
 
The numbers of contributing ophthalmologists and additional practitioners involved in 
recipient follow-up are shown in Table 1.3. The follow-up practitioners listed in Table 1.3 
are exclusive of contributing surgeons. Follow-up practitioners are mostly other 
ophthalmologists, but include general practitioners, optometrists and hospital registrars. 
Overall, 55% of contributors perform grafts.  
 
Table 1.3 Contributors in each state 
 
 Contributing 
Surgeons 
Follow-up 
Practitioners 
Number of contributors with ≥50 
records per state  
State No. % No.  % No. Graft total 
Surgeons Total / State Total 
% 
NSW 126 20% 79 13% 27 5707/6882 83% 
VIC 90 14% 49 8% 14 3066/4023 76% 
WA 48 8% 15 2% 10 1662/2174 76% 
SA 43 7% 31 5% 7 1679/2025 83% 
QLD 26 4% 75 12% 3 2536/2651 96% 
TAS 8 <1% 5 <1% 1 328/433 76% 
ACT 3 <1% 11 2% 0 0/14 0% 
NT 1 <1% 4 <1% 0 1/3 33% 
OVERSEAS - - 9 1% 0 - - 
Sub total 345 55% 278 45% 62 14979/18205 82% 
Total Contributors 623 (100%) 62 surgeons performed  
82% of the grafts 
 
 
It can be seen that 62 ophthalmologists, 18% of all contributing surgeons, contributed 82% 
of all registered graft records. 
 
 
 
1.2.3 The ‘centre effect’ 
 
69 surgeons have contributed 25 or more records with follow up for penetrating grafts. Of 
these, 27 surgeons also performed ≥25 penetrating grafts for keratoconus. Penetrating 
graft survival stratified by individual surgeons is shown in figures 1.3 & 1.4. 
 
Figure 1.3 shows graft survival for those grafts performed by surgeons that performed ≥25 
penetrating grafts with follow up for keratoconus (Log Rank Statistic=58.88; df=26; 
p<0.00001). 
 
Figure 1.4 shows graft survival for penetrating grafts performed by surgeons that performed 
≥25 penetrating grafts with follow up excluding those performed for keratoconus (Log rank 
Statistic=337.15; df=68; p<0.00001). 
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Figure 1.3 The centre effect:  penetrating grafts (keratoconus only) 
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Figure 1.4 The centre effect:  penetrating grafts (keratoconus excluded) 
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The centre effect exerts a strong influence on corneal graft survival.  Plainly, some of the 
observed variation in outcome can be attributed to marked variations in indications for graft 
within different practices. 
 
However the centre effect is also of significance when only grafts for keratoconus are 
considered, suggesting that intra-operative factors or post-operative management may 
influence graft outcome.   
 
1.2.4 Outcome: influence of surgeon workload per year 
 
Figure 1.5 shows the survival of all penetrating grafts for keratoconus performed by the 12 
surgeons with a workload of 25 or more penetrating grafts per year on average, compared 
with those whose workload is less than 25 grafts per year (Log Rank Statistic=22.08; df=1; 
p<0.00001).  
 
Figure 1.5 Number of grafts performed/year (penetrating grafts for keratoconus 
only) 
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Number At Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
≥ 25 grafts/year 2310 1072 561 322 161 64 10 n/a 
< 25 grafts/year 1856 886 462 227 120 41 8 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
≥ 25 grafts/year 2310 .978 .964 .921 .732 n/a 
< 25 grafts/year 1856 .960 .932 .843 .703 n/a 
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Figure 1.6 compares graft survival for grafts excluding those first grafts for keratoconus 
(Log Rank Statistic=14.22; df=1; p=0.0002). 
 
In both keratoconus and non keratoconus cases, graft survival is slightly but significantly 
better for those surgeons with a high workload. 
 
Figure 1.6 Number of grafts performed/year (penetrating grafts only, keratoconus 
excluded) 
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Number At Risk 
 
Identity Initially  3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
≥ 25 grafts/year 4124 1460 585 262 109 25 2 n/a 
< 25 grafts/year 5060 1765 764 313 139 37 8 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
≥ 25 grafts/year 4124 .839 .647 .493 .396 n/a 
< 25 grafts/year 5060 .798 .615 .472 .340 n/a 
 
 
For the first time, there is a statistically significant difference in surgeon workload 
for both keratoconus and non-keratoconus cases.  Graft survival is higher for 
surgeons with a high workload. 
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PENETRATING CORNEAL GRAFT SURVIVAL  
KERATOCONUS ONLY: EFFECT OF CASE-LOAD 
≥ 25 grafts/year:     98% at 1 year 
 Mean Survival 16.88 years   96% at 5 years 
 (SE=0.24; 95% CI: 16.41, 17.35)  92% at 10 years 
 Median Survival approx. 19 years  73% at 15 years 
< 25 grafts/year:      96% at 1 year 
 Mean Survival 15.65 years   93% at 5 years 
 (SE=0. 30; 95% CI: 15.05, 16.25)  84% at 10 years 
 Median Survival approx. 18 years  70% at 15 years 
 
 
 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL  
KERATOCONUS EXCLUDED: EFFECT OF CASE-LOAD 
≥ 25 grafts/year:     84% at 1 year 
 Mean Survival 10.79 years   65% at 5 years 
 (SE=0.28; 95% CI: 10.24, 11.34)  49% at 10 years 
 Median Survival approx. 10 years  40% at 15 years 
< 25 grafts/year:      80% at 1 year 
 Mean Survival 9.95 years   62% at 5 years 
 (SE=0.24; 95% CI: 9.48, 10.42)  47% at 10 years 
 Median Survival approx. 10 years  34% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability  
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1.2.5 Outcome: according to era 
 
A comparison of graft survival since the Australian Corneal Graft Registry began is shown 
in Figure 1.7. Grafts performed in 4 year blocks, 1985-1988, 1989-1992, 1993-1996, 1997-
2000 and 2001-2006 were compared (Log Rank Statistic=39.15; df=4; p<0.00001). Graft 
survival appears significantly worse for those grafted in the 1993-1996 period. 
 
Figure 1.7 Graft outcome measured in groups of years (penetrating grafts only) 
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Number At Risk 
 
Identity Initially  3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
1985 - 1988 1689 813 518 319 236 122 28 0 
1989 - 1992 3551 1640 931 549 270 45 0 n/a 
1993 - 1996 2880 1275 654 256 23 n/a n/a n/a 
1997 - 2000 2730 1189 269 0 n/a n/a n/a n/a 
2001 - 2006 2500 266 0 n/a n/a n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
1985 - 1988    1689 .847 .729 .637 .566 n/a 
1989 - 1992    3551 .856 .735 .632 .483 n/a 
1993 - 1996    2880 .848 .696 .536 n/a n/a 
1997 - 2000    2730 .881 .745 .554 n/a n/a 
2001 - 2006    2500 .895 .379 n/a n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
STRATIFIED BY ERA 
1985-1988:       85% at 1 year 
 Mean Survival 12.88 years   73% at 5 years 
 (SE=0.27; 95% CI: 12.36, 13.41)  64% at 10 years 
 Median Survival 17 years   57% at 15 years 
1989-1992:      86% at 1 year 
 Mean Survival 11.27 years   74% at 5 years 
 (SE=0.17; 95% CI: 10.93, 11.60)  63% at 10 years 
 Median Survival 14 years   48% at 15 years 
1993-1996:      85% at 1 year 
 Mean Survival 8.73 years   70% at 5 years 
  (SE=0.13; 95% CI: 8.48, 8.99)   54% at 10 years 
  Median Survival 11 years  
1997-2000:      88% at 1 year  
 Mean Survival 6.36 years   75% at 5 years 
 (SE=0.07; 95% CI: 6.23, 6.49)   55% at 10 years   
 Median Survival approx. 8 years   
2001-2006:      90% at 1 year 
 Mean Survival 4.25 years   38% at 5 years 
 (SE =0.04; 95% CI: 4.17, 4.34)    
 Median Survival 5 years    
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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1.2.6 Outcome: whether followed by contributing 
surgeon or another practitioner 
 
Figure 1.8 compares graft outcome for first grafts for keratoconus, stratified by whether the 
graft has been followed by the contributing surgeon or by another practitioner (Log Rank 
Statistic=6.63; df=1; p=0.0100).   
 
Figure 1.8   Follow-up surgeon/other practitioner - 1st graft for keratoconus only 
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Number At Risk 
 
Identity Initially  3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Followed by surgeon 3313 1497 785 421 218 77 13 n/a 
Followed elsewhere 912 470 241 131 65 29 5 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Followed by surgeon 3313 .963 .941 .880 .766 n/a 
Followed elsewhere 912 .986 .971 .899 .694 n/a 
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Figure 1.9 compares the outcome for all grafts excluding those performed for keratoconus, 
followed by the contributing surgeon or by another practitioner (Log Rank Statistic=174.57; 
df=1; p<0.00001). 
 
Graft survival is better when the patient is followed up elsewhere in both keratoconus and 
non keratoconus cases.  
 
Figure 1.9 Follow-up surgeon/other practitioner - keratoconus excluded 
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Number At Risk 
 
Identity Initially  3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Followed by surgeon 8127 2646 1074 458 197 42 7 n/a 
Followed elsewhere 1806   753   332 143   60 23 4 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Followed by surgeon 8127 .790 .595 .447 .331 n/a 
Followed elsewhere 1806 .919 .783 .635 .476 n/a 
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OVERALL CORNEAL GRAFT SURVIVAL  
FOLLOWUP SURGEON; KERATOCUS ONLY 
Followed by surgeon:     96% at 1 year 
 Mean Survival 16.23 years   94% at 5 years 
 (SE=0.22; 95% CI: 15.81, 16.66)  88% at 10 years 
 Median Survival approx. 19 years  77% at 15 years 
Followed elsewhere:    99% at 1 year 
 Mean Survival 16.58 years   97% at 5 years 
 (SE=0.38; 95% CI: 15.85, 17.32)  90% at 10 years 
 Median Survival approx. 19 years  69% at 15 years 
 
 
 
 
 
 
 
OVERALL CORNEAL GRAFT SURVIVAL  
FOLLOWUP SURGEON; KERATOCONUS EXCLUDED 
Followed by surgeon:     79% at 1 year 
 Mean Survival 9.77 years   60% at 5 years 
 (SE=0.20; 95% CI: 9.37, 10.17)  45% at 10 years 
 Median Survival approx. 9 years  33% at 15 years 
Followed elsewhere:    92% at 1 year 
 Mean Survival 12.55 years   78% at 5 years 
 (SE=0.36; 95% CI: 11.85, 13.25)  64% at 10 years 
 Median Survival approx. 16 years  48% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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1.3 SUMMARY OF OVERVIEW AND 
CONTRIBUTOR INFORMATION 
 
 As of 1st September 2006, 18205 grafts had been registered of which 94% 
were penetrating, 5.5% were lamellar, and 0.5% were limbal. 
 Overall, 78% of grafts have been followed on at least one occasion, 34% of 
grafts are known to be lost to follow-up, 5% of grafts can no longer be 
followed because of recipient death, and 22% of grafts have failed. 
 Penetrating corneal graft survival is 73% at 5 years. 
Lamellar corneal graft survival is 69% at 5 years. 
Limbal allograft survival is 42% at 5 years. 
 Corneal grafts have been entered into the Registry from all states and 
territories: NSW 38%, VIC 22%, QLD 14%, SA 12%, WA 11%, TAS 2%, 
ACT and NT <1%. 
 82% of grafts have been contributed by 18% of all contributing surgeons. 
 A centre effect operates within the database for grafts for keratoconus, and 
for all grafts excluding those performed for keratoconus. 
 Surgeons who perform 25 or more grafts per year on average appear to 
achieve better results in terms of graft survival than do those who perform 
fewer grafts.  
 Patients who were followed up by another practitioner have a better 
outcome compared with patients who were followed up by the surgeon. 
This is probably due to case selection. 
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2. DONORS AND EYE-BANKING 
 
2.1 CAUSE OF DONOR DEATH 
 
 
The major cause of donor death is listed in Table 2.1.  Diseases of the cardiac/circulatory 
system remain by far the most common cause of death in corneal donors, followed by 
strokes and other haemorrhages, and malignancies.   
 
Table 2.1 Causes of donor death 
 
Cause of death related to Number of 
eyes 
% 
Cardiac/circulatory system  5719 31% 
Cerebrovascular system 3122 17% 
Malignancy 2894 16% 
Trauma/accident/poisoning/medical misadventure 1900 11% 
Respiratory system 1861 6% 
Other specified cause 
 Includes: digestive system 391 
   nervous system  355 
   genitourinary system 281 
   cardiogenic shock 250 
1547 13% 
Unknown to ACGR 1138 6% 
Total 18181  100% 
 
 
24 grafts were performed using live donors and/or the cornea used was from the recipient’s 
contralateral eye. 
 
 
All Kaplan-Meier plots and associated tables in this chapter have been calculated 
using penetrating grafts only. 
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Kaplan-Meier survival curves for penetrating grafts for the most common causes of donor 
death are shown in Figure 2.1 (Log Rank Statistic=27.15; df=5; p<0.00001). 
 
Closer inspection revealed that 48% of corneas in the trauma/accidental death group were 
used for patients with keratoconus, compared with 27% in the cardiac group, 31% in the 
cerebrovascular group, 29% in the malignancy group 29% in other causes of death group 
and 26% in the respiratory group.  Further, 53% of the recipients in the trauma group were 
40 years of age or younger at the time of graft compared with 26% in the cardiac group, 
31% in the cerebrovascular group, 30% in the other cause of death group, 29% in the 
malignancy group and 26% in the respiratory group. When donors dying from trauma are 
removed from the analysis, there is no longer a significant difference amongst groups (Log 
Rank Statistic=4.02; df=4; p=0.403). 
 
Figure 2.1 Cause of donor death (penetrating grafts only) 
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Number At Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Cerebrovascular 2548 998 428 185 79 36 8 n/a 
Malignancy 2086 764 356 168 75 22 4 n/a 
Trauma/accident 1321 570 262 132 63 16 0 n/a 
Respiratory 1350 510 205 102 47 9 1 n/a 
Other 1169 457 194 72 35 7 1 n/a 
Cardiac/circulatory 3919 1536 724 339 157 58 11 n/a 
 
Graft survival (at years post-graft) 
Identity 
No. 
initially at 
risk 1 5 10 15 20 
Cerebrovascular 2548 .857 .735 .599 .521 n/a 
Malignancy 2086 .856 .709 .588 .474 n/a 
Trauma/accident 1321 .886 .800 .700 .600 n/a 
Respiratory 1350 .870 .723 .668 n/a n/a 
Other 1169 .868 .727 .597 n/a n/a 
Cardiac/circulatory 3919 .866 .719 .586 .479 n/a 
Australian Corneal Graft Registry Report 2007 29 
DONORS AND EYE-BANKING 
 
 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL  
CAUSE OF DONOR DEATH 
Cerebrovascular:     86% at 1 year 
 Mean Survival 11.98 years   73% at 5 years 
 (SE=0.30; 95% CI: 11.38, 12.57)  60% at 10 years 
 Median Survival 16 years   52% at 15 years 
Malignancy:      86% at 1 year 
 Mean Survival 11.75 years   71% at 5 years 
 (SE=0.32; 95% CI: 11.12, 12.38)   59% at 10 years 
 Median Survival 13 years   47% at 15 years 
Trauma/accident:     89% at 1 year 
 Mean Survival 12.63 years   80% at 5 years 
 (SE=0.29; 95% CI: 12.06, 13.19)   70% at 10 years 
 Median Survival 17 years   60% at 15 years 
Respiratory:     87% at 1 year 
 Mean Survival 12.55 years   72% at 5 years 
 (SE=0.33; 95% CI: 11.91, 13.19)  67% at 10 years 
 Median Survival approx. 15 years   
Other :      87% at 1 year 
 Mean Survival 12.89 years   73% at 5 years 
 (SE=0.47; 95% CI: 11.97, 13.81)   60% at 10 years 
 Median Survival approx. 15 years   
 
Cardiac/circulatory:    87% at 1 year 
 Mean Survival 12.11 years   72% at 5 years 
 (SE=0.26; 95% CI: 11.60, 12.62)  59% at 10 years 
 Median Survival 14 years   48% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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2.2 DONOR GENDER 
 
The gender of corneal donors continues to show the expected preponderance of males 
(Table 2.2), given the causes of donor death (see table 2.1). 
 
Table 2.2 Donor gender 
 
Penetrating 
grafts 
Lamellar 
grafts 
Limbal 
grafts 
Total Gender 
No. % No. % No. % No. % 
Male 10435 57% 544 3% 66 <1% 11045 61%
Female 5826 32% 412 2% 32 <1% 6270 34%
Unknown 829 5% 57 <1% 4 <1% 890 5%
TOTAL 17090 94% 1013 6% 102 <1% 18205 100%
 
2.3 DONOR AGE 
 
Donor age at death ranged from 11 days to 99 years.  The age distribution is plotted in 
histogram form in Figure 2.2. 
 
Figure 2.2 Donor age in decades 
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Figures 2.3, 2.4 and 2.5 show the influence of donor age on corneal graft survival.  Figure 
2.3 shows the influence of donor age in 20 year blocks on the cohort of penetrating grafts 
(Log Rank Statistic=100.66; df=4; p<0.00001). Corneal graft survival appears to be 
influenced by donor age when the total cohort is examined. 
 
Figure 2.3 Donor age in 20 year blocks (penetrating grafts only) 
 
TRIAL TIME (YEARS POST GRAFT)
21.0018.0015.0012.009.006.003.000.00
PR
O
BA
BI
LI
TY
 O
F 
G
RA
FT
 S
UR
VI
VA
L
1.0
0.8
0.6
0.4
0.2
0.0
>80 years
61-80 years
41-60 years
21-40 years
0-20 years
 
 
Number At Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
  0-20 years 982 443 216 118 48 10 0 n/a 
21-40 years 1313 547 281 145 71 20 2 n/a 
41-60 years 3583 1424 639 305 150 53 9 n/a 
61-80 years 6488 2445 1090 493 230 73 16 n/a 
  >80 years 975 322 146 63 30 11 1 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
  0-20 years  982 .896 .805 .709 .516 n/a 
21-40 years 1313 .893 .824 .737 .566 n/a 
41-60 years  3583 .883 .761 .633 .543 n/a 
61-80 years 6488 .852 .698 .576 .468 n/a 
  >80 years 975 .821 .656 .528 .426 n/a 
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Figure 2.4 shows the influence of donor age on grafts for keratoconus only (Log Rank 
Statistic=2.60; df=4; p=0.6268).  Donor age does not appear to affect graft survival in the 
subset of patients with keratoconus.  For further explanation of curves that drop to zero 
please refer to page 8. 
 
Figure 2.4 Donor age (penetrating grafts for keratoconus only) 
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Number At Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
  0-20 years 438 224 113 65 26 4 0 n/a 
21-40 years 680 319 167 86 42 13 1 n/a 
41-60 years 1368 614 287 150 76 34 6 n/a 
61-80 years 1521 726 408 225 123 46 11 n/a 
  >80 years 154 77 49 24 15 9 0 n/a 
 
Graft survival (at years post-graft) Identity  No. initially at risk 1 5 10 15 20 
  0-20 years  438 .972 .941 .855 .759 n/a 
21-40 years 680 .969 .951 .905 .696 n/a 
41-60 years  1368 .970 .952 .883 .737 n/a 
61-80 years 1521 .967 .946 .856 .697 n/a 
  >80 years 154 .984 .964 .920 .818 n/a 
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Figure 2.5 shows the influence of donor age on the survival of grafts performed for all 
indications excluding keratoconus (Log Rank Statistic=15.99; df=4; p=0.0030).  Some 
effect of donor age on graft survival is apparent in this cohort, with donors under 20 years 
achieving better than expected survival and those over 80 years appearing to have worse 
than expected survival rates. 
 
Figure 2.5 Donor age (penetrating grafts, keratoconus excluded) 
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Number At Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
  0-20 years 543 219 103 53 22 6 n/a n/a 
21-40 years 632 228 114 59 29 7 1 n/a 
41-60 years 2214 810 352 155 75 19 3 n/a 
61-80 years 4966 1719 682 268 107 27 5 n/a 
  >80 years 820 245 97 39 15 2 1 n/a 
 
Graft survival (at years post-graft) Identity  No. initially at risk 1 5 10 15 20 
  0-20 years  543 .834 .694 .589 .350 n/a 
21-40 years 632 .808 .683 .560 .440 n/a 
41-60 years  2214 .828 .643 .485 .393 n/a 
61-80 years 4966 .815 .616 .463 .342 n/a 
  >80 years 820 .787 .582 .426 .307 n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
DONOR AGE IN 20 YEAR BLOCKS 
 
0-20 years:      90% at 1 year 
 Mean Survival 12.33 years   80% at 5 years 
 (SE=0.35; 95% CI: 11.65, 13.02)  71% at 10 years 
 Median Survival 16 years   52% at 15 years 
21-40 years:      89% at 1 year 
 Mean Survival 13.78 years   82% at 5 years 
 (SE=0.41; 95% CI: 12.98, 14.58)  74% at 10 years 
 Median Survival 17 years   57% at 15 years 
41-60 years:      88% at 1 year 
 Mean Survival 13.04 years   76% at 5 years 
 (SE=0.29; 95% CI: 12.46, 13.62)   63% at 10 years 
 Median Survival 17 years   54% at 15 years 
61-80 years:      85% at 1 year 
 Mean Survival 11.88 years   70% at 5 years 
 (SE=0.21; 95% CI: 11.46, 12.29)   58% at 10 years 
 Median Survival 14 years   47% at 15 years 
>80 years:      82% at 1 year 
 Mean Survival 10.52 years   66% at 5 years 
 (SE=0.42; 95% CI: 9.69, 11.35)   53% at 10 years 
 Median Survival 11 years   43% at 15 years 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
DONOR AGE; KERATOCONUS ONLY 
 
0-20 years:      97% at 1 year 
 Mean Survival 15.07 years   94% at 5 years 
 (SE=0.40; 95% CI: 14.28, 15.86)  86% at 10 years 
 Median Survival 17 years   76% at 15 years 
21-40 years:      97% at 1 year 
 Mean Survival 16.20 years   95% at 5 years 
 (SE=0.58; 95% CI: 15.07, 17.34)  90% at 10 years 
 Median Survival 17 years   70% at 15 years 
41-60 years:      97% at 1 year 
 Mean Survival 15.81 years   95% at 5 years 
 (SE=0.29; 95% CI: 15.24, 16.37)   88% at 10 years 
 Median Survival approx.18 years  74% at 15 years 
61-80 years:      97% at 1 year 
 Mean Survival 16.33 years   95% at 5 years 
 (SE=0.28; 95% CI: 15.78, 16.89)   86% at 10 years 
 Median Survival approx. 18 years  70% at 15 years 
>80 years:      98% at 1 year 
 Mean Survival 15.88 years   96% at 5 years 
 (SE=0.44; 95% CI: 15.01, 16.75)   92% at 10 years 
 Median Survival approx. 17 years  82% at 15 years 
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PENETRATING CORNEAL GRAFT SURVIVAL 
DONOR AGE; KERATOCONUS EXCLUDED 
0-20 years:      83% at 1 year 
 Mean Survival 10.13 years   69% at 5 years 
 (SE=0.42; 95% CI: 9.31, 10.94)  59% at 10 years 
 Median Survival 13 years   35% at 15 years 
21-40 years:      81% at 1 year 
 Mean Survival 11.23 years   68% at 5 years 
 (SE=0.52; 95% CI: 10.22, 12.24)  56% at 10 years 
 Median Survival 12 years   44% at 15 years 
41-60 years:      83% at 1 year 
 Mean Survival 10.71 years   64% at 5 years 
 (SE=0.38; 95% CI: 9.97, 11.45)   48% at 10 years 
 Median Survival 10 years   39% at 15 years 
61-80 years:      81% at 1 year 
 Mean Survival 10.02 years   62% at 5 years 
 (SE=0.26; 95% CI: 9.51, 10.53)   46% at 10 years 
 Median Survival 9 years   34% at 15 years 
>80 years:      79% at 1 year 
 Mean Survival 8.93 years   58% at 5 years 
 (SE=0.51; 95% CI: 7.93, 9.93)   43% at 10 years 
 Median Survival 8 years   31% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
 
 
 
We return to the issue of donor age in chapter 8. 
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2.4 DEATH-TO-ENUCLEATION AND  
DEATH-TO-GRAFT TIMES 
 
Death-to-enucleation and death-to-graft times are shown in Table 2.4. Death-to-enucleation 
times were available for 97% of penetrating grafts, 95% of lamellar grafts and 99% of limbal 
grafts. Death-to-graft times were available for 84% penetrating, 77% lamellar and 85% 
limbal grafts respectively. 
 
Table 2.4       Corneal collection times for penetrating, lamellar and limbal grafts 
 
 Penetrating Grafts 
Time Total Median time 
in hours 
Range: 
hours (days) 
Death-to-enucleation times  16650 6       1-37   (0-3) 
Death-to-graft times 14440 62 2-999  (0-42) 
Death-to-graft times for 
storage in: 
    
MK medium 
Optisol 
CSM 
K-Sol 
Moist Pot 
4106 
5927 
3178 
645 
280 
  46 
  98 
  82 
118 
  21 
3-410  
3-999  
12-832  
8-783  
2-384 
(0-17) 
(0-42) 
(0-33) 
(0-35) 
(0-16) 
 
 Lamellar Grafts 
Time Total Median time 
in hours 
Range: 
hours (days) 
Death-to-enucleation times  965   8 1-59    (0-2) 
Death-to-graft times 768 145   7-1104  (0-46) 
Death-to-graft times for 
storage in: 
    
Moist Pot  
Optisol  
CSM  
MK medium 
398 
225 
68 
54 
178 
120 
244 
  81 
7-1104 
15-1000 
46-1067 
13–464 
(0-46) 
(0-42) 
(2-44) 
(0-19) 
 
 Limbal Grafts 
Time Total 
 
Median time 
in hours 
Range: 
hours (days) 
Death-to-enucleation times  101   6 1-17   (0-1) 
Death-to-graft times 87 37 6-999  (0-42) 
Death-to-graft times for 
storage in: 
    
Moist Pot  
Optisol 
MK medium 
CSM 
65 
14 
4 
4 
 32 
116 
 54 
327 
  6-999  
 27-349 
26-173 
100-665    
(0-42)  
(1-15) 
  (1-7) 
(4-28) 
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The influence of increasing death-to-enucleation time on penetrating graft survival is 
illustrated in Figure 2.6.  Death-to-enucleation times of 3 hours or less were compared with 
times of: over 3 hours and up to 6 hours; over 6 hours and up to 9 hours; over 9 hours and 
up to 12 hours; and over 12 hours. 
 
Figure 2.6 Death-to-enucleation times (penetrating grafts only) 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
>0 and ≤3 hours 3869 1730 900 475 232 79 9 n/a 
>3 and ≤6 hours 3673 1418 640 301 153 57 14 n/a 
>6 and ≤9 hours 2946 1079 464 198 88 17 3 n/a 
>9 and ≤12 hours 2043 692 273 108 37 12 1 n/a 
>12 hours 803 262 95 42 20 2 0 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
>0 and ≤3 hours 3869 .869 .754 .622 .491 n/a 
>3 and ≤6 hours 3673 .863 .734 .627 .543 n/a 
>6 and ≤9 hours 2946 .869 .711 .594 .419 n/a 
>9 and ≤12 hours 2043 .858 .713 .601 .423 n/a 
>12 hours 803 .867 .732 .643 .292 n/a 
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Of the 803 penetrating corneal grafts that were enucleated >12 hours after donor death, 
only 7 were >24 hours. The vast majority (603) were enucleated between 13-16 hours 
(inclusive) after donor death. These curves are not significantly different from each other 
(Log Rank Statistic=5.54; df=4; p=0.2365). 
 
 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
DEATH TO ENUCLEATION TIME 
>0 and ≤3 hours:     87% at 1 year 
 Mean Survival 12.30 years   75% at 5 years 
 (SE=0.21; 95% CI: 11.89, 12.71)   62% at 10 years 
 Median Survival 16 years   49% at 15 years 
>3 and ≤6 hours:     86% at 1 year 
 Mean Survival 12.77 years   73% at 5 years 
 (SE=0.27; 95% CI: 12.24, 13.29)  63% at 10 years 
 Median Survival 16 years   54% at 15 years 
>6 and ≤9 hours:     87% at 1 year 
 Mean Survival 11.15 years   71% at 5 years 
 (SE=0.27; 95% CI: 10.61, 11.68)   59% at 10 years 
 Median Survival 14 years   42% at 15 years 
>9 and ≤12 hours:     86% at 1 year 
 Mean Survival 11.85 years   71% at 5 years 
 (SE=0.40; 95% CI: 11.06, 12.64)  60% at 10 years 
 Median Survival approx. 14 years  42% at 15 years 
>12 hours:      87% at 1 year 
 Mean Survival 11.67 years   73% at 5 years 
 (SE=0.75; 95% CI: 10.19, 13.15)  64% at 10 years 
 Median Survival approx. 15 years  29% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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Figure 2.7 shows death-to-graft times stratified in number of days for penetrating grafts 
(Log Rank Statistic=11.08; df=7; p=0.1350). Death-to-graft time exerts no significant 
influence on graft survival. 
 
Figure 2.7 Death-to-graft times (penetrating grafts only) 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
1 day 1088 504 303 162 93 41 9 n/a 
2 days 2339 1044 529 263 132 49 11 n/a 
3 days 2421 1026 487 238 119 34 2 n/a 
4 days 2021 790 330 146 59 19 5 n/a 
5 days 1515 527 213 95 37 9 1 n/a 
6 days 1148 380 137 50 22 4 n/a n/a 
7 days 572 174 53 17 4 1 n/a n/a 
Over 7 days 394 138 57 26 11 2 n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
1 day 1088 .846 .723 .613 .533 n/a 
2 days 2339 .861 .736 .616 .512 n/a 
3 days 2421 .868 .736 .657 .508 n/a 
4 days 2021 .864 .721 .578 .508 n/a 
5 days 1515 .879 .742 .622 n/a n/a 
6 days 1148 .878 .762 .623 .266 n/a 
7 days 572 .844 .690 .442 n/a n/a 
Over 7 days 394 .846 .705 .588 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
DEATH TO GRAFT TIME 
1 day:      85% at 1 year 
 Mean Survival 12.22 years   72% at 5 years 
 (SE=0.34; 95% CI: 11.55, 12.88)  61% at 10 years 
 Median Survival 16 years   53% at 15 years 
2 days:      86% at 1 year 
 Mean Survival 12.24 years   74% at 5 years 
 (SE=0.30; 95% CI: 11.66, 12.82)  62% at 10 years 
 Median Survival 16 years   51% at 15 years 
3 days:      87% at 1 year 
 Mean Survival 12.17 years   74% at 5 years 
 (SE=0.25; 95% CI: 11.69, 12.65)  66% at 10 years 
 Median Survival 17 years   51% at 15 years 
4 days:      86% at 1 year 
 Mean Survival 12.08 years   72% at 5 years 
 (SE=0.33; 95% CI: 11.43, 12.73)  58% at 10 years 
 Median Survival 18 years   51% at 15 years 
5 days:      88% at 1 year 
 Mean Survival 12.82 years   74% at 5 years 
 (SE=0.47; 95% CI: 11.89, 13.75)  62% at 10 years 
 Median Survival 13 years    
6 days:      88% at 1 year 
 Mean Survival 11.07 years   76% at 5 years 
 (SE=0.37; 95% CI: 10.35, 11.79)  62% at 10 years 
 Median Survival 16 years   27% at 15 years 
7 days:      84% at 1 year 
 Mean Survival 9.01 years   69% at 5 years 
 (SE=0.54; 95% CI: 7.94, 10.07)  44% at 10 years 
 Median Survival 9 years   
Over 7 days:     85% at 1 year 
 Mean Survival 10.17 years   70% at 5 years 
 (SE=0.55; 95% CI: 9.08, 11.26)  59% at 10 years 
 Median Survival 12 years   
  
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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2.5 CORNEAL STORAGE MEDIA 
 
The corneal storage media in which donor corneas were preserved are shown in Table 2.5.   
 
Table 2.5 Corneal storage media 
 
Storage medium Penetrating Lamellar Limbal 
Optisol 7542 44% 289 29% 18 18% 
 
  
    
M-K medium 4549 27% 71 7% 7 7% 
 
  
    
CSM 3552 21% 78 7% 4 4% 
 
  
    
Moist pot 327 2% 509 50% 72 71% 
 
  
    
K-Sol 682 4% 22 2% - 
 
  
    
DexSol 187 1% - - 
 
  
    
Organ Culture 92 <1% 2 <1% - 
 
  
    
Frozen 1 <1% 20 2% - 
 
  
    
Unknown to ACGR 158 <1% 22 2% 1 <1% 
     
Total 17090   (100%) 1013 (100%) 102 (100%) 
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Figure 2.8 shows the influence of storage medium on survival of grafts (Log Rank 
Statistic=18.45; df=4; p=0.001). Type of storage medium significantly influences corneal 
graft survival, with Optisol performing better than other media. 
 
Figure 2.8 Storage media (penetrating grafts only) 
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Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Moist Pot 310 146 89 54 35 21 7 n/a 
M-K Medium 4363 2065 1197 666 352 129 21 n/a 
Superseded media* 3864 1627 763 320 125 13 0 n/a 
Organ culture 88 41 28 13 5 2 n/a n/a 
Optisol 4583 1242 259 47 6 n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Moist Pot 310 .830 .694 .648 .572 n/a 
M-K Medium 4363 .853 .722 .617 .514 n/a 
Superseded media* 3864 .860 .723 .589 .394 n/a 
Organ culture 88 .805 .729 .579 n/a n/a 
Optisol 4583 .886 .751 .567 n/a n/a 
 
* Superseded media: CSM, K-Sol and DexSol 
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PENETRATING CORNEAL GRAFT SURVIVAL 
STORAGE MEDIUM 
Moist Pot:      83% at 1 year 
 Mean Survival 12.61 years   69% at 5 years 
 (SE=0.58; 95% CI: 11.47, 13.75)  65% at 10 years 
 Median Survival 19 years   57% at 15 years 
M-K Medium:     85% at 1 year 
 Mean Survival 12.38 years   72% at 5 years 
 (SE=0.20; 95% CI: 11.99, 12.77)   62% at 10 years 
 Median Survival 16 years   51% at 15 years 
Superseded media:    86% at 1 year 
 Mean Survival 11.00 years   72% at 5 years 
 (SE=0.20; 95% CI: 10.61, 11.40)  59% at 10 years 
 Median Survival 13 years   39% at 15 years 
Organ culture:     80% at 1 year 
 Mean Survival 9.65 years   73% at 5 years 
 (SE=0.83; 95% CI: 8.03, 11.27)  58% at 10 years 
 Median Survival 13 years   
Optisol:      89% at 1 year 
 Mean Survival 9.16 years   75% at 5 years 
 (SE=0.21; 95% CI: 8.75, 9.57)  57% at 10 years 
          Median Survival 11 years    
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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2.5.1 Optisol storage time 
 
Figure 2.9 compares graft outcome for Optisol-preserved corneas stored for periods of  
0-48 hours, 49-96 hours, 97-144 hours and more than 144 hours (Log Rank Statistic=2.66; 
df=3; p=0.4475).  Corneal storage time in Optisol does not influence graft survival. It should 
be noted that 441 grafts preserved in Optisol had no storage time listed. 
 
Figure 2.9  Optisol storage time (penetrating grafts only) 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 15 years 
<=48 hours 1374 397 76 9 0 n/a 
49 - 96 hours 1306 380 64 14 1 n/a 
97-144 hours 1135 324 81 12 0 n/a 
>=145 hours 327 103 38 12 0 n/a 
 
Graft survival (at years post-graft) Identity No. initially  at risk 1 5 10 15 20 
<=48 hours 1374 .878 .746 .599 n/a n/a 
49 - 96 hours 1306 .893 .757 .562 n/a n/a 
97-144 hours 1135 .886 .749 .602 n/a n/a 
>=145 hours 327 .867 .731 .469 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
OPTISOL STORAGE TIME 
0 - 48 hours:     88% at 1 year 
 Mean Survival 8.99 years   75% at 5 years 
 (SE=0.28; 95% CI: 8.44, 9.53)  60% at 10 years 
 Median Survival approx. 12 years   
49 - 96 hours:     89% at 1 year 
 Mean Survival 9.10 years   76% at 5 years 
 (SE=0.46; 95% CI: 8.19, 10.01)  56% at 10 years 
 Median Survival 11 years   
97 - 144 hours:     89% at 1 year 
 Mean Survival 8.76 years   75% at 5 years 
 (SE=0.29; 95% CI: 8.19, 9.33)  60% at 10 years 
          Median Survival approx. 12 years   
≥145 hours:      87% at 1 year 
 Mean Survival 8.18 years   73% at 5 years 
 (SE=0.40; 95% CI: 7.39, 8.97)  47% at 10 years 
 Median Survival 10 years   
  
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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2.6  DONOR PROCUREMENT SOURCE 
 
Figure 2.10 shows the influence of donor procurement source on corneal graft survival  
(Log Rank Statistic=19.24; df=5; p<0.002).  For the Kaplan-Meier curve below, the Eye 
Banks have been de-identified. Procurement sources included the Eye Banks in SA 
(n=2004), QLD (n=1471), NSW (n=4439), WA (n=1233) and VIC (n=2500, including 60 
corneas procured from Victorian Forensic Pathology) and corneas that were privately 
procured, years ago, by the operating surgeon (n= 1703). Where a surgeon did not appear 
to have recorded an eye bank number, the graft was included with the eye bank of the 
State where it was sourced.  
 
Figure 2.10 Corneal procurement source (penetrating grafts only) 
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Graft survival (at years post-graft) Identity 1 5 10 15 20 
Non eye bank  .873 .769 .661 .557 n/a 
Eye bank 1  .868 .728 .596 .452 n/a 
Eye bank 2  .877 .705 .556 n/a n/a 
Eye bank 3  .837 .706 .615 .521 n/a 
Eye bank 4  .866 .716 .553 n/a n/a 
Eye bank 5  .876 .775 .679 .502 n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
DONOR CORNEA PROCUREMENT SOURCE 
Private procurement:     87% at 1 year 
 Mean Survival 12.74 years   77% at 5 years 
 (SE=0.26; 95% CI: 12.24, 13.24)  66% at 10 years 
 Median Survival 17 years   56% at 15 years 
Eye bank 1:      87% at 1 year 
 Mean Survival 11.59 years   73% at 5 years 
 (SE=0.23; 95% CI: 11.15, 12.04)  60% at 10 years 
 Median Survival 16 years   45% at 15 years 
Eye bank 2:      88% at 1 year 
 Mean Survival 9.02 years   70% at 5 years 
 (SE=0.26; 95% CI: 8.52, 9.52)  56% at 10 years 
 Median Survival approx. 13 years   
Eye bank 3:      84% at 1 year 
 Mean Survival 12.55 years   70% at 5 years 
 (SE=0.31; 95% CI: 11.94, 13.16)  61% at 10 years 
 Median Survival 16 years   52% at 15 years 
Eye bank 4:      87% at 1 year 
 Mean Survival 8.92 years   72% at 5 years 
 (SE=0.17; 95% CI: 8.60, 9.25)  55% at 10 years 
 Median Survival 12 years   
Eye bank 5:      88% at 1 year 
 Mean Survival 12.87 years   77% at 5 years 
 (SE=0.41; 95% CI: 12.07, 13.67)  68% at 10 years 
 Median Survival 16 years   50% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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2.7 MULTI-ORGAN DONORS 
 
One thousand, one hundred and forty seven corneas, representing 6% of those registered, 
were collected from multi-organ donors and used for 1108 penetrating, 32 lamellar and 7 
limbal grafts.  Follow-up after graft has been recorded for 760 penetrating grafts, 18 
lamellar grafts and 6 limbal grafts.  Figure 2.11 shows the survival curve for the 760 
penetrating grafts for which follow-up is available (Log Rank Statistic=12.84; df=1; 
p=0.0003).  Graft survival is significantly better for corneas retrieved from multi-organ 
donors than from cadaveric donors. 
 
Figure 2.11 Multi-organ donors (penetrating grafts only) 
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Number at Risk 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Cadaveric donors 12590 4908 2292 1092 524 165 28 n/a 
Multi-organ donors 760 275 80 32 5 0 n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Cadaveric donors 12590 .863 .728 .612 .503 n/a 
Multi-organ donors 760 .899 .814 .634 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
MULTI-ORGAN DONORS 
Cadaveric donors:     86% at 1 year 
 Mean Survival 12.36 years   73% at 5 years 
 (SE=0.15; 95% CI: 12.05, 12.66)  62% at 10 years 
 Median Survival 16 years   50% at 15 years 
Multi-organ donors:    90% at 1 year 
 Mean Survival 11.23 years   81% at 5 years 
 (SE=0.45; 95% CI: 10.35, 12.10)  63% at 10 years 
 Median Survival approx. 15 years  
  
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
 
 
 
 
 
2.7.1 Multi-Organ Donors vs Cadaveric donors 
 
Tables 2.6, 2.7, 2.8, and 2.9 compare gender, age, cause of death, death-to-enucleation 
times and death-to-graft times of multi-organ donors and cadaveric donors. Multi-organ 
donors tend to be relatively younger than cadaveric donors, and are more likely to have 
died from cerebrovascular disease or trauma/accident/poisoning. 
 
Table 2.6 Gender of multi-organ donors 
 
 Multi-organ donors Cadaveric donors 
Gender No. of eyes % No. of eyes % 
Male 
Female 
Unknown to ACGR 
635 
492 
20 
55% 
43% 
2% 
10410 
5778 
870 
61% 
34% 
5% 
Total 1147 100% 17058 100% 
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Figure 2.12 Age of multi-organ donors 
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Figure 2.13 Cause of death of multi-organ donors 
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CAUSE OF DONOR DEATH 
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Table 2.9 Death-to-enucleation and death-to-graft times for multi-organ donors 
 
 Multi-organ donors Cadaveric donors 
 Death-to- 
enucleation 
time 
Death-to- 
graft time 
Death-to -
enucleation 
time 
Death-to-
graft time 
Median time 
(hours) 
2 66 6 69 
Range (hours) 1-23 3-802 1-59 2-1104 
Total number of 
grafts for which 
data are available 
1127/1147 904/1147 16589/17058 14402/17058 
 
 
 
 
2.8 PRIMARY NON-FUNCTIONING GRAFTS 
 
 
Grafts that fail to clear in the early post-operative period are considered to be primary  
non-functioning grafts (PNFs). 
 
Thus far, 137 PNFs have been recorded by 60 surgeons, out of 14158 grafts that have 
been followed.  This number represents penetrating, lamellar and limbal grafts. Of these, 
only 3 ‘pairs’ of cornea (from the same donor), representing 6 primary non-functioning 
grafts, have been recorded by the Australian Corneal Graft Registry.  The remaining 131 
primary non-functioning grafts were from separate donors. 
 
Table 2.10 shows features of corneas used in primary non-functioning grafts. 
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Table 2.10 Features of primary non-functioning grafts 
 
 
Feature No. % 
Procurement source:   
Private: 9     7% 
Eyebank: 128   93% 
1 75 55% 
4 23 17% 
3 17 12% 
5 6 4% 
2 7 5% 
Death to enucleation times   
≤6 hours 65 47% 
>6 hours 67 49% 
Not known to ACGR 5 4% 
Storage medium   
CSM 51 37% 
Optisol 47 34% 
MK medium 27 20% 
Moistpot 6 5% 
K-Sol 3 2% 
Unknown to ACGR 3 2% 
Donor age   
≤7 years 1 <1% 
>80 years 11 8% 
Main indication for graft   
Keratoconus (inc hydrops) 37 27% 
Pseudophakic bullous keratopathy 36 26% 
Previous failed graft 21 15% 
Aphakic bullous keratopathy 9 7% 
Fuchs' dystrophy 7 5% 
Scars 7 5% 
Interstitial keratitis/abscess 3 2% 
Peters' anomaly 2 1% 
Perforation 5 4% 
Miscellaneous 10 7% 
 
Total corneas 
 
137 
 
 
100% 
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2.9 SUMMARY OF DONOR AND EYE-
BANKING INFORMATION 
 
 The most common cause of donor death related to diseases of the 
cardiac/circulatory system, followed by strokes and other haemorrhages, 
and malignancy.  No influence of cause of donor death on graft survival 
was observed, other than that corneas collected from victims of traumatic or 
accidental death appeared to show improved survival.  However, such 
corneas were preferentially used for recipients with keratoconus.  
 Corneas used for transplantation were collected from men and women in 
the ratio of approximately 1.8:1. 
 Approximately 65% of corneas were retrieved from donors aged  
51-80 years at the time of death.  Donor age exerted no influence on 
survival of grafts performed for keratoconus, but for all other indications for 
penetrating keratoplasty, better survival was achieved with corneas from 
younger donors, at least in univariate analysis. 
 Median death-to-enucleation time for penetrating grafts was 6 hours.  
Median death-to-graft time was 62 hours.  Neither death-to-enucleation nor 
death-to-graft time affected corneal graft survival significantly. 
 Most corneas are currently stored in Optisol in Eye Banks.  Corneal storage 
time in Optisol does not affect graft survival. 
 Over 93% of all corneas used for transplantation were retrieved from non-
beating heart donors and 6% from multi-organ donors. The multi-organ 
donor pool has quite different characteristics from the pool from which the 
majority of corneas are drawn.  In particular, multi-organ donors tended to 
be younger and were more likely to have died from strokes/haemorrhage or 
from traumatic or accidental death than cadaveric donors. Corneas from 
multi-organ donors exhibited better survival after transplantation than did 
those from cadaveric donors.  
 Less than 1% of all corneas failed to function in the immediate post-
operative period. 
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3. RECIPIENTS   
 
 
3.1 RECIPIENT AGE AT GRAFT 
 
 
Recipient age at graft varied from 14 days to 97 years and 5 months with a median age of 
59 years.  Figure 3.1 shows the spread of recipient ages, with peaks in the  
20-40 and 60-80 age ranges. 
 
 
Figure 3.1 Age at graft 
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Except where indicated, all Kaplan-Meier plots and associated tables in this chapter 
have been calculated using penetrating grafts only. 
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Figure 3.2 shows graft survival for all penetrating grafts for keratoconus. Age at graft 
appears to have no significant effect on survival in this cohort (Log Rank Statistic=0.93;   
df=2; p= 0.6279). 
 
Figure 3.2 Recipient age (keratoconus only) 
TRIAL TIME (YEARS POST GRAFT)
21.0018.0015.0012.009.006.003.000.00
PR
O
B
A
B
IL
IT
Y 
O
F 
G
R
A
FT
 S
U
R
VI
VA
L
1.0
0.8
0.6
0.4
0.2
0.0
=>35 years
25 to 34 years
<=24 years
 
 
 
Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
≤24 years 1298 615 296 146 72 25 6 n/a 
25 - 34 years 1358 597 300 160 82 31 5 n/a 
≥35 years 1510 748 428 244 128 50 7 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
≤24 years 1298 .964 .946 .889 .805 n/a 
25 - 34 years 1358 .978 .958 .887 .805 n/a 
≥35 years 1510 .968 .946 .860 .754 n/a 
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Figure 3.3 shows graft survival for all penetrating grafts excluding keratoconus. The 
majority of recipients grafted for reasons other than keratoconus are aged over 70 years at 
the time of transplantation.  Age at graft appears to have no significant effect on graft 
survival when keratoconus is excluded (Log Rank Statistic=8.09; df=4; p=0.0885). 
 
Figure 3.3 Recipient age (keratoconus excluded) 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
≤44 years 1324 509 261 131 69 30 6 n/a 
45 - 59 years 1400 549 260 146 61 14 0 n/a 
60 - 69 years 1687 693 336 158 79 11 3 n/a 
70 - 79 years 2916 1039 382 115 36 6 1 n/a 
≥80 years 1852 432 109 25 2 n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
≤44 years 1324 .807 .674 .553 .429 n/a 
45 - 59 years 1400 .811 .623 .476 .320 n/a 
60 - 69 years 1687 .810 .616 .465 .342 n/a 
70 - 79 years 2916 .818 .617 .444 n/a n/a 
≥80 years 1852 .828 .622 .494 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
RECIPIENT AGE; KERATOCONUS ONLY 
Aged ≤24 years:     96% at 1 year   
  Mean Survival 17.05 years   95% at 5 years 
 (SE=0.31; 95% CI: 16.44, 17.65)  89% at 10 years 
 Median Survival 19 years   80% at 15 years 
 
Aged 25 to 34 years:     98% at 1 year 
 Mean Survival 16.03 years   96% at 5 years 
 (SE=0.36; 95% CI: 15.34, 16.73)  89% at 18 years 
 Median Survival 18 years   80% at 15 years 
 
Aged ≥35 years:     97% at 1 year 
 Mean Survival 16.17 years   95% at 5 years 
 (SE=0.29; 95% CI: 15.60, 16.74)   86% at 10 years 
 Median Survival approx. 17 years  75% at 15 years 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
RECIPIENT AGE; EXCLUDING KERATOCONUS 
Aged ≤44 years:     81% at 1 year 
 Mean Survival 11.04 years   67% at 5 years 
 (SE=0.38; 95% CI: 10.30, 11.77)  55% at 10 years 
 Median Survival 12 years   43% at 15 years 
 
Aged 45 - 59 years:     81% at 1 year 
 Mean Survival 9.25 years   62% at 5 years 
 (SE=0.28; 95% CI: 8.71, 9.79)  48% at 10 years 
 Median Survival 10 years   32% at 15 years 
 
Aged 60 - 69 years:     81% at 1 year 
 Mean Survival 10.30 years   62% at 5 years 
 (SE=0.36; 95% CI: 9.61, 11.00)   46% at 10 years 
 Median Survival 9 years   34% at 15 years 
 
Aged 70 - 79 years:     82% at 1 year 
 Mean Survival 9.66 years   62% at 5 years 
 (SE=0.29; 95% CI: 9.10, 10.22)   44% at 10 years 
 Median Survival 9 years    
 
Aged ≥80 years:     83% at 1 year 
 Mean Survival 8.76 years   62% at 5 years 
 (SE=0.31; 95% CI: 8.15, 9.37)   49% at 10 years 
 Median Survival 10 years    
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
p = probability  
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3.1.1 Infant, child and adolescent recipients 
 
3.1.1.1 Congenital abnormalities 
 
Eighty nine first ipsilateral grafts were performed for congenital abnormalities, including 
Peters’ anomaly (26), congenital glaucoma (19), aniridia (16), congenital cataract (13), 
congenital opacities (5), anterior segment anomalies (3), limbal dysplasia (1), congenital 
endothelial dystrophy (2), anophthalmos (1) and unspecified anomaly (3). 
 
Figure 3.4 shows the effect of Peters' anomaly or other congenital abnormality as the 
indication for graft (Log Rank Statistic=0.38; df=1; p=0.5394). Corneal grafts for these 
conditions were performed at any age, not just during childhood. 
 
Figure 3.4 Peters' anomaly or other congenital abnormalities 
(overall first grafts only) 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Peters’ anomaly  26 6 1 n/a n/a n/a n/a n/a 
Other congenital 
abnormalities 63 22 14 9 7 4 n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 2 8 15 20 
Peters’ anomaly  26 .709 .516 n/a n/a n/a 
Other congenital 
abnormalities 63 .698 .642 .562 .375 n/a 
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3.1.1.2 Paediatric recipients 
 
The Registry database has records of 710 penetrating graft recipients who were under the 
age of 20 years at the time of graft and who have been followed since graft.  Figure 3.5 
shows graft survival of recipients under the age of 20 years at the time of graft in 5 year 
blocks (Log Rank Statistic=87.86; df=3; p<0.0001). Recipients under 4 years old appear to 
have a significantly poorer graft survival rate than older recipients whilst those over 14 
years appear to have a significantly better graft survival rate.  
 
Figure 3.5 Paediatric recipients 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
0 – 4 years 63 23 13 8 7 4 n/a n/a 
5 – 9 years 26 10 8 5 3 n/a n/a n/a 
10 – 14 years 130 67 28 14 5 3 n/a n/a 
15 – 19 years 491 246 108 61 34 8 n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
0 – 4 years 63 .646 .497 .421 .280 n/a 
5 – 9 years 26 .810 .664 n/a n/a n/a 
10 – 14 years 130 .891 .823 n/a n/a n/a 
15 – 19 years 491 .948 .908 .863 n/a n/a 
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FIRST OVERALL CORNEAL GRAFT SURVIVAL 
CONGENITAL ABNORMALITIES 
Peters’ anomaly:     71% at 1 year 
 Mean Survival 6.11 years   52% at 2 years 
 (SE=1.16; 95% CI: 3.84, 8.38)    
 Median Survival approx. 5 years  
 
Congenital abnormality:     70% at 1 year 
 Mean Survival 9.76 years   64% at 2 years 
 (SE=1.09; 95% CI: 7.63, 11.90)  56% at 8 years 
 Median Survival 16 years   37% at 15 years 
 
 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
PAEDIATRIC RECIPIENTS  
Aged 0 - 4 years:     65% at 1 year 
 Mean Survival 7.66 years   50% at 5 years 
 (SE=1.09; 95% CI: 5.53, 9.79)  42% at 10 years 
 Median Survival 5 years   28% at 15 years  
 
Aged 5 - 9 years:      81% at 1 year 
 Mean Survival 8.66 years   66% at 5 years 
 (SE=1.31; 95% CI: 6.10, 11.22)   
 Median Survival approx. 7 years    
 
Aged 10 - 14 years:     89% at 1 year 
 Mean Survival 15.92 years   82% at 5 years 
 (SE=0.70; 95% CI: 14.54, 17.30)    
 Median Survival approx. 16 years    
 
Aged 15 - 19 years:     95% at 1 year 
 Mean Survival 15.98 years   91% at 5 years 
 (SE=0.36; 95% CI: 15.27, 16.69)   86% at 10 years 
 Median Survival approx. 18 years    
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
p = probability  
 
Australian Corneal Graft Registry Report 2007 61 
RECIPIENTS 
3.1.2 Elderly recipients 
 
The Registry database has records of 1,863 penetrating graft recipients who were over the 
age of 80 years at the time of graft and who have been followed since graft.  Figure 3.6 
compares graft survival of those recipients under 80 years of age at the time of graft with 
recipients over 80 years of age at time of graft (Log Rank Statistic=34.27; df=1; p<0.0001). 
Recipients over 80 years old appear to have a significantly poorer survival rate than 
younger recipients. However, as shown in figure 3.7, when stratified in groups of 80-84 
years, 85-89 years and 90 years of age and over at time of graft (Log Rank Statistic=0.39; 
df=2; p=0.8228) the survival rate is not significantly different over this age. 
 
Figure 3.6 Elderly recipients compared to younger recipients 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
0 to 79 years 11482 4748 2263 1099 527 167 28 n/a 
≥80 years 1863 434 109 25 2 n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
0 to 79 years 11482 .871 .744 .625 .513 n/a 
≥80 years 1863 .828 .623 .494 n/a n/a 
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Figure 3.7 Elderly recipients (over 80 years of age at graft) 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 15 years 
≥80 & <85 years 1177 305 87 10 2 n/a 
≥85 & <90 years 535 108 20 4 n/a n/a 
≥90 years 151 21 2 1 0 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially  at risk 1 5 10 15 
≥80 & <85 years 1177 .827 .620 .492 n/a 
≥85 & <90 years 535 .834 .626  n/a n/a 
≥90 years 151 .811 .574 n/a n/a 
 
Of the 151 recipients over 90 years of age, 125 received a first graft and 26 were being 
regrafted. A total of 28 grafts (19%) in the over 90 age group have failed. Of the 26 
regrafts, 11 have failed. 
 
The most common indication for graft in the over 90 age group was pseudophakic bullous 
keratopathy (52%).  The most common cause of graft failure was rejection (33%).  Of the 
151 recipients over 90 years of age at time of graft, the longest recorded survival time is 11 
years, with the patient still alive at the last follow-up. Of the 123 surviving grafts in this 
group, 71 patients were still alive at the last follow-up. Of the 54 graft recipients recorded 
as having died, all except 2 died with functioning grafts. 
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PENETRATING CORNEAL GRAFT SURVIVAL 
YOUNGER VERSUS ELDERLY RECIPIENTS 
<80 years of age:     87% at 1 year 
 Mean Survival 12.57 years   74% at 5 years 
 (SE=0.16; 95% CI: 12.27, 12.88)  62% at 10 years 
 Median Survival 16 years   51% at 15 years 
≥80 years of age:     83% at 1 year 
 Mean Survival 8.76 years   62% at 5 years 
 (SE=0.31; 95% CI: 8.15, 9.36)  49% at 10 years 
 Median Survival 10 years  
 
 
 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
VERY ELDERLY RECIPIENTS 
≥80 & <85 years of age:    83% at 1 year 
 Mean Survival 8.72 years   62% at 5 years 
 (SE=0.36; 95% CI: 8.02, 9.42)  49% at 10 years 
 Median Survival 10 years  
≥85 & <90 years of age:    83% at 1 year 
 Mean Survival 6.96 years   63% at 5 years 
 (SE=0.32; 95% CI: 6.33, 7.58)    
 Median Survival approx. 8 years   
≥90 years of age:     81% at 1 year 
 Mean Survival 6.87 years   57% at 5 years 
 (SE=0.88; 95% CI: 5.15, 8.60)   
 Median Survival 9 years    
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
p = probability  
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3.2 RECIPIENT GENDER 
 
Thus far, 8728 males and 8362 females have received penetrating grafts, 619 males and 
394 females have received lamellar grafts, and 67 males and 35 females have received 
limbal grafts.  Figure 3.7 shows the influence of recipient gender on penetrating corneal 
graft survival (Log Rank Statistic=0.35; df=1; p=0.5561).  Gender plays no significant role in 
graft survival overall. 
 
Figure 3.8 Recipient gender 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Female 6605 2663 1235 594 276 79 14 n/a 
Male 6745 2516 1137 530 253 88 14 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Female 6605    .868 .735 .615 .495 n/a 
Male 6745    .864 .730 .616 .516 n/a 
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Figures 3.9 and 3.10 examine the influence of donor-recipient gender match.  Figure 3.9 
compares survival of penetrating grafts performed for keratoconus, stratified according to 
the gender of donor and recipient. A significant effect becomes apparent when genders 
were mismatched (Log Rank Statistic=12.72; df=3; p=0.0053). The significant difference in 
p value appears to be due to a poorer survival rate when corneas from male donors are 
used for female recipients. There may be a biological explanation for this. 
 
Figure 3.9 Gender match (keratoconus only) 
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Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Donor & recipient female 591 292 164 100 57 26 2 n/a 
Donor male; recipient 
female 865 382 202 98 53 19 3 n/a 
Donor female; recipient 
male 1013 518 274 143 72 19 4 n/a 
Donor & recipient male 1476 645 314 167 87 37 8 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Donor & recipient female 591 .969 .945 .905 .870 n/a 
Donor male;  
recipient female 1013 .969 .949 .830 .562 n/a 
Donor female;  
recipient male 865 .979 .965 .909 .807 n/a 
Donor & recipient male 1476 .967 .943 .898 .687 n/a 
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Figure 3.10 shows survival curves stratified according to donor and recipient  
gender for all grafts performed for indications other than keratoconus  
(Log Rank Statistic=22.41; df=3; p<0.0001).  When indicators other than keratoconus are 
analysed, poorer survival rates become apparent when both donor and recipient were 
male. 
 
Figure 3.10 Gender match (keratoconus excluded) 
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Number at Risk 
 
Identity Initially  3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Donor & recipient 
female 1692 610 262 110 52 11 3 n/a 
Donor male; 
recipient female 2953 1077 443 192 80 20 4 n/a 
Donor female; 
recipient male 1428 469 203 87 43 11 n/a n/a 
Donor & recipient 
male 2599 857 343 141 43 17 3 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Donor & recipient both 
female 
1692 .827 .653 .491 .305 n/a 
Donor male;  
recipient female 2953 .831 .644 .511 .417 n/a 
Donor female;  
recipient male 1428 .807 .622 .481 .327 n/a 
Donor & recipient both 
male 
2599 .794 .588 .428 .258 n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
RECIPIENT GENDER 
Female:      87% at 1 year 
 Mean Survival 12.49 years   73% at 5 years 
 (SE=0.21; 95% CI: 12.07, 12.90)  61% at 10 years 
 Median Survival 15 years   49% at 15 years 
Male:       86% at 1 year 
 Mean Survival 12.34 years   73% at 5 years 
 (SE=0.22; 95% CI: 11.91, 12.78)  62% at 10 years 
 Median Survival 16 years   52% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
p = probability  
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PENETRATING CORNEAL GRAFT SURVIVAL 
GENDER MISMATCH; KERATOCONUS ONLY 
Donor & recipient both female:   97% at 1 year 
 Mean Survival 16.72 years   94% at 5 years 
 (SE=0.26; 95% CI: 16.21, 17.22)  90% at 10 years 
 Median Survival approx. 18 years  87% at 15 years 
Donor male & recipient female:   97% at 1 year 
 Mean Survival 15.35 years   95% at 5 years 
 (SE=0.41; 95% CI: 14.55, 16.15)  83% at 10 years 
 Median Survival 18 years   56% at 15 years 
Donor female & recipient male:   98% at 1 year 
 Mean Survival 17.10 years   96% at 5 years 
 (SE=0.39; 95% CI: 16.35, 17.86)  91% at 10 years 
 Median Survival approx. 19 years  81% at 15 years 
Donor & recipient both male:   97% at 1 year 
 Mean Survival 16.27 years   94% at 5 years 
 (SE=0.34; 95% CI: 15.60, 16.94)  90% at 10 years 
 Median Survival 19 years   69% at 15 years 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
GENDER MISMATCH; KERATOCONUS EXCLUDED 
Donor & recipient both female:   83% at 1 year 
 Mean Survival 9.85 years   65% at 5 years 
 (SE=0.32; 95% CI: 9.22, 10.49)  49% at 10 years 
 Median Survival 10 years   30% at 15 years 
Donor male & recipient female:   83% at 1 year 
 Mean Survival 10.94 years   64% at 5 years 
 (SE=0.34; 95% CI: 10.28, 11.61)  51% at 10 years 
 Median Survival 11 years   42% at 15 years 
Donor female & recipient male:   81% at 1 year 
 Mean Survival 9.05 years   62% at 5 years 
 (SE=0.28; 95% CI: 8.50, 9.61)  48% at 10 years 
  Median Survival 10 years   33% at 15 years 
Donor & recipient both male:   79% at 1 year 
 Mean Survival 9.51 years   59% at 5 years 
 (SE=0.35; 95% CI: 8.82, 10.20)  43% at 10 years 
 Median Survival 8 years   26% at 15 years 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
df = degrees of freedom 
p  = probability   
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3.3 PRE-GRAFT MORBIDITIES 
 
3.3.1 Vascularisation 
 
The effect of pre-graft vascularisation on graft outcome is shown in Figure 3.11. Graft 
survival decreases according to the number of quadrants of the cornea that contain vessels 
at the time of graft (Log Rank Statistic =894.02; df=4; p<0.00001). 
 
Figure 3.11 Pre-graft vascularisation, penetrating grafts 
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Identity Initially  3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Not vascularised 9062 3794 1837 908 432 141 24 n/a 
1 quadrant 861 285 94 27 8 1 n/a n/a 
2 quadrants 1449 520 205 95 50 7 1 n/a 
3 quadrants 749 262 120 53 26 14 3 n/a 
4 quadrants 1229 322 116 41 13 4 n/a n/a 
 
Graft survival (at years post-graft) 
Identity 
No. 
initially 
at risk 1 5 10 15 20 
Not vascularised 9062 .909 .810 .705 .580 n/a 
1 quadrant 861 .861 .655 .490 n/a n/a 
2 quadrants 1449 .795 .594 .479 .306 n/a 
3 quadrants 749 .761 .573 .419 .322 n/a 
4 quadrants 1229 .686 .453 .252 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
PREGRAFT CORNEAL NEOVASCULARIZATION 
Not vascularised:     91% at 1 year 
 Mean Survival 13.92 years   81% at 5 years 
 (SE=0.18; 95% CI: 13.56, 14.28)  70% at 10 years 
 Median Survival 17 years   58% at 15 years 
1 quadrant vascularised:    86% at 1 year 
 Mean Survival 9.95 years   65% at 5 years 
 (SE=0.44; 95% CI: 9.09, 10.81)  49% at 10 years 
 Median Survival 10 years  
2 quadrants vascularised:    79% at 1 year 
 Mean Survival 9.55 years   59% at 5 years 
 (SE=0.35; 95% CI: 8.86, 10.25)   48% at 10 years 
 Median Survival 10 years   31% at 15 years 
3 quadrants vascularised:    76% at 1 year 
 Mean Survival 9.11 years   57% at 5 years 
 (SE=0.47; 95% CI: 8.19, 10.03)   42% at 8 years 
 Median Survival 8 years   32% at 15 years 
4 quadrants vascularised:    69% at 1 year 
 Mean Survival 6.33 years   45% at 5 years 
 (SE=0.30; 95% CI: 5.74, 6.91)  25% at 10 years 
 Median Survival 5 years  
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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3.3.2 Inflammation 
 
Figure 3.12 shows the effect on graft outcome of first ipsilateral grafts where the eye had 
never been inflamed, compared with eyes that were inflamed at graft, or that had a history 
of inflammation in the past.  A history of inflammation was judged to have occurred in any 
graft where there had been a record of steroids being administered during the 2 week 
period prior to graft, or where the grafted eye had undergone previous surgery.   
 
Anterior segment inflammation at any time represents a significant factor for subsequent 
graft failure (Log Rank Statistic=1149.63; df=3; p<0.00001). 
 
Figure 3.12 Pre-graft inflammation 
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Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Never inflamed 5934 2764 1428 739 371 126 23 n/a 
Inflamed in past, not at graft,  3247 1082 413 169 73 17 1 n/a 
Not in past, inflamed at graft  300 91 34 10 7 1 n/a n/a 
Inflamed at graft and in past 1301 393 161 59 16 7 1 n/a 
 
Graft survival (at years post-graft) 
Identity 
No. 
initially 
at risk 1 5 10 15 20 
Never inflamed 5934  .954 .911 .824 .646 n/a 
Inflamed in past, not at graft, 3247  .854 .656 .506 .380 n/a 
Not in past, inflamed at graft 300  .710 .538 .395 n/a n/a 
Inflamed at graft and in past 1301  .737 .500 .368 n/a n/a 
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3.3.3 Intraocular pressure (pre-graft or at graft) 
 
The effect of raised intraocular pressure (IOP) on graft survival is shown in Figure 3.13.  
Recipients with raised pressure at time of graft and in the past are compared with 
recipients in whom there had been a history of raised pressure but who had a normal 
pressure at the time of graft, with those with raised pressure at graft but not in the past, and 
with those in whom raised intraocular pressure had never been recorded. Raised 
intraocular pressure at any time prior to, or at graft, is a significant risk factor for corneal 
graft failure (Log Rank Statistic=676.72; df=3; p<0.00001). 
 
Figure 3.13 Intraocular pressure (pre-graft/at time of graft) 
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Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Never raised 9825 4007 1859 883 413 137 22 n/a 
Raised in past only 1639 515 197 70 32 7 n/a n/a 
Raised at graft only 37 13 2 n/a n/a n/a n/a n/a 
Raised in both past and graft 331 112 45 19 12 n/a n/a n/a 
 
Graft survival (at years post-graft) 
Identity 
No. 
initially at 
risk 1 5 10 15 20 
Never raised 9825 .894  .795 .693 .582 n/a 
Raised in past only 1639 .747 .464 .281 .195 n/a 
Raised at graft only 37 .771 .507 n/a n/a n/a 
Raised in both past and graft 331 .735 .506 .381 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
EFFECT OF INFLAMMATION 
Never inflamed:     95% at 1 year 
 Mean Survival 15.84 years   91% at 5 years 
 (SE=0.21; 95% CI: 15.43, 16.26)  82% at 10 years 
 Median Survival 18 years   65% at 15 years 
Inflamed in past, not at graft:   85% at 1 year 
 Mean Survival 10.32 years   66% at 5 years 
 (SE=0.27; 95% CI: 9.79, 10.84)   51% at 10 years 
 Median Survival 11 years   38% at 15 years 
Not in past, inflamed at graft,:   71% at 1 year 
 Mean Survival 7.77 years   54% at 5 years 
 (SE=0.56; 95% CI: 6.66, 8.87)   39% at 10 years 
 Median Survival 7 years    
Inflamed at graft and in past:   74% at 1 year 
 Mean Survival 8.45 years   50% at 5 years 
 (SE=0.41; 95% CI: 7.65, 9.24)  37% at 10 years 
 Median Survival 6 years    
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
HISTORY OF RAISED IOP 
IOP never raised:     89% at 1 year 
 Mean Survival 13.57 years   79% at 5 years 
 (SE=0.18; 95% CI: 13.21, 13.93)  69% at 10 years 
 Median Survival 17 years   58% at 15 years 
IOP raised in past only:    75% at 1 year 
 Mean Survival 7.11 years   46% at 5 years 
 (SE=0.32; 95% CI: 6.49, 7.73)  28% at 10 years 
 Median Survival 5 years   19% at 15 years 
IOP raised at graft only:    77% at 1 year 
 Mean Survival 5.39 years   51% at 5 years 
 (SE=0.76; 95% CI: 3.90, 6.88)   
 Median Survival approx. 4 years   
IOP raised in both past and graft:  73% at 1 year 
 Mean Survival 7.08 years   51% at 5 years 
 (SE=0.44; 95% CI: 6.22, 7.95)  38% at 10 years 
 Median Survival 6 years   
 
 
KEY: n/a  =  not applicable   df = degrees of freedom 
 SE = standard error   p = probability 
 Cl = confidence interval 
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3.4 MAIN INDICATION FOR GRAFT 
 
Table 3.1 Main indications for penetrating keratoplasty 
 
Indication for graft Sub-total Total % 
Keratoconus   5395 32% 
Uncomplicated  5183   
With hydrops  193   
Keratoglobus  19   
Bullous keratopathy   4460 26% 
Pseudophakic  3493   
Aphakic  613   
Phakic pre-graft  217   
Unspecified  137   
Failed previous graft   3307 19% 
Endothelial decompensation    707   
Unspecified  594   
Keratoconus  493   
HSV/HZO  145   
Graft rejection     318   
Corneal dystrophies  165   
Perforation  138   
Non-herpetic infections  141   
 Abscess 83    
 Mycotic ulcer 24    
 Endophthalmitis 11    
 Pseudomonas 11    
 Miscellaneous 1  12    
Astigmatism  140   
Scars/opacities  122   
Primary non-functioning grafts  90   
Trauma  74   
Glaucoma  36   
Ulcer - unspecified  35   
Burns  28   
Descemetocoele  20   
Cataract  32   
Wound dehiscence  15   
ICE syndrome  14   
Corneal Dystrophy 
   
1249 
 
7% 
Fuchs' dystrophy  1047   
Granular dystrophy  50   
Lattice dystrophy  33   
Polymorphous dystrophy  26   
Macular dystrophy  24   
Crystalline dystrophy  11   
Anterior dystrophy  5   
Juvenile dystrophy  7   
Unspecified dystrophy  46   
Herpetic Eye Disease 
   
737 
 
4% 
Scar resulting from herpetic eye disease  435   
Active HSV  100   
Herpetic perforation  145   
HZO  13   
Scarring - result of HZO infection  44   
Corneal scars and opacities  
      (no history of herpetic disease) 
   
 
448 
 
 
3% 
Unspecified scars and opacities  397   
Trachomatous scar  43   
Possible current trachoma  8   
Corneal ulcers (non HSV) 
   
344 
 
2% 
Perforated  266   
Marginal, central or unspecified  53   
Recurrent erosions  11   
Scarring - result of marginal, central or unspecified ulcer  14   
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Indication for graft Sub-total Total % 
Accidental injury   289 1.7% 
Unspecified trauma  52   
Trauma (perforated)  8   
Scarring - result of trauma  172   
Burns   13   
Burns (perforated)  6   
Scarring - result of burns  38   
Non-herpetic infections   211 1.2% 
Corneal abscess  80   
Scarring - result of corneal abscess  30   
Mycotic ulcer  37   
Scarring - result of mycotic ulcer  2   
Acanthamoeba keratitis  18   
Scarring - result of Acanthamoeba keratitis  5   
Endophthalmitis  10   
Scarring - result of endophthalmitis  4   
Pseudomonas  8   
Scarring - result of Pseudomonas infection  8   
Syphilitic interstitial keratitis  5   
Scarring - result of syphilitic interstitial keratitis  1   
Streptococcus viridans  1   
Scleral abscess  2   
Interstitial keratitis   165 <1% 
Unspecified interstitial keratitis  131   
Scarring - result of interstitial keratitis  34   
Descemetocoele   62 <1% 
Unspecified descemetocoele  60   
Scarring – result of descemetocoele  2   
Congenital abnormalities   64 <1% 
Peters' anomaly  27   
Other 2  28   
Scarring - result of congenital abnormalities  9   
Corneal degenerations 3   109 <1% 
Metabolic deposits 4   37 <1% 
ICE syndrome   54 <1% 
Miscellaneous 5   119 <1% 
Unknown to ACGR   40 <1% 
TOTAL  17090 100% 
 
1 including Acanthamoeba (3); Streptococcus (2); Pneumococcus (1); candidiasis (1); aspergillosis (1); Fusarium (1); 
syphilitic interstitial keratitis (1); epidemic keratoconjunctivitis (1); unspecified mycoses (1).  
2 including corneal opacities (8); congenital cataracts (4); anomalies of anterior segment (3); congenital glaucoma (3); 
aniridia (3); microcornea (2); congenital syphilis (2); congenital endothelial dystrophy (2); congenital rubella (1).  
3 including corneal ectasia (63); unspecified corneal degeneration (14); rupture in Descemet's membrane (8); Salzmann's 
nodular dystrophy (7); unspecified corneal membrane change (6); macular degeneration (4); myopic degeneration (2); 
Terrien's marginal degeneration (2); keratomalacia (1);  discrete colliquative keratopathy (1); neurotrophic ulcer (1). 
4 including band shaped keratopathy (16); deposits associated with metabolic disorders (11); stromal pigmentations (4);  
unspecified corneal deposits (3);  calcareous degeneration (3). 
5 including astigmatism (22); cataract (20); neovascularisation (12); glaucoma (10); unspecified keratitis (9); patient’s other 
cornea used for autologous graft (6); corneal staphyloma (4); retinal detachment, defect or haemorrhage (4); squamous 
cell carcinoma (4); aphakia (4); benign neoplasm (3); epithelial defect (2); synechiae (2); corneal pannus (2); scleral 
disorders (2); corneal tuberculosis (1); gonococcal ophthalmia (1); Fusarium infection (1); cystinosis (1); BMH (benign 
monoclonal hypergammaglobulinemia) (1); porphyria (1); hypopyon (1); Fuchs’ heterochromic cyclitis (1); atopic 
keratoconjunctivitis (1); ocular cicatricial pemphigoid (1); Stevens-Johnson syndrome (1); rosacea keratitis (1); acquired 
keratoderma (1). 
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Figure 3.14 shows the survival curves for the main indications for graft as shown in Table 
3.1. (Log Rank Statistic= 1578.24; df=11; p<0.00001). 
 
Figure 3.14 Main indications for penetrating graft 
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Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Other 164 58 31 18 9 5 n/a n/a 
Keratoconus 4183 1964 1024 549 282 105 18 n/a 
Failed previous graft 2540 848 335 146 62 n/a n/a n/a 
Fuchs’ dystrophy and corneal 
dystrophies 946 444 227 99 43 9 3 n/a 
Bullous keratopathy 3535 1152 406 145 45 9 1 n/a 
Herpetic eye disease 587 256 133 74 39 13 3 n/a 
Scars (non-herpetic) 397 152 72 30 20 3 n/a n/a 
Accidental injury  247 90 39 14 5 1 n/a n/a 
Corneal degeneration or deformity 146 45 22 13 8 3 n/a n/a 
Interstitial keratitis 137 64 31 13 7 0 n/a n/a 
Specified, non-herpetic infections 139 31 18 6 3 n/a n/a n/a 
Ulcers 292 59 22 13 6 2 n/a n/a 
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Graft survival (at years post-graft) 
Identity 
No. 
initially  
at risk 1 5 10 15 20 
Other 164 .820 .589 .475 .317 n/a 
Keratoconus 4183 .970 .949 .886 .777 n/a 
Failed previous graft 2540 .749 .535 .365 n/a n/a 
Fuchs’ dystrophy and corneal 
dystrophies 946 .943 .834 .728 .547 n/a 
Bullous keratopathy 3535 .831 .596 .419 .239 n/a 
Herpetic eye disease 587 .860 .752 .588 .470 n/a 
Scars (non-herpetic) 397 .884 .774 .664  n/a n/a 
Accidental injury  247 .842 .700 .466 n/a n/a 
Corneal degeneration or deformity 146 .805 .665 .578 n/a n/a 
Interstitial keratitis 137 .923 .868 .696 n/a n/a 
Specified, non-herpetic infections 139 .660 .539 n/a n/a n/a 
Ulcers 292 .621 .450 .323 n/a n/a 
 
 
It should be noted that: 
 the curve for bullous keratopathy includes pseudophakic, aphakic and unspecified 
bullous keratopathy. 
 the curve for corneal dystrophy includes Fuchs' dystrophy, granular, lattice, 
polymorphous, macular, anterior, juvenile, crystalline and unspecified dystrophies. 
Fuchs’ dystrophy has been separated from other corneal dystrophies in section 
3.5.4. 
 the curve for herpetic eye disease includes active and non-active HSV and HZO. 
 the curve for scars and opacities (non-herpetic) does not include scars where 
ulcers, burns or trauma were the reason for graft. 
 non-herpetic infections include abscess, mycotic ulcer, endophthalmitis, 
Acanthamoeba keratitis and Pseudomonas infection. 
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PENETRATING CORNEAL GRAFT SURVIVAL 
INDICATION FOR GRAFT 
Other:      82% at 1 year 
 Mean Survival 9.34 years   59% at 5 years 
 (SE=0.74; 95% CI: 7.89, 10.80)   47% at 10 years 
 Median Survival 9 years   32% at 15 years 
Keratoconus:      97% at 1 year 
 Mean Survival 16.33 years   95% at 5 years 
 (SE=0.19; 95% CI: 15.96, 16.70)  89% at 10 years 
 Median Survival 19 years   78% at 15 years 
Failed previous graft:     75% at 1 year 
 Mean Survival 8.04 years   53% at 5 years 
 (SE=0.26; 95% CI: 7.53, 8.55)   36% at 10 years 
 Median Survival 6 years    
Fuchs’ dystrophy and corneal dystrophies:  94% at 1 year 
 Mean Survival 14.74 years   83% at 5 years 
 (SE=0.58; 95% CI: 13.61, 15.88)  73% at 10 years 
 Median Survival approx.17 years  55% at 15 years 
Bullous keratopathy:      83% at 1 year 
 Mean Survival 8.93 years   60% at 5 years 
 (SE=0.28; 95% CI: 8.39, 9.48)   42% at 10 years 
 Median Survival 8 years   24% at 15 years 
Herpetic eye disease:     86% at 1 year 
 Mean Survival 12.72 years   75% at 5 years 
 (SE=0.54; 95% CI: 11.65, 13.78)  59% at 10 years 
 Median Survival 17 years   47% at 15 years 
Scars (non-herpetic):    88% at 1 year 
 Mean Survival 10.86 years   77% at 5 years 
 (SE=0.44; 95% CI: 9.99, 11.72)   66% at 10 years 
 Median Survival approx. 14 years   
Accidental injury:      84% at 1 year 
 Mean Survival 9.65 years   70% at 5 years 
 (SE=0.73; 95% CI: 8.22, 11.08)   47% at 10 years 
 Median Survival 10 years    
Corneal degeneration or deformity:    80% at 1 year  
 Mean Survival 10.29 years   66% at 5 years 
 (SE=0.80; 95% CI: 8.72, 11.85)   58% at 10 years 
 Median Survival 14 years    
Interstitial keratitis:      92% at 1 year 
 Mean Survival 11.72 years   87% at 5 years 
 (SE=0.55; 95% CI: 10.65, 12.80)  70% at 10 years 
 Median Survival approx. 14 years   
Infections (non-herpetic):     66% at 1 year 
 Mean Survival 6.54 years   54% at 5 years 
 (SE=0.65; 95% CI: 5.26, 7.82)   
 Median Survival 6 years    
Ulcers:       62% at 1 year 
 Mean Survival 7.05 years   45% at 5 years 
 (SE=0.64; 95% CI: 5.80, 8.31)   32% at 10 years 
 Median Survival 4 years    
 
 
KEY: SE = standard error Cl = confidence interval 
 df = degrees of freedom p = probability 
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3.5 EFFECT OF SPECIFIC INDICATION FOR 
GRAFT ON GRAFT SURVIVAL 
 
3.5.1 Keratoconus, keratoconus with hydrops, 
keratoconus with Down syndrome, or keratoglobus 
 
The effects of uncomplicated keratoconus, keratoconus with acute hydrops, keratoconus 
with Down syndrome/intellectual disability, or keratoglobus as reasons for graft are shown 
in Figure 3.15. (Log Rank Statistic=90.16; df=3; p<0.00001). 
 
Figure 3.15 Keratoconus, keratoconus with hydrops, keratoconus with Down 
syndrome/intellectual disability, or keratoglobus 
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Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Keratoconus  4543 2103 1083 566 288 111 19 n/a 
Keratoconus with hydrops 132 53 18 10 4 n/a n/a n/a 
Keratoglobus 25 13 8 6 3 1 n/a n/a 
Keratoconus with Down 
syndrome 
59 28 18 11 4 1 n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Keratoconus  4543 .964 .933 .866 .750 n/a 
Keratoconus with hydrops 132 .906 .811 .695 n/a n/a 
Keratoglobus 25 .747 .588 .490 n/a n/a 
Keratoconus with Down 
syndrome 59 .789 .708 .480 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
KERATOCONUS 
Keratoconus:      96% at 1 year 
 Mean Survival 15.96 years   93% at 5 years 
 (SE=0.19; 95% CI: 15.60, 16.33)  87% at 10 years 
 Median Survival 19 years   75% at 15 years 
Keratoconus with hydrops:   91% at 1 year 
 Mean Survival 11.31 years   81% at 5 years 
 (SE=0.69; 95% CI: 9.96, 12.67)  69% at 10 years 
 Median Survival approx. 14 years   
Keratoglobus:     75% at 1 year 
 Mean Survival 8.94 years   59% at 5 years 
 (SE=1.53; 95% CI: 5.94, 11.94)  49% at 10 years 
 Median Survival 9 years   
Keratoconus with Down syndrome 
or intellectual disability:    79% at 1 year 
 Mean Survival 9.53 years   71% at 5 years 
 (SE=0.98; 95% CI: 7.61, 11.44)  48% at 10 years 
 Median Survival 10 years   
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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3.5.2 Bullous keratopathy 
 
Figure 3.16 shows the effect of transplantation for bullous keratopathy on the survival of a 
first ipsilateral graft.  Long term survival is plainly poor compared with survival in the 
remainder of the database (Log Rank Statistic=555.34; df=1; p<0.00001).  
 
Figure 3.16 Bullous keratopathy 
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Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Balance of database for 
first grafts 7210 3157 1618 828 421 141 24 n/a 
Bullous keratopathy 3535 1153 406 145 45 9 1 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 
for first grafts 
7210 .921 .860 .775 .678 n/a 
Bullous keratopathy 3535 .830 .599 .421 .240 n/a 
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Figure 3.17 compares graft survival for bullous keratopathy in aphakes and pseudophakes. 
There is no significant difference between the curves (Log Rank Statistic=1.47; df=1;  
p=0.226). 
 
Figure 3.17 Types of bullous keratopathy 
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Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Aphakic bullous 
keratopathy 463 159 59 24 11 3 0 n/a 
Pseudophakic bullous 
keratopathy 2751 878 297 97 26 4 1 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Aphakic bullous 
keratopathy 463 .799 .568 .428 .292 n/a 
Pseudophakic bullous 
keratopathy 2751 .836 .605 .445 .262 n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
BULLOUS KERATOPATHY 
Balance of database for first grafts:  92% at 1 year 
 Mean Survival 15.00 years   86% at 5 years 
 (SE=0.20; 95% CI: 14.61, 15.38)  77% at 10 years 
 Median Survival 18 years   68% at 15 years 
Bullous keratopathy:     83% at 1 year 
 Mean Survival 8.96 years   60% at 5 years 
 (SE=0.28; 95% CI: 8.41, 9.50)  42% at 10 years 
 Median Survival 8 years   24% at 15 years 
  
 
 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
APHAKIC AND PSEUDOPHAKIC BULLOUS KERATOPATHY 
Aphakic bullous keratopathy:    80% at 1 year 
 Mean Survival 8.72 years   57% at 5 years 
 (SE=0.57; 95% CI: 7.60, 9.84)  43% at 10 years 
 Median Survival 7 years   29% at 15 years 
Pseudophakic bullous keratopathy:  84% at 1 year 
 Mean Survival 9.24 years   60% at 5 years 
 (SE=0.37; 95% CI: 8.52, 9.96)  44% at 10 years 
 Median Survival 8 years   26% at 15 years 
  
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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3.5.3 Previous failed ipsilateral graft 
 
The influence of ipsilateral graft number is shown in Figure 3.18.  Graft survival falls with 
increasing graft number (Log Rank Statistic=738.20; df=4; p<0.00001). 
 
Figure 3.18 The effect of previous grafts in the grafted eye 
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Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
1st graft 10782 4330 2036 977 467 151 25 n/a 
2nd graft 1928 669 268 121 52 14 3 n/a 
3rd graft 449 133 54 21 8 2 n/a n/a 
4th graft 96 28 10 4 1 n/a n/a n/a 
5th & subsequent graft 95 23 4 1 n/a n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
1st graft 10782 .893 .781 .677 .575 n/a 
2nd graft 1928 .784 .575 .425 .252 n/a 
3rd graft 449 .683 .475 .238 n/a n/a 
4th graft 96 .649 .358 .111 n/a n/a 
5th & subsequent graft 95 .517 .181 n/a n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
GRAFT NUMBER 
1st graft:       89% at 1 year 
 Mean Survival 13.46 years   78% at 5 years 
 (SE=0.17; 95% CI: 13.12, 13.80)  68% at 10 years 
 Median Survival 17 years   57% at 15 years 
2nd graft:      78% at 1 year 
 Mean Survival 8.81 years   57% at 5 years 
 (SE=0.31; 95% CI: 8.20, 9.42)  42% at 10 years 
 Median Survival 8 years   25% at 15 years 
3rd graft:      68% at 1 year 
 Mean Survival 6.09 years   47% at 5 years 
 (SE=0.42; 95% CI: 5.26, 6.92)  24% at 10 years 
 Median Survival 5 years  
4th graft:      65% at 1 year 
 Mean Survival 4.56 years   36% at 5 years 
 (SE=0.58; 95% CI: 3.43, 5.70)  11% at 10 years 
 Median Survival 4 years  
5th and subsequent grafts:   52% at 1 year 
 Mean Survival 2.86 years   18% at 5 years 
 (SE=0.47; 95% CI: 1.93, 3.79)   
 Median Survival 2 years  
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability  
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3.5.3.1 The effect of reason for failure of a previous graft 
 
Figure 3.19 investigates the effect of different reasons for failure of a previous ipsilateral 
graft on the survival of the current graft. The data in this figure have been analysed taking 
into account cases where the main indication is failed graft. The secondary indication and 
primary and secondary presenting indications have been predicated as causation (Log 
Rank Statistic=145.86; df=8; p<0.00001). 
 
Figure 3.19 The effect of reason for failure of a previous graft 
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Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Primary graft failure 93 37 16 8 3 2 n/a n/a 
Unspecified graft failure 996 361 148 60 26 5 0 n/a 
Rejection 411 119 48 24 13 5 1 n/a 
Herpetic infection 199 68 27 12 7 1 n/a n/a 
Non viral infection 162 46 17 9 0 n/a n/a n/a 
Astigmatism 109 56 23 11 3 1 n/a n/a 
Corneal ulcer/perforation 78 10 1 n/a n/a n/a n/a n/a 
Corneal oedema 420 124 41 18 8 2 n/a n/a 
Glaucoma 90 29 14 3 2 n/a n/a n/a 
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Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Primary graft failure 93 .787 .723 .662 n/a n/a 
Unspecified graft failure 996 .813 .606 .422 .211 n/a 
Rejection 411 .670 .414 .292 .176 n/a 
Herpetic infection 199 .684 .438 .327 n/a n/a 
Non viral infection 162 .638 .431 .197 n/a n/a 
Astigmatism 109 .933 .801 .671 n/a n/a 
Corneal ulcer/perforation 78 .457 .263 .000  n/a n/a 
Corneal oedema 420 .770 .524 .316 n/a n/a 
Glaucoma 90 .678 .391  .096 n/a n/a 
 
 
 
Regrafts for astigmatism and primary graft failures appear to have better graft survival than 
those for other reasons, whilst those regrafted for infections, glaucoma and ulcers have a 
poorer graft survival. 
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PENETRATING CORNEAL GRAFT SURVIVAL 
REASON FOR FAILURE OF PREVIOUS GRAFT 
 
Primary graft failure:   
 Mean Survival 10.71 years   79% at 1 year 
 (SE=0.80; 95% CI: 9.13, 12.29)  72% at 5 years 
 Median Survival approx. 15 years  66% at 10 years 
 
Unspecified graft failure:    81% at 1 year 
 Mean Survival 8.56 years   61% at 5 years 
 (SE=0.36; 95% CI: 7.86, 9.26)  42% at 10 years 
 Median Survival 8 years   21% at 15 years 
 
Rejection: 
          Mean Survival 6.63 years   67% at 1 year 
 (SE=0.50; 95% CI: 5.64, 7.61)  41% at 5 years 
 Median Survival 3 years   29% at 10 years 
       18% at 15 years 
 
Herpetic infection: 
          Mean Survival 6.32 years   68% at 1 year 
 (SE=0.61; 95% CI: 5.12, 7.52)  44% at 5 years 
 Median Survival approx 4 years  33% at 10 years 
 
Non-Viral Infection: 
          Mean Survival 5.02 years   64% at 1 year 
 (SE=0.45; 95% CI: 4.14, 5.90)  43% at 5 years 
 Median Survival 4 years   20% at 10 years 
 
Astigmatism: 
          Mean Survival 11.17 years   93% at 1 year 
 (SE=0.86; 95% CI: 9.49, 12.85)  80% at 5 years 
 Median Survival 12 years   67% at 10 years 
 
Corneal ulcer/perforation: 
          Mean Survival 3.29 years   46% at 1 year 
 (SE=0.61; 95% CI: 2.08, 4.49)  26% at 5 years 
 Median Survival 1 year     0% at 10 years 
 
Corneal oedema: 
          Mean Survival 8.44 years   77% at 1 year 
 (SE=0.69; 95% CI: 7.09, 9.79)  52% at 5 years 
 Median Survival 6 years   32% at 10 years 
 
Glaucoma: 
 Mean Survival 4.20 years   68% at 1 year 
 (SE=0.50; 95% CI: 3.22, 5.19)  39% at 5 years 
 Median Survival 3 years   10% at 10 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom M   
 p = probability  
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3.5.4 Corneal dystrophy 
 
Figure 3.20 shows the survival of first grafts for Fuchs' dystrophy compared with other 
corneal dystrophies (Log rank Statistic=2.00; df=1; p=0.1577). 
 
Figure 3.20 Fuchs’ and other corneal dystrophies 
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Identity Initially  3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Fuchs’ dystrophy 1201 528 245 108 42 5 1 n/a 
Other dystrophies 171 89 47 26 16 5 2 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Fuchs’ dystrophy 1201 .941 .814 .694 n/a n/a 
Other dystrophies 171 .926 .878 .801 .526 n/a 
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Figure 3.21 separates out the graft survival for different types of corneal dystrophy. 
Dystrophies include macular dystrophy (22), lattice dystrophy (27), granular dystrophy (34), 
posterior polymorphous dystrophy (23), and a miscellaneous group which includes 
unspecified (46), Reis-Buckler’s syndrome (4), crystalline (11), and Meesman’s dystrophy 
(4).  The type of dystrophy does not appear to influence graft survival significantly  
(Log rank Statistic=6.10; df=5; p=0.296). 
 
Figure 3.21 Corneal Dystrophies 
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Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Fuchs’ dystrophy 1201 528 245 108 42 5 1 n/a 
Granular dystrophy 34 19 11 4 2 n/a n/a n/a 
Lattice dystrophy 27 n/a 8 2 1 1 0 n/a 
Macular dystrophy 22 10 4 1 n/a n/a n/a n/a 
Other dystrophies 65 33 20 16 11 4 2 n/a 
Posterior polymorphous 
dystrophy 
23 12 4 2 1 n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Fuchs’ dystrophy 1201 .941 .814 .694 n/a n/a 
Granular dystrophy 34 .971 n/a n/a .000 n/a 
Lattice dystrophy 27 n/a .900 n/a n/a n/a 
Macular dystrophy 22 .861 .574 n/a n/a n/a 
Other dystrophies 65 .920 .860 .806 .604 n/a 
Posterior polymorphous 
dystrophy 23 .870 .598 n/a n/a n/a 
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OVERALL CORNEAL GRAFT SURVIVAL 
FUCHS’ DYSTROPHY 
Fuchs’ dystrophy:      94% at 1 year 
 Mean Survival 14.50 years   81% at 5 years 
 (SE=0.46; 95% CI: 13.60, 15.40)  69% at 10 years 
 Median Survival approx. 20 years  
Other dystrophies:     93% at 1 year 
 Mean Survival 14.85 years   88% at 5 years 
 (SE=0.85; 95% CI: 13.18, 16.53)  80% at 10 years 
 Median Survival approx. 19 years  53% at 15 years 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
CORNEAL DYSTROPHIES 
Fuchs’ dystrophy:      94% at 1 year 
 Mean Survival 14.50 years   81% at 5 years 
 (SE=0.46; 95% CI: 13.60, 15.40)  69% at 10 years 
 Median Survival approx. 14 years   
Granular dystrophy:    97% at 1 year 
 Mean Survival 11.65 years   0% at 15 years 
 (SE=0.43; 95% CI: 10.81, 12.48)   
 Median Survival 12 years    
Lattice dystrophy:     90% at 5 years 
 Mean Survival 14.00 years    
 (SE=0.95; 95% CI: 12.14, 15.86)   
 Median Survival approx. 15 years  
Macular dystrophy:    86% at 1 year 
 Mean Survival 8.37 years   57% at 5 years 
 (SE=1.17; 95% CI: 6.09, 10.66)   
 Median Survival approx. 11 years  
Other dystrophies:     92% at 1 year 
 Mean Survival 15.44 years   86% at 5 years 
 (SE=1.08; 95% CI: 13.33, 17.56)  81% at 10 years 
 Median Survival approx. 19 years  60% at 15 years 
Posterior polymorphous dystrophy:  87% at 1 year 
 Mean Survival 9.71 years   60% at 5 years 
 (SE=1.27; 95% CI: 7.23, 12.20)   
 Median Survival approx. 9 years  
 
 
KEY: n/a  =  not applicable   df = degrees of freedom 
 SE = standard error   p = probability 
 Cl = confidence interval 
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3.5.5 Herpes simplex virus infection 
 
The effect of herpetic eye disease on a first graft is shown in more detail in Figure 3.22.  
Outcomes of grafts for inactive herpetic disease, active herpetic disease and for perforated 
herpetic ulcers are compared (Log rank Statistic=30.18; df=2; p<0.00001). 
 
Figure 3.22 The effect of herpetic eye disease on graft survival 
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Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Active HSV/HZO at graft 69 28 8 4 3 2 n/a n/a 
Perforated herpetic ulcer 113 32 17 9 5 2 n/a n/a 
Inactive HSV scar 404 199 111 60 31 8 2 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Active HSV/HZO at graft 69 .763 .502 .329 n/a n/a 
Perforated herpetic ulcer 113 .687 .534 .468 n/a n/a 
Inactive HSV scar 404 .889 .810 .613 .464 n/a 
 
Not surprisingly, graft survival is significantly poorer for recipients with active herpetic 
infection at the time of graft than for those with inactive disease. 
 
The major reason given for the failure of grafts performed for active herpetic infection is 
rejection (24%). However, in 20% of the grafts that have failed, there has been a 
recurrence of herpetic infection at some time during the post-graft period. 
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PENETRATING CORNEAL GRAFT SURVIVAL 
HSV INFECTION 
Active HSV/HZO at graft:    76% at 1 year 
          Mean Survival 9.05 years   50% at 5 years 
 (SE=1.50; 95% CI: 6.10, 12.00)  33% at 10 years 
 Median Survival 7 years    
Perforated herpetic ulcer:    69% at 1 year 
 Mean Survival 8.73 years   53% at 5 years 
 (SE=0.88; 95% CI: 7.00, 10.46)  47% at 10 years 
 Median Survival 10 years  
Inactive HSV scar:     89% at 1 year 
 Mean Survival 13.24 years   81% at 5 years 
 (SE=0.66; 95% CI: 11.95, 14.54)  61% at 10 years 
 Median Survival 17 years   46% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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3.5.6 Non-herpetic infections 
 
Graft survival for various infective indications for transplantation is shown in Figure 3.23.  
(Log Rank Statistic=31.64, df=4; p<0.00001). Corneal grafts performed for an abscess or 
interstitial keratitis appear to have better graft survival than those for other non-herpetic 
infections. 
 
Figure 3.23 Non-herpetic infections 
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Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Non-herpetic perforation 294 51 11 5 2 n/a n/a n/a 
Abscess/interstitial keratitis  368 133 67 22 9 2 n/a n/a 
Mycotic ulcer 78 15 4 1 n/a n/a n/a n/a 
Endophthalmitis 27 9 3 n/a n/a n/a n/a n/a 
Acanthamoeba 24 11 7 1 n/a n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Non-herpetic perforation 294 .592 .373 .224 n/a n/a 
Abscess/interstitial 
keratitis (not perforated) 368 .787 .672 .538 n/a n/a 
Mycotic ulcer 78 .537 .417 .000 n/a n/a 
Endophthalmitis 27 .611 .123 n/a n/a n/a 
Acanthamoeba 24 .750 .625 n/a n/a n/a 
Australian Corneal Graft Registry Report 2007 95 
RECIPIENTS 
 
 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
INFECTIONS 
Non-herpetic perforation:     59% at 1 year 
 Mean Survival 5.64 years   37% at 5 years 
 (SE=0.63; 95% CI: 4.42, 6.87)  22% at 10 years 
 Median Survival 3 years  
Abscess/interstitial keratitis 
(not perforated):     79% at 1 year 
 Mean Survival 9.33 years   67% at 5 years 
 (SE=0.49; 95% CI: 8.38, 10.29)  54% at 10 years 
 Median Survival 12 years   
 
Mycotic ulcer: 
         Mean Survival 4.55 years   54% at 1 year 
 (SE=0.63; 95% CI: 3.31, 5.78)  42% at 5years 
 Median Survival 2 years   0% at 10 years 
 
Endophthalmitis: 
          Mean Survival 3.18 years   61% at 1 year 
 (SE=0.59; 95% CI: 2.03, 4.33)  12% at 5 years 
 Median Survival 3 year  
 
Acanthamoeba: 
          Mean Survival 8.38 years   75% at 1 year 
 (SE=1.14; 95% CI: 4.84, 7.64)  62% at 5 years 
 Median Survival approx. 12 years   
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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3.5.7 Burns and trauma 
 
Outcome of first grafts performed for burns (chemical or thermal) or trauma is shown in 
Figure 3.24 (Log Rank Statistic=6.04, df=1; p=0.0140).  As might be expected, outcome of 
corneal transplantation following burns is rather poor. 
 
Figure 3.24 The effect of burns and trauma 
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Identity Initially  3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Trauma 269 96 41 16 5 1 n/a n/a 
Burns 65 21 8 3 2 n/a n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Trauma 269 .846 .706 .529 n/a n/a 
Burns 65 .730 .566 .220 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
BURNS AND TRAUMA 
Trauma:      85% at 1 year 
 Mean Survival 10.13 years   71% at 5 years 
 (SE=0.69; 95% CI: 8.78, 11.48)  53% at 10 years 
 Median Survival 11 years    
Burns:      73% at 1 year 
 Mean Survival 6.08 years   57% at 5 years 
 (SE=0.79; 95% CI: 4.53, 7.63)  22% at 10 years 
 Median Survival 6 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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3.5.9 Descemetocoele 
 
The influence of a descemetocoele as the indication for transplantation on the survival of a 
first graft is shown in Figure 3.25.  The presence of descemetocoele is a risk factor for graft 
failure (Log Rank Statistic=46.80; df=1; p<0.00001). 
 
Figure 3.25 The effect of descemetocoele on graft survival 
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Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Balance of database 10694 4302 2024 970 461 148 24 n/a 
Descemetocoele 88 28 12 7 6 3 n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 10694 .895 .783 .679 .578 n/a 
Descemetocoele 88 .646 .517 .414 .311 n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
DESCEMETOCOELE 
Balance of database:    89% at 1 year 
 Mean Survival 13.53 years   78% at 5 years 
 (SE=0.18; 95% CI: 13.19, 13.87)  68% at 10 years 
 Median Survival 17 years   58% at 15 years 
Descemetocoele:     65% at 1 year 
 Mean Survival 8.66 years   52% at 5 years 
 (SE=1.26; 95% CI: 6.20, 11.12)  41% at 10 years 
 Median Survival 6 years   31% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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3.6 SUMMARY OF RECIPIENT-RELATED 
FACTORS 
 
 The distribution of recipient age at graft is bimodal, with peaks at around 
20-40 years and around 60-80 years. 
 A weak influence of recipient age on graft survival is apparent. 
 Recipient gender does not influence graft survival, but there may be a weak 
effect of gender mismatch between donor and recipient. 
 The sequelae of corneal vascularisation, inflammation and raised IOP prior 
to, or at the time of graft, all exert significant negative influences on graft 
survival. 
 The main indications for penetrating keratoplasty are keratoconus (32%), 
bullous keratopathy (26%), failed previous graft (19%), corneal dystrophy 
(7%), and herpetic eye disease (4%).  These broad indications account for 
88% of penetrating grafts. 
 Graft survival for uncomplicated keratoconus and for the corneal 
dystrophies is very good.  Graft survival for bullous keratopathy, previous 
failed graft, burns, corneal ulcers, active HSV, infection, corneal 
perforations, endophthalmitis and mycotic ulcers is relatively poor. 
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4. PROCEDURES AT TIME OF 
GRAFT AND INFLUENCE OF 
INTRAOCULAR LENSES  
 
 
 
4.1 OPERATIVE PROCEDURES AT GRAFT 
 
 
4.1.1 Hostbed size of graft  
 
The hostbed size of the graft was recorded for 16,198 penetrating grafts, and ranged from 
2.0 mm to 16.0 mm.  Figure 4.1 shows the effect of graft size on the outcome of the 12,691 
followed grafts with recorded graft size (Log Rank Statistic=422.36; df=6; p<0.00001). 
Grafts sized between 7.5 mm and 8.5 mm fare better than grafts that are larger or smaller.  
 
Table 4.1 shows the reasons for failure of grafts of different sizes.  Rejection is the major 
cause of failure, except for very large grafts, where infection becomes a problem. No 
difference is apparent in the reason for failure amongst different graft sizes. 
 
 
All Kaplan-Meier plots and associated tables in this chapter have been calculated 
using penetrating grafts only. 
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Figure 4.1 Graft size 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Less than 7 mm 198 58 22 11 5 2 n/a n/a 
7.0 - 7.4 mm 1539 627 283 146 77 29 5 n/a 
7.5 – 7.9 mm 5526 2288 1101 536 246 76 12 n/a 
8.0 - 8.4 mm 4641 1753 789 361 172 53 10 n/a 
8.5 – 8.9 mm 510 169 56 25 12 3 n/a n/a 
9.0 – 9.9 mm 180 44 17 2 n/a n/a n/a n/a 
10.0 mm thru highest 97 16 5 2 n/a n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Less than 7 mm 198 .639 .505 .315 n/a n/a 
7.0 - 7.4 mm 1539 .832 .636 .515 .434 n/a 
7.5 – 7.9 mm 5526 .888 .767 .653 .520 n/a 
8.0 - 8.4 mm 4641 .885 .774 .668 .558 n/a 
8.5 – 8.9 mm 510 .805 .619 .490 n/a n/a 
9.0 – 9.9 mm 180 .705 .512 .189 n/a n/a 
10.0 mm thru highest 97 .442 .288 n/a n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
GRAFT SIZE 
<7.0 mm:      64% at 1 year 
 Mean Survival 7.56 years   50% at 5 years 
 (SE=0.83; 95% CI: 5.93, 9.19)  31% at 10 years 
 Median Survival 6 years   
≥7.0 – 7.4 mm:     83% at 1 year 
 Mean Survival 10.78 years   64% at 5 years 
 (SE=0.37; 95% CI: 10.06, 11.50)  51% at 10 years 
 Median Survival 11 years   43% at 15 years 
≥7.5 – 7.9 mm:     89% at 1 year 
 Mean Survival 12.83 years   77% at 5 years 
 (SE=0.24; 95% CI: 12.36, 13.29)  65% at 10 years 
 Median Survival 16 years   52% at 15 years 
≥8.0 – 8.4 mm:     88% at 1 year 
 Mean Survival 13.11 years   77% at 5 years 
 (SE=0.23; 95% CI: 12.66, 13.55)  67% at 10 years 
 Median Survival 17 years   56% at 15 years 
≥8.5 – 8.9 mm:     80% at 1 year 
 Mean Survival 9.47 years   62% at 5 years 
 (SE=0.51; 95% CI: 8.47, 10.47)  49% at 10 years 
 Median Survival 11 years   
≥9.0 – 9.9 mm:     70% at 1 year 
 Mean Survival 6.08 years   51% at 5 years 
 (SE=0.76; 95% CI: 4.59, 7.56)  19% at 10 years 
 Median Survival 6 years 
≥10.0 mm:      44% at 1 year 
 Mean Survival 4.55 years   29% at 5 years 
 (SE=1.09; 95% CI: 2.41, 6.68)   
 Median Survival 1 year 
 
 
 
KEY: n/a    =  not applicable 
 SE     = standard error 
 Cl      = confidence interval 
 df = degrees of freedom 
 p = probability 
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Table 4.1 Main reasons for graft failure according to hostbed size 
 
 
Graft 
size mm 
Total 
followed 
Total 
failed
% Main reasons for failure No. 
failed 
% 
<7.0 198 88 44% Rejection 24 27 
  Infection1 18 20 
  Endothelial cell failure 13 15 
  Unspecified failure 7 8 
  Glaucoma 6 7 
  Retinal detachment 3 3 
  Neovascularisation 3 3 
  Primary non-function 2 2 
       
7.0 - <8.5 11706 2361 20% Rejection 747 32 
  Endothelial cell failure 406 17 
  Infection2 314 13 
  Unspecified failure 258 11 
  Glaucoma 190 8 
  Primary non-function 112 5 
  Trauma 56 2 
  Neovascularisation 48 2 
  Epithelial defect 42 2 
  Scars and opacities 30 1 
       
8.5 - <9.0 510 141 28% Infection3 45 32 
  Rejection 39 28 
  Endothelial cell failure 14 10 
  Unspecified failure 12 8 
  Glaucoma 9 6 
  Trauma 4 3 
  Primary non-function 4 3 
       
≥9.0 277 128 46% Infection4 47 37 
  Rejection 34 27 
   Unspecified failure 9 7 
    Corneal melt 8 6 
    Endothelial cell failure 6 5 
    Glaucoma 5 4 
    Neovascularisation 4 3 
 
1 includes perforated ulcer (6); endophthalmitis (5); abscess (4); HSV (1); mycotic ulcer (1);  
phthisical eye (1). 
2 includes abscess (96); HSV (76); corneal ulcer (38); perforated ulcer (35); endophthalmitis (33);  
blind hypotensive eye (14); mycotic ulcer (9); pseudomonas (3); unspecified viral infection (3); 
streptococcus infection (2); Acanthamoeba (1); Fusarium (1); gonococcal infection (1); HZO (1); 
trachoma (1). 
3 abscess (8); HSV (7); mycotic ulcers (7); perforated ulcers (7); ulcers (7); Acanthamoeba (3);   
endophthalmitis (2); hypotony of eye (2); Pseudomonas infection (1); Streptococcus infection (1). 
4 mycotic ulcers (10); endophthalmitis (9); HSV (6); perforated ulcers (6); abscess (5); ulcers (3);   
Acanthamoeba (2); hypotony of eye (2); Pseudomonas infection (2); Streptococcus infection (1). 
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4.1.2 Accompanying procedures at graft 
 
Table 4.2 lists the operative procedures that took place at the time of graft for all 
penetrating grafts in the database; 7,543 procedures were carried out during 6,899         
graft operations (ie in 40% of the cohort). 
 
It should be noted that data are no longer collected on ECCE/ICCE or the type of 
intraocular lens.  Cataract extraction with an IOL inserted at the time of graft is categorised 
as a triple procedure. 
 
Table 4.2 Overview of operative procedures at graft 
 
Procedure Sub-total No. % of total grafts 
Procedures dealing with IOLs  2437 14% 
IOL removed and exchanged at graft 1373   
IOL inserted into aphakic eye 500   
Removal of IOL - patient left aphakic 270   
Cataract removed and patient left aphakic 195   
Reposition existing IOL 99   
Triple procedure   1743 10% 
Vitrectomy  1675 10% 
Iris procedures:  1229 7% 
 Peripheral iridectomy 981   
 Pupilloplasty 84   
 Iris repair/reconstruction 59   
 Synechiolysis 55   
 Division of anterior synechiae 50   
Glaucoma procedures:  113 <1% 
 Trabeculectomy 61   
 Valve (implant/trimming etc) 46   
 Cyclodialysis 6   
Tarsorrhaphy  58 <1% 
Sphincterotomy  36 <1% 
Gunderson flap/conjunctival flap  21 <1% 
Anterior segment clearance/wash  19 <1% 
Temporary keratoprosthesis  (9 inserted/1 removed)  10 <1% 
Retinal repair  8 <1% 
Miscellaneous other procedures  194 1% 
TOTAL PROCEDURES 7543 during 6899 graft operations 
(40%) 
TOTAL GRAFTS  17090 100% 
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4.1.3 Influence of vitrectomy 
 
The influence of vitrectomy, performed at the time of graft, on subsequent corneal graft 
survival is shown in Figure 4.2 (Log Rank Statistic=148.62; df=1; p<0.00001). 
 
Figure 4.2  Vitrectomy 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Balance of database 12007 4754 2202 1061 504 158 25 n/a 
Vitrectomy 1343 429 170 63 25 9 3 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 12007 .873 .751 .638 .527 n/a 
Vitrectomy 1343 .798 .559 .396 .258 n/a 
 
The main reasons for failure of grafts where a vitrectomy was performed at the time of graft 
were rejection (21%), bullous keratopathy and aphakia (10%), glaucoma (8%) and infection 
(3%). Of the 685 penetrating grafts that failed, 15 cases were reported to be primary non-
functions. 
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PENETRATING CORNEAL GRAFT SURVIVAL 
VITRECTOMY 
Balance of database:    87% at 1 year 
 Mean Survival 12.74 years   75% at 5 years 
 (SE=0.16, 95% CI: 12.41, 13.06)  64% at 10 years 
 Median Survival 16 years   53% at 15 years 
Vitrectomy:      80% at 1 year 
 Mean Survival 8.88 years   56% at 5 years 
 (SE=0.41, 95% CI: 8.09, 9.68)  40% at 10 years 
 Median Survival 6 years   26% at 15 years 
 
 
 
KEY: n/a    =  not applicable 
 SE     = standard error 
 Cl      = confidence interval 
 df = degrees of freedom 
 p = probability 
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4.1.4 Lens insertion 
 
Figure 4.3 compares graft survival for those recipients who were phakic, aphakic or 
pseudophakic at graft (and have remained so), with those recipients who had an IOL 
inserted or removed at the time of graft. Recipients undergoing an IOL insertion at the time 
of graft fare better than those retaining an existing intraocular lens, or those that remain 
aphakic (Log Rank Statistic=875.66; df=4; p<0.00001). 
 
Figure 4.3     Lens status before and after graft 
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 Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Aphakic pre & post graft 683 196 74 31 18 n/a n/a n/a 
Phakic pre & post graft 6513 2958 1522 798 394 140 24 n/a 
Pseudophakic pre & post graft  2575 3746 1153 380 123 39 4 n/a 
IOL inserted at time of graft 1972 756 354 157 73 18 2 n/a 
IOL removed at time of graft 242 81 28 9 3 1 n/a n/a 
 
Graft survival (at years post-graft) 
Identity 
No. 
initially at 
risk 1 5 10 15 20 
Aphakic pre & post graft 683 .721 .468 .292 n/a n/a 
Phakic pre & post graft 6513 .922 .859 .761 .644 n/a 
Pseudophakic pre & post graft 3746 .815 .580 .399 .248 n/a 
IOL inserted at time of graft 1972 .851 .697 .588 .451 n/a 
IOL removed at time of graft 242 .715 .504 .435 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
LENS STATUS 
Aphakic pre & post graft:    72% at 1 year 
 Mean Survival 6.97 years   47% at 5 years 
 (SE=0.45; 95% CI: 6.09, 7.86)  29% at 10 years 
 Median Survival 5 years   
Phakic pre & post graft:    92% at 1 year 
 Mean Survival 14.67 years   86% at 5 years 
 (SE=0.20; 95% CI: 14.28, 15.06)  76% at 10 years 
 Median Survival 18 years   64% at 15 years 
Pseudophakic pre & post graft:   81% at 1 year 
 Mean Survival 8.54 years   58% at 5 years 
 (SE=0.26; 95% CI: 8.02, 9.06)  40% at 10 years 
 Median Survival 7 years   25% at 15 years 
IOL inserted at time of graft:   85% at 1 year 
 Mean Survival 12.16 years   70% at 5 years 
 (SE=0.36; 95% CI: 11.46, 12.87)  59% at 10 years 
 Median Survival 13 years   45% at 15 years 
IOL removed at time of graft:   71% at 1 year 
 Mean Survival 9.47 years   50% at 5 years 
 (SE=0.80; 95% CI: 7.91, 11.03)  43% at 10 years 
 Median Survival 6 years   
 
 
 
KEY: n/a    =  not applicable 
 SE     = standard error 
 Cl      = confidence interval 
 df = degrees of freedom 
 p = probability 
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4.1.4.1 Triple and staged procedures 
 
Figure 4.4 compares the graft survival of triple and staged procedures with graft survival in 
those patients who underwent cataract removal at graft but who have remained aphakic 
(Log Rank Statistic=110.38. df=2, p<0.00001). 
 
Triple procedures are defined as cataract removal and IOL insertion at the time of corneal 
graft.  Staged procedures are defined as cataract removal at time of corneal graft and IOL 
insertion at some time after the graft, during the follow-up period. 
 
Figure 4.4 Triple versus staged versus cataract removal and continuing aphakic 
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Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Triple procedure 1325 533 255 112 52 12 1 n/a 
Staged procedure 372 220 121 58 26 8 1 n/a 
Cataract removal at graft, 
still aphakic 
114 32 12 4 1 n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Triple procedure 1325 .887 .775 .667 .546 n/a 
Staged procedure 372 .948 .813 .664 n/a n/a 
Cataract removal at 
graft, still aphakic 
114 .657 .358 .137 n/a n/a 
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We did not observe any significant difference in graft survival between the cohort who 
underwent a triple procedure compared with the cohort who underwent a staged procedure 
(Log Rank Statistic=2.63; df=1, p=0.1049).  However, both cohorts show significantly better 
graft survival than the cohort in whom a cataract was removed at the time of corneal 
transplantation, but who have remained aphakic (Log Rank Statistic=106.26; df=1, 
p<0.00001).  The main reasons for corneal graft failure in the group who underwent 
cataract removal at graft and who remained aphakic were: rejection (33%), endothelial 
defects (11%), glaucoma (9%), bullous keratopathy and endophthalmitis (6%) each 
(excludes cases (47) with an unspecified reason for failure).  
 
 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
TRIPLE AND STAGED PROCEDURES 
Triple procedure:     89% at 1 year 
 Mean Survival 13.73 years   77% at 5 years 
 (SE=0.45; 95% CI: 12.84, 14.61)  67% at 10 years 
 Median Survival approx. 16 years  55% at 15 years 
Staged Procedure:     95% at 1 year 
 Mean Survival 13.21 years   81% at 5 years 
 (SE=0.51; 95% CI: 12.22, 14.21)  66% at 10 years 
 Median Survival approx. 17 years   
Cataract removal at graft, still aphakic:  66% at 1 year 
 Mean Survival 4.92 years   36% at 5 years 
 (SE=0.65; 95% CI: 3.64, 6.21)  14% at 10 years 
 Median Survival 3 years 
 
 
 
KEY: n/a    =  not applicable 
 SE     = standard error 
 Cl      = confidence interval 
 df = degrees of freedom 
 p = probability 
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4.2 SUMMARY OF EFFECT OF 
PROCEDURES AT TIME OF GRAFT AND 
INFLUENCE OF INTRAOCULAR LENSES 
 
 Graft size is correlated with graft survival.  Grafts within the size range of 
about 7.5 to 8.5 mm in diameter fare best.  By comparison, larger and 
smaller grafts show reduced survival.  Rejection is a major cause of graft 
failure across all groups, but infection also causes the loss of large grafts. 
 In 40% of corneal grafts, some other specified procedure was carried out 
at the same time.  The most frequently-performed of these procedures 
were a manipulation involving the crystalline lens or an intraocular lens 
(14%) and vitrectomy (10%). 
 Graft survival is poorer in aphakes than in phakic or pseudophakic 
recipients. 
 Graft survival does not differ between the cohorts who have undergone a 
triple procedure or a staged lens implant. 
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5. POST-GRAFT EVENTS 
 
5.1 REASONS FOR GRAFT FAILURE 
 
 
Table 5.1 lists the main reasons for failure of 2894 failed penetrating grafts. 
 
Table 5.1 Reason for graft failure 
 
Reason Sub-total Total % 
Rejection   886 31% 
not specified  707   
with endothelial cell failure  45   
with glaucoma  36   
with vascularisation  17   
with HSV  17   
with abscess  16   
with ulcer (includes 2 perforated)  12   
with corneal degeneration  5   
with epithelial defect  4   
with scars and opacities  4   
with retinal detachment  3   
with keratoconus/keratoglobus  2   
with ICE syndrome  2   
with trauma  2   
other  14   
     
Endothelial cell failure   602 21% 
primary graft failure  130   
with pseudophakic bullous keratopathy  142   
with bullous keratopathy  63   
with aphakic bullous keratopathy  8   
not specified  259   
     
Infection   377 13% 
HSV  92   
unspecified 57    
with rejection 8    
with endothelial cell failure 5    
with ulcers 5    
with perforation 4    
with abscess 3    
with neovascularisation 3    
with glaucoma 2    
with band-shaped keratopathy 1    
with ectasia 1    
with hypotony 1    
with scars 1    
with uveitis 1    
HZO  1   
Mycotic ulcers (3 of which were perforated)  25   
Perforated ulcers  57   
unspecified 37    
with abscess 6    
with HSV 3    
with corneal degeneration 2    
with Stevens-Johnson syndrome 2    
other 7    
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Reason Sub-total Total % 
Corneal abscess  120   
unspecified 72    
with perforation 10    
with endophthalmitis 6    
with pseudomonas infection 6    
with rejection 5    
with scars 4    
with glaucoma 3    
with endothelial cell failure 2    
with dehiscence 2    
Other 10    
Endophthalmitis  55   
Pseudomonas  10   
Acanthamoeba  6   
Streptococcus  5   
Unspecified viral infection  2   
Epidemic keratoconjunctivitis (Shipyard eye)  1   
Fusarium  1   
Gonococcus  1   
Trachoma  1   
Glaucoma   235 8% 
with endothelial cell failure  30   
with rejection  18   
with congenital defect  4   
with epithelial defect  3   
with implantation cysts  3   
with uveitis  3   
with vascularisation  3   
with HSV  2   
with perforated ulcer  2   
with endophthalmitis  2   
Other   14   
not specified  151   
Vascularisation   50 2% 
Ulcers (unspecified)   47 2% 
Trauma   65 2% 
Epithelial defect   49 2% 
Scars and opacities   31 1% 
Unspecified corneal degeneration   29 1% 
Astigmatism   36 1% 
Phthisis bulbi   15 <1% 
Retinal detachment   10 <1% 
Iris disorders   21 <1% 
Wound dehiscence   10 <1% 
Hypotony   9 <1% 
Band-shaped keratopathy    8 <1% 
Descemetocoele    8 <1% 
Keratoconus    8 <1% 
Miscellaneous *   91 3% 
Unknown to ACGR   307 11% 
TOTAL   2894 100% 
 
* expulsive choroidal haemorrhage (7); dystrophies (7); corneal ectasia (6); keratitis (6); corneal membrane changes (5); 
calcareous degeneration of cornea (4); phthisical cornea (4); cataract (3); recurrent erosion of cornea (3); retinal vein 
occlusion (3); rheumatoid arthritis (3); squamous cell carcinoma (3); congenital defect (2); dacryoadenitis (2); dry eye 
syndrome (2); hypopyon (2); ICE syndrome (2); Stevens-Johnson syndrome (2); vitreous haemorrhage (2); aniridia (1); 
aphakia (1); anterior segment ischaemia (1); conjunctival cornea (1); conjunctival melanoma (1); conjunctival scarring (1); 
dysplasia (1); erythroderma (1); flat anterior chamber (1); keratoconus with hydrops (1); keratoglobus (1);  
lipid keratopathy (1); meibomianitis (1); Munchausen syndrome (1); ocular pemphigus (1); Peters' anomaly (1); 
pneumonia due to streptococcus (1); recurrent pterygium (1); Reis-Bucklers dystrophy (1); scleral necrosis (1);  
secondary cataract (1); silicone oil (1); trichiasis (1). 
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5.2 TIME TO SUTURE REMOVAL 
 
All Kaplan-Meier plots and associated tables in this chapter have been calculated 
using penetrating grafts only. 
 
Figure 5.1 shows the influence of time of suture removal on graft survival  
(Log Rank Statistic=161.80; df=4; p<0.0001). As observed in previous analyses, early 
suture removal is associated with an increased risk of graft failure.  Of the 538 grafts in 
which sutures were removed by 6 months post graft, 138 (25%) failed.   
 
Figure 5.1 Time from graft to suture removal 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Less than 6 months 538 172 94 49 24 9 3 n/a 
  6-12 months 1681 751 389 205 110 37 6 n/a 
12-18 months 2648 1275 562 274 132 49 5 n/a 
18-24 months 1178 601 252 104 52 22 4 n/a 
Over 24 months 1279 989 502 263 127 37 7 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Less than 6 months 538 .781 .710 .640 n/a n/a 
  6-12 months 1681 .912 .825 .756 .656 n/a 
12-18 months 2648 .959 .866 .725 .643 n/a 
18-24 months 1178 .965 .860 .745 .582 n/a 
Over 24 months 1279 .987 .891 .798 .680 n/a 
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The reasons for failure of these grafts are shown in Table 5.2. Reasons for graft failure in 
the cohort for early suture removal were very similar to that of the whole cohort. 
 
Table 5.2 Reasons for graft failure associated with removal of all sutures by        
<6 months post-operatively 
 
 
 
Reason for failure Sub-
total 
Total % 
Rejection  43 32% 
with oedema 3   
with recurrent ulceration  3   
with vascularisation 2   
with unspecified corneal degeneration 2   
with pannus 1   
with dry eye syndrome 1   
with stromal melt 1   
with glaucoma 1   
unspecified 29   
Endothelial cell failure  12 9% 
Infection  18 13% 
Mycotic ulcer 2   
Abscess 7   
HSV 5   
Endophthalmitis 4   
Glaucoma  12 9% 
with PBK 1   
with neovascularisation 1   
with chronic uveitis 1   
with peripheral synechiae 1   
with keratitis 1   
unspecified 7   
Neovascularisation  5 4% 
Ulcer  10 8% 
perforated 5   
central 2   
unspecified 3   
Trauma  2 1% 
Epithelial defect  3 2% 
Scars and opacities  2 1% 
Astigmatism  4 3% 
Phthisical eye  4 3% 
Miscellaneous¹  9 7% 
Unknown to ACGR  10 8% 
TOTAL  134 100%
¹    Includes:  retinal detachment (2); expulsive haemorrhage (1); descemetocoele (1); band shaped keratopathy (1); 
corneal ectasia (1); striate keratitis (1); recurrence of dystrophy (1); corneal melt (1); ocular ischaemia (1). 
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PENETRATING CORNEAL GRAFT SURVIVAL 
TIME TO SUTURE REMOVAL 
Less than 6 months:     78% at 1 year 
 Mean Survival 11.94 years   71% at 5 years 
 (SE=0.50; 95% CI: 10.96, 12.92)  64% at 10 years 
 Median Survival 18 years    
6-12 months:     91% at 1 year 
 Mean Survival 15.13 years   82% at 5 years 
 (SE=0.33; 95% CI: 14.48, 15.79)  76% at 10 years 
 Median Survival approx. 17 years  66% at 15 years 
12-18 months:     96% at 1 year 
 Mean Survival 14.42 years   87% at 5 years 
 (SE=0.28; 95% CI: 13.87, 14.96)  72% at 10 years 
 Median Survival 18 years   64% at 15 years 
18-24 months:     96% at 1 year 
 Mean Survival 14.41 years   86% at 5 years 
 (SE=0.42; 95% CI: 13.59, 15.22)  74% at 10 years 
 Median Survival 17 years   58% at 15 years 
Over 24 months:     99% at 1 year 
 Mean Survival 15.45 years   89% at 5 years 
 (SE=0.40; 95% CI: 14.67, 16.23)  80% at 10 years 
 Median Survival 17 years   68% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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5.3 POST-GRAFT COMPLICATIONS 
 
5.3.1 Microbial keratitis/stitch abscess 
 
The development of microbial keratitis or stitch abscess is associated with poor corneal 
graft survival (Log Rank Statistic=145.73; df=1; p<0.00001). 
 
Figure 5.2 Microbial keratitis/stitch abscess 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Balance of database 12971 5007 2286 1086 509 163 28 n/a 
Microbial keratitis or 
stitch abscess 
379 174 83 36 18 4 n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 12971 .871 .742 .628 .522 n/a 
Microbial keratitis or 
stitch abscess 379 .701 .490 .331 n/a n/a 
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5.3.2 Uveitis 
 
Post-operative uveitis is another risk factor for corneal graft failure (Log Rank            
Statistic= 22.99; df=1; p=<0.00001). 
 
Figure 5.3 Uveitis 
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Number at Risk 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Balance of database 13113 5045 2292 1081 504 159 28 n/a 
Uveitis 237 136 77 40 23 8 n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 13113 .867 .736 .621 .509 n/a 
Uveitis 237 .777 .593 .440 n/a n/a 
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5.3.3 Synechiae 
 
Development of synechiae is a risk factor for graft failure, as shown in Figure 5.4 (Log 
Rank Statistic= 56.45; df=1; p=<0.00001). 
 
Figure 5.4 Synechiae 
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Number at Risk 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Balance of database 13018 5027 2294 1084 514 162 26 n/a 
Synechiae 332 154 75 37 13 5 1 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 13018 .868 .738 .625 .515 n/a 
Synechiae 332 .762 .555 .374 .299 n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
MICROBIAL KERATITIS/STITCH ABCESS 
Balance of database:     87% at 1 year 
 Mean Survival 12.64 years   74% at 5 years 
 (SE=0.16; 95% CI: 12.33, 12.95)  63% at 10 years 
 Median Survival 16 years   52% at 15 years 
Microbial keratitis or stitch abscess:  70% at 1 year 
 Mean Survival 7.06 years   49% at 5 years 
 (SE=0.43; 95% CI 6.22, 7.91)  33% at 10 years 
 Median Survival 5 years    
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
UVEITIS 
Balance of database:     87% at 1 year 
 Mean Survival 12.49 years   74% at 5 years 
 (SE=0.16, 95% CI: 12.18, 12.79)  62% at 10 years 
 Median Survival approx. 16 years  51% at 15 years 
Uveitis:      78% at 1 year 
 Mean Survival 9.21 years   59% at 5 years 
 (SE=0.54, 95% CI: 8.14, 10.27)  44% at 10 years 
 Median Survival 8 years    
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
SYNECHIAE 
Balance of database:     87% at 1 year 
 Mean Survival 12.56 years   74% at 5 years 
 (SE=0.16, 95% CI: 12.25, 12.87)  62% at 10 years 
 Median Survival 16 years   51% at 15 years 
Synechiae:      76% at 1 year 
 Mean Survival 8.78 years   55% at 5 years 
 (SE=0.56, 95% CI: 7.68, 9.87)  37% at 10 years 
 Median Survival 8 years   30% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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5.3.4 Post-graft vascularisation 
 
The effect of post-graft vascularisation on graft survival is shown in Figure 5.5 
(Log Rank Statistic=318.07; df=1; p<0.00001). Graft neovascularisation is a significant risk 
factor for graft failure. 
 
Figure 5.5 Post-graft vascularisation 
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Number at Risk 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Balance of database 12367 4775 2168 1024 481 153 25 n/a 
Post-graft vascularisation 983 406 201 98 47 14 3 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 12367 .880 .754 .638 .534 n/a 
Post-graft vascularisation 983 .694 .510 .397 .242 n/a 
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5.3.5 Post operative rise in intraocular pressure 
 
A post-operative rise in intraocular pressure is a significant risk factor for corneal graft 
failure (Log Rank Statistic=151.25; df=1; p<0.00001). 
 
Figure 5.6 Post-operative rise in intraocular pressure 
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Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
No rise in intraocular 
pressure since graft 
11304 4295 1976 957 460 151 28 n/a 
Post-operative rise in 
intraocular pressure 
2046 888 396 167 69 16 0 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
No rise in intraocular 
pressure since graft 11304 .874 .759 .651 .541 n/a 
Post-operative rise in 
intraocular pressure 2046 .822 .612 .458 .291 n/a 
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5.3.5.1 Effect of post-operative rise in intraocular pressure 
 
Of the 2046 grafts recording a rise in intraocular pressure in the post-graft period, 748 
(37%) have failed.  The main reasons for failure of these grafts are shown in Table 5.3. 
 
Table 5.3 Reasons for graft failure in cases where raised intraocular pressure 
was recorded in the post-graft period 
 
Reason Sub-total Total % 
Glaucoma  220 29% 
no other indication reported 144   
with endothelial decompensation 27   
with rejection 18   
with vascularisation 3   
with endophthalmitis 2   
with perforated ulcer 2   
with epithelial defect  2   
with HSV 2   
with uveitis 2   
with implantation cysts 2   
Miscellaneous 16   
Graft rejection  215 29% 
no other indication reported 149   
with glaucoma 32   
with endothelial decompensation 15   
with vascularisation 4   
with abscess 4   
with ulcer 2   
Miscellaneous 9   
Endothelial failure  175 23% 
unspecified 99   
with pseudophakic bullous keratopathy 32   
with aphakic bullous keratopathy 21   
with glaucoma 12   
primary non-function 5   
Miscellaneous 6   
Infections  47 6% 
abscess 19   
HSV 15   
endophthalmitis 5   
perforated ulcer 3   
mycotic ulcer 2   
Acanthamoeba keratitis 1   
streptococcus 1   
unspecified viral infection 1   
Epithelial failure  13 2% 
Neovascularisation  12 2% 
Unspecified ulcers  11 1.5% 
Trauma  10 1.5% 
Phthisis bulbi  8 1% 
Miscellaneous  37 5% 
TOTAL  748 100% 
 
Glaucoma was the primary reason for graft failure in 29% of failed grafts. This disease 
featured as a primary or secondary cause of failure in 298 (40%) of the cases listed. 
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5.3.5.2 Post-graft operative procedures for glaucoma 
 
Post-graft operative surgery for glaucoma has been performed on 406 (20%) of grafts in 
which a post-operative rise in IOP was recorded.  Table 5.4 lists the procedures that have 
been performed. 
 
Table 5.4 Operative procedures used to control post-graft raised intraocular 
pressure 
 
Name No. % of grafts 
Trabeculectomy 174 40% 
Valve implant 103 24% 
Other glaucoma procedures 40 9% 
Miscellaneous 29 7% 
Not specified 85 19% 
TOTAL PROCEDURES 437 over 406 grafts (100%) 
 
∗ Please note that in many cases surgeons have performed two or three operative 
procedures, and in these cases, all procedures have been included. 
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5.3.6 Rejection episodes since graft 
 
The effect of occurrence of a rejection episode during the post-operative period is shown in 
Figure 5.7 (Log Rank Statistic=1034.58; df=1; p<0.00001). 
 
Figure 5.7 Rejection episodes since graft 
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Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
No rejection episodes 10856 4147 1878 889 430 136 23 n/a 
One or more rejection 
episodes 
2494 1036 494 235 99 30 5 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
No rejection episodes 10856 .903 .806 .707 .592 n/a 
One or more rejection 
episodes 2494 .715 .485 .343 .234 n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
POST-GRAFT VASCULARISATION 
Balance of database:     88% at 1 year 
 Mean Survival 12.91 years   75% at 5 years 
 (SE=0.17, 95% CI: 12.58, 13.23)  64% at 10 years 
 Median Survival 16 years   53% at 15 years 
Post-graft vascularisation:   69% at 1 year 
 Mean Survival 8.08 years   51% at 5 years 
 (SE=0.34, 95% CI: 7.42, 8.75)  40% at 10 years 
 Median Survival 6 years   24% at 15 years 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
RISE IN IOP 
No rise in intraocular pressure since graft:  87% at 1 year 
 Mean Survival 12.99 years   76% at 5 years 
 (SE=0.17; 95% CI: 12.66, 13.32)  65% at 10 years 
 Median Survival 16 years   54% at 15 years 
Post-operative rise in intraocular pressure: 82% at 1 year 
 Mean Survival 9.15 years   61% at 5 years 
 (SE=0.23; 95% CI: 8.69, 9.61)  46% at 10 years 
 Median Survival 8 years   29% at 15 years 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
REJECTION EPISODES 
No rejection episodes:     90% at 1 year 
 Mean Survival 13.90 years   81% at 5 years 
 (SE=0.19; 95% CI: 13.54, 14.27)  71% at 10 years 
 Median Survival 17 years   59% at 15 years 
One or more rejection episodes:   71% at 1 year 
 Mean Survival 7.76 years   48% at 5 years 
 (SE=0.21; 95% CI: 7.34, 8.18)  34% at 10 years 
 Median Survival 5 years   23% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
Australian Corneal Graft Registry Report 2007 129 
POST-GRAFT EVENTS 
 
5.4 POST-GRAFT OPERATIVE PROCEDURES 
 
Table 5.5 Post-graft operative procedures 
 
Procedure Sub- 
total 
Number of 
procedures 2 
% of 
followed 
Refractive surgery  1613 12% 
Repeat graft (reported to ACGR in follow-up1)  1116 8% 
Cataract extraction and IOL implant  620 5% 
Yag laser  485 4% 
Glaucoma surgery   484 4% 
 Trabeculectomy 200   
 Valve implant 113   
 Cyclocryotherapy 38   
 Vitrectomy 2   
 Miscellaneous 43   
 Type of surgery not advised to ACGR 88   
Wound repair  438 3% 
Enucleation following graft failure  137 1% 
Remove IOL - eye left aphakic  126 <1% 
Vitrectomy/anterior vitrectomy  94 <1% 
Gunderson/conjunctival flap  68 <1% 
Tarsorrhaphy  66 <1% 
IOL implant into aphakic eye  65 <1% 
Retinal surgery  49 <1% 
Cataract extraction - no IOL implant  26 <1% 
Laser (unspecified)  23 <1% 
Ectropion/entropion repair  17 <1% 
Exchange IOL and replace new IOL  16 <1% 
Scraping/biopsy  11 <1% 
Ptosis repair  11 <1% 
Strabismus surgery  10 <1% 
Division of anterior synechiae  5 <1% 
Miscellaneous procedures  146 1% 
Total procedures 5626 
Total grafts followed 13350 
 
1 This figure is probably higher as surgeons do not always advise of regrafts on follow-up forms. 
2 Some grafts have had more than one operative procedure since graft.  This table lists all procedures and provides a 
percentage calculated from the total number of grafts followed. 
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5.4.1 Refractive surgery 
 
Figure 5.8 shows the effect of any form of post-graft refractive surgery on graft survival 
(Log Rank Statistic=242.63; df=1; p<0.00001). Data were carried over from one follow-up 
to the next. 
 
Figure 5.8 The effect of refractive surgery 
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Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Balance of database 11737 4254 1894 885 414 126 21 n/a 
Any refractive surgery  
post-graft 
1613 927 476 237 113 41 7 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 11737 .848 .705 .585 .478 n/a 
Any refractive surgery 
post-graft 1613 .985 .910 .803 .619 n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
EFFECT OF REFRACTIVE SURGERY 
Balance of database:     85% at 1 year 
 Mean Survival 11.84 years   70% at 5 years 
 (SE=0.17, 95% CI: 11.51, 12.18)  58% at 10 years 
 Median Survival 14 years   48% at 15 years 
Any refractive surgery post-graft:  98% at 1 year 
 Mean Survival 15.25 years   91% at 5 years 
 (SE=0.30, 95% CI: 14.65, 15.84)  80% at 10 years 
 Median Survival approx. 19 years  62% at 15 years 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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5.5 SUMMARY OF POST-GRAFT EVENTS 
 
 The major reasons for failure of penetrating grafts are irreversible 
rejection (31%), endothelial cell failure (21%), infection including 
recurrent HSV keratitis (13%), and glaucoma (8%). 
 Removal of graft sutures within 6 months of the time of transplantation is 
a risk factor for graft failure. 
 A variety of post-operative events are associated with graft failure.  
These include development of microbial keratitis or a stitch abscess 
(affecting 3% of grafts), uveitis (2%), synechiae (3%), graft 
neovascularisation (7%), rejection episodes (19%) and a rise in 
intraocular pressure (15%) in the grafted eye. 
 Over 42% of grafted eyes have undergone some form of operative 
procedure since the time of corneal transplantation. 
 In 12% of cases, a refractive procedure has been performed on the 
grafted eye.  
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6. VISUAL OUTCOME 
 
 
6.1 DESIRED OUTCOME 
 
The Australian Corneal Graft Registry has recorded a desired outcome for 14,321 (79%) of 
the 18,205 penetrating grafts entered.  These outcomes are shown in Figure 6.1 and  
Table 6.1. 
 
Figure 6.1 Reasons for graft 
 
Table 6.1 Reasons for graft 
 
Reason for Graft Number % 
Improvement in visual acuity 10095 70% 
Pain and visual acuity 1975 14% 
Structural repair 858 6% 
Pain relief 566 4% 
Improved cosmesis 58 <1% 
Mixture of reasons 769 5% 
TOTAL 14321 100% 
 
Structural 
repair 6% 
Pain  4%
 
     Improved cosmesis <1% 
Pain/visual 
acuity 14% 
Improve visual 
acuity 71%
Mixture of 
reasons 5%
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6.1.1 Desired outcome and actual visual outcome 
achieved 
 
Table 6.2 shows whether visual acuity in the grafted eye at the most recent follow-up was 
better, worse or the same as before graft.  Categories marked with an asterisk are mutually 
exclusive. 
 
 
Table 6.2 Visual outcome compared with reason for graft 
 
Reason for Graft Number 
followed
VA 
Better 
VA 
Same 
VA 
Worse 
Not 
known 
*   Where the only 
reason for graft was to 
improve visual acuity    
7384 
(100%) 
4187 
(56%) 
499 
(7%) 
571 
(8%) 
2127 
(29%) 
Where one of the 
reasons for graft was to 
improve visual acuity 
9214 
(100%) 
5184 
(57%) 
757 
(8%) 
776 
(8%) 
2497 
(27%) 
*   Where the only 
reason for graft was to 
relieve pain 
457 
(100%) 
150 
(33%) 
72 
(16%) 
45 
(10%) 
190 
(41%) 
*   Where the only 
reason for graft was 
cosmesis 
19 
(100%) 
4 
(21%) 
3 
(16%) 
3 
(16%) 
9 
(47%) 
*   Where the only 
reason for graft was 
structural repair 
342 
(100%) 
91 
(27%) 
52 
(15%) 
43 
(12%) 
156 
(46%) 
Where the reason for 
graft was vision and 
pain  
1438 
(100%) 
784 
(55%) 
208 
(14%) 
167 
(12%) 
279 
(19%) 
Where the reason for 
graft was vision and 
repair  
228 
(100%) 
115 
(50%) 
25 
(11%) 
25 
(11%) 
63 
(28%) 
Where there were a 
mixture of reasons for 
graft, not stated above 
39 
(100%) 
13 
(33%) 
6 
(15%) 
8 
(20%) 
12 
(32%) 
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6.2 OVERALL VISUAL ACUITY 
 
Figure 6.2 shows the best corrected visual acuity in the grafted eye at the time of the most 
recent follow-up.  Post-graft visual acuity has been recorded for 11,431 penetrating grafts.  
Of these 5,187 (45%) have recorded a best corrected acuity of 6/12 or better;  6,297 (55%) 
have achieved 6/18 or better; and 2,955 (26%) record a visual acuity of less than 6/60.  In 
an additional 1919 cases, information was not available. 
 
 
Figure 6.2 Best corrected visual acuity in grafted eye at last follow-up 
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CF = count fingers at 1 metre,   HM = hand movements,   LP = light perception,   NLP = no light perception 
 
 
 
 
BEST CORRECTED SNELLEN ACUITY AT MOST 
RECENT POST-OPERATIVE VISIT 
6/12 or better 5187 39% 
6/18 or better 6297 47% 
6/24 - 6/60 2179 16% 
Less than 6/60 2955 22% 
Unknown/not recorded 1919 14% 
Percentages shown in this box are for all 13350 followed penetrating grafts 
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6.2.1 Comparison of recipient characteristics where 
post-graft visual acuity is ≥ 6/18 or <6/18 
 
The categories below are not mutually exclusive for either set of comparisons. 
 
Table 6.3 Comparison where post-graft vision is  ≥6/18  or  <6/18 
 
Description VA equal to or better 
than 6/18 
VA is worse than 6/18 
 No. % No. % 
Reasons for grafting     
Vision 4299 66% 2249 34% 
Pain/Vision 454 37% 782 63% 
Pain 67 18% 301 82% 
Other (combinations) 122 35% 228 65% 
Tectonic 43 17% 204 83% 
Cosmesis 6 38% 10 62% 
Not advised 1306 49% 1360 51% 
Presenting disease     
Keratoconus 3462 83% 731 17% 
Keratoconus with hydrops 98 72% 39 28% 
Fuchs' dystrophy 738 62% 453 38% 
HSV - history (not at graft) 288 52% 271 48% 
Non herpetic scar 281 49% 296 51% 
Previous graft failure 770 37% 1274 63% 
Pseud. bullous keratopathy 810 31% 1814 69% 
HSV – active at graft 48 28% 122 72% 
Aphakic bullous keratopathy 90 24% 289 76% 
Perforation 58 22% 211 78% 
Lens at last follow-up     
Phakic 4335 75% 1460 25% 
Pseudophakic 1803 38% 2995 62% 
Aphakic 159 19% 679 81% 
Operative procedure at graft     
Triple procedure 627 55% 520 45% 
Cataract removed  661 54% 633 46% 
Peripheral iridectomy 183 46% 214 54% 
Anterior vitrectomy 251 23% 824 77% 
Trabeculectomy 10 22% 35 78% 
Operative procedure post-graft     
Refractive surgery performed 1057 70% 450 30% 
Cataract removed; IOL inserted 329 65% 178 35% 
Insertion of IOL  160 57% 123 44% 
Yag/mechanical capsulotomy 240 55% 194 45% 
Cataract removed; no IOL 7 27% 19 73% 
Complications in follow-up     
Major astigmatism 1471 63% 844 37% 
Cataract affecting VA 149 46% 177 54% 
Rejection episodes  810 39% 1273 61% 
Amblyopia 147 38% 235 62% 
Uveitis 68 34% 133 66% 
Raised IOP post-graft 580 31% 1323 69% 
Neovascularisation 267 31% 601 69% 
Stitch abscess/microbial keratitis 97 30% 224 70% 
HSV in post-operative period 72 27% 192 73% 
Maculopathy 321 25% 977 75% 
Synechiae 65 21% 234 79% 
CME 154 18% 713 82% 
Retinal detachment 22 12% 170 88% 
Graft has failed 67 3% 1840 97% 
Recipient age     
Recipient age ≥80 years 443 28% 1111 72% 
TOTAL 6297 (55%) 5134 (45%) 
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In summary, for those recipients who achieved 6/18 or better in their graft, proportionately 
more were grafted to improve their vision, suffered from keratoconus as the indication for 
graft, were phakic, and had undergone a refractive surgical procedure to the graft, 
compared with recipients who achieved worse than 6/18 in their graft.  In the latter group, 
there was a relative excess of grafts performed for pain relief or structural repair, bullous 
keratopathy, perforation or previous failed graft, together with more aphakes, 
pseudophakes and elderly recipients, and more recipients who had suffered cystoid 
macular oedema, retinal detachment or whose graft had failed. 
 
6.2.2 Post-graft changes in visual acuity 
 
In 8546 of cases, both pre-operative and post-operative Snellen visual acuities were 
available.  Figure 6.3 shows the number of lines of improvement or worsening in visual 
acuity since graft, as measured at the most recent follow-up. 
 
Figure 6.3 Changes in Snellen acuity after graft. 
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Number of lines on the 
Snellen Chart 
Surviving grafts 
No.           % 
Failed grafts 
No.           % 
Total Grafts 
No.           % 
VA worse by 5-10 lines 22 <1 28 <1 50 <1 
VA worse by 2-4 lines 245 3 235 3 480 6 
VA worse by 1 line 284 3 264 3 548 6 
VA unchanged 689 8 420 5 1109 13 
VA better by 1 line 841 10 203 2 1044 12 
VA better by 2-4 lines 2602 30 127 2 2729 32 
VA better by 5-10 lines 2565 30 21 <1 2586 30 
Sub Totals 7248 85% 1298 15% 8546 100%
TOTAL   8546   (100%) 
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Of the 1078 grafts for which acuity had decreased, 527 (49%) had failed, and of the 1109 
grafts for which visual acuity remained unchanged, 420 (38%) had failed. Interestingly, 351 
grafts reported as having failed actually recorded a better visual acuity at the last follow-up 
than they did at the time of graft.  No post-operative change from the pre-graft visual acuity 
was recorded for 1109 grafts. These data are examined more closely in Table 6.4.  
Categories are not mutually exclusive. 
 
Table 6.4 No change in visual acuity post-graft 
 
Description Number % 
Reasons for graft   
Vision 516 46% 
Pain & vision 208 19% 
Pain 72 6% 
Tectonic 52 5% 
Cosmesis 3 <1% 
Not advised 201 18% 
Other combinations 57 5% 
Presenting disease   
Pseudophakic bullous keratopathy 412 37% 
Previous graft failure 274 25% 
Keratoconus 186 17% 
Fuchs' dystrophy 105 9% 
Non herpetic scar 58 5% 
Aphakic bullous keratopathy 56 5% 
HSV - history - not active at time of graft 55 5% 
Perforation 37 3% 
HSV - active at time of graft 26 2% 
Lens status at last follow-up   
Pseudophakic 666 60% 
Phakic 328 30% 
Aphakic 115 10% 
Operative procedure at graft   
Anterior vitrectomy 177 16% 
Cataract removed 127 11% 
Triple procedure 113 10% 
Peripheral iridectomy 42 4% 
Operative procedure post-graft   
Refractive surgery performed 94 8% 
Yag/mechanical capsulotomy 31 3% 
Cataract removed; IOL inserted 31 3% 
Cataract removed; no IOL 20 2% 
Complications in follow-up   
Graft has failed 420 38% 
Raised IOP post-graft 289 26% 
Any rejection episodes since graft 285 26% 
Maculopathy 218 20% 
Major astigmatism 162 15% 
Neovascularisation 127 11% 
CME 126 11% 
Synechiae 59 5% 
Stitch abscess or microbial keratitis 44 4% 
Cataract affecting VA 40 4% 
Amblyopia 38 3% 
HSV in post-operative period 36 3% 
Retinal detachment 31 3% 
Uveitis 17 1% 
Recipient age   
Recipient age ≥80 253 23% 
TOTAL GRAFTS 1109  
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CHANGE IN SNELLEN ACUITY AFTER GRAFT 
 
Better      6359    (48%) 
Same      1109    (  8%) 
Worse      1078    (  8%) 
VA not advised to ACGR   4804    (36%) 
[Calculated as a percentage of all followed penetrating grafts (13,350)] 
 
 
 
In most cases in which the change in Snellen acuity after graft cannot be determined, the 
Registry is unaware of the pre-operative acuity. 
 
 
 
 
 
 
 
 
 
6.3 VISUAL OUTCOME RELATED TO 
PRESENTING DISEASE 
 
 
The following pages show the visual outcome of penetrating grafts performed for  
keratoconus, Fuchs' dystrophy, aphakic or pseudophakic bullous keratopathy, previously 
failed grafts or herpetic infection.  These are the most common indications for penetrating 
corneal transplantation in our database. 
 
In each case we provide two charts - the first showing the post-graft Snellen visual acuities, 
and the second showing the number of lines of improvement or worsening in visual acuity 
compared with the pre-operative acuity.  Failed grafts are included where information is 
available. 
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6.3.1 Keratoconus 
 
Figure 6.4 Visual outcome:   keratoconus 
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Seventy percent of all grafts performed for keratoconus achieved a post-graft visual acuity 
of 6/12 or better, and 78% achieved 6/18 or better.  In the 88% of cases where the visual 
acuity was provided both before and after graft, at least one line of improvement on the 
Snellen chart was achieved after graft. 
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6.3.2 Fuchs' dystrophy 
 
Figure 6.5 Visual outcome:   Fuchs' dystrophy 
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Forty eight percent of all grafts performed for Fuchs' dystrophy achieved a post-graft visual 
acuity of 6/12 or better, 61% achieved 6/18 or better and 78% achieved 6/60 or better.  In 
the 74% of cases where the ACGR was provided with VA both before and after graft, at 
least one line of improvement on the Snellen chart was achieved after graft. 
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6.3.3 Aphakic bullous keratopathy 
 
Figure 6.6 Visual outcome:  aphakic bullous keratopathy 
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Twelve percent of grafts performed for aphakic bullous keratopathy achieved a visual acuity 
of 6/12 or better, 19% achieved 6/18 or better and 40% achieved 6/60 or better.  In the 62% 
of cases where visual acuities were provided both before and after grafting, at least one 
line of improvement on the Snellen chart was achieved after graft. 
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6.3.4 Pseudophakic bullous keratopathy 
 
Figure 6.7 Visual outcome:  pseudophakic bullous keratopathy 
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Seventeen percent of grafts performed for pseudophakic bullous keratopathy achieved a 
post-graft visual acuity of 6/12 or better, 27% achieved 6/18 or better and 49% achieved 
6/60 or better.  In 63% of cases, at least one line of improvement on the Snellen chart was 
achieved after graft. 
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6.3.5 Previous failed graft 
 
Figure 6.8 Visual outcome:   previous failed graft 
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Twenty four percent of grafts performed for a previously failed graft achieved a post-graft 
visual acuity of 6/12 or better, 30% achieved 6/18 or better and 47% achieved 6/60 or 
better.  In the 67% of cases in which visual acuity was reported both before and after graft, 
at least one line of improvement on the Snellen chart was achieved after graft. 
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6.3.6 Herpetic infection 
 
Figure 6.9 Visual outcome:   herpetic infection 
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In recipients in whom HSV infection had been recorded at any time pre-graft, 29% of the 
cohort achieved a post-graft visual acuity of 6/12 or better, 39% achieved 6/18 or better and 
56% achieved 6/60 or better.  In the 69% of cases where visual acuity was provided both 
before and after graft, at least one line of improvement on the Snellen chart was achieved 
after graft. 
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In those cases where HSV was active at the time of graft, 16% achieved a visual acuity of 
6/12 or better, 23% achieved 6/18 or better and 42% achieved 6/60 or better (not 
illustrated).  
 
In those cases where HSV was not active at time of graft, 21% achieved a visual acuity of 
6/12 or better, 48% achieved 6/18 or better and 70% achieved 6/60 or better (not 
illustrated). 
 
 
 
 
 
 
6.4 FACTORS AFFECTING VISUAL 
POTENTIAL OF THE GRAFTED EYE 
 
 
Table 6.5 lists some of the factors which have affected the visual potential of the grafted 
eye (penetrating grafts only).  The factors are not necessarily mutually exclusive. 
 
 
Table 6.5 Factors affecting visual potential of the grafted eye 
 
Description Total % 
Astigmatism (>5D = 2457)  (irregular  = 451) 2908 22% 
Graft failure 2894 22% 
Maculopathy (unspecified) 1415 11% 
Anisometropia 1104 8% 
Cystoid macular oedema 952 7% 
Glaucoma 851 6% 
Opacity/scar 422 3% 
Amblyopia 416 3% 
Myopia 343 3% 
Cataract  341 3% 
Aphakia  276 2% 
Retinal detachment 216 2% 
Other retinal problem 76 <1% 
Diabetic retinopathy 59 <1% 
Other factors 339 3% 
Total penetrating grafts                     = 13350 (100%) 
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6.5 ASTIGMATISM 
 
 
Figure 6.10 is a histogram of the most recent post-operative measure of regular 
astigmatism, where recorded.  Keratometry was available for 2,237 (17%) of the 
penetrating grafts in the Australian Corneal Graft Register.  For 1,424 (64%) of these grafts, 
the post-operative astigmatism was ≥5 dioptres. 
 
Post-operative astigmatism of less than 5 dioptres is no longer recorded in the Registry.  
 
 
Figure 6.10 Dioptres of regular astigmatism in the grafted eye at last follow-up 
 
 
340 350
225
187
101 96
38 32 23 11 10 11
0
50
100
150
200
250
300
350
400
5 6 7 8 9 10 11 12 13 14 15 >16
DIOPTRES OF REGULAR ASTIGMATISM
N
U
M
B
ER
 O
F 
G
R
A
FT
S
 
 
 
 
148 Australian Corneal Graft Registry Report 2007 
VISUAL OUTCOME 
6.6 REFRACTIVE SURGERY 
 
 
Table 6.6 lists refractive surgical procedures performed on penetrating grafts.  One or more 
procedures were carried out on 1,613 grafts (12% of penetrating grafts followed).   
 
 
Table 6.6 Refractive surgery 
 
Procedure Number  % 
Suture adjustment 688 34% 
Relaxing incisions 656 31% 
Compression sutures 286 14% 
LASIK 112 5% 
Excimer/PARK/laser  83 4% 
Wedge resection 66 3% 
Other 83 4% 
Unknown procedure 111 5% 
Total procedures 2085 100% 
2085 procedures over 1613 grafts  
(12% of all followed grafts) 
 
 
6.6.1 Correction following refractive surgery 
 
Table 6.7 shows the method of correction used for the 1,613 grafts that have undergone 
refractive surgery. 
 
 
Table 6.7 Correction following refractive surgery 
 
Method of correction Number  % 
Spectacles 869 54% 
Contact lens 113 7% 
Spectacles and contact lens 53 3% 
No correction/not advised 578 36% 
TOTAL 1613 100% 
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6.6.2 Has refractive surgery improved visual acuity? 
 
 
Figure 6.11 shows the Snellen acuities in those 1,613 penetrating grafts that have 
undergone refractive surgery.  Visual acuity is equal to or better than 6/12 in 878 (54%) of 
these cases, better than or equal to 6/18 in 1,056 (65%), and better than or equal to 6/60 in 
1,317 (82%).  This compares with 45% for 6/12 or better, 55% for 6/18 or better and 74% 
for 6/60 or better in the database as a whole. 
 
 
Figure 6.11 Snellen visual acuities for grafts that have undergone refractive 
surgery 
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Figure 6.12 shows the number of lines of improvement on the Snellen chart for those grafts 
where visual acuity has been provided both pre-graft and post-graft, and which underwent 
refractive surgery.    
 
In comparison, Figure 6.13 shows grafts that have not undergone refractive surgery post-
operatively.  Snellen acuity appears slightly better in the group that has undergone 
refractive surgery to the graft. 
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Figure 6.12 Change in lines on the Snellen chart for grafts that have undergone 
refractive surgery 
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Of the 1,042 for whom we have information, 844 (81%) show an improvement in visual 
acuity, 94 (9%) are unchanged since before graft and 104 (10%) are worse. 
 
Figure 6.13 Change in lines on the Snellen chart for grafts that have not 
undergone refractive surgery 
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Of those 11,737 grafts that have not undergone refractive surgery, visual acuities both 
before and after graft have been provided for 7,501.  Of these, 5,514 (74%) show an 
improvement in visual acuity, 1,013 (13%) show no change since before graft and 974 
(13%) are worse. 
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6.7 TRIPLE PROCEDURES 
 
6.7.1 Snellen acuity 
 
Figure 6.14 shows the visual acuity at most recent follow-up for 1332 triple procedures. 
 
Figure 6.14  Visual acuities for all triple procedure grafts 
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6.7.2 Visual improvement after graft: triple procedure 
 
Figure 6.15 shows the number of lines of change on the Snellen chart for triple procedures. 
 
Figure 6.15 Triple procedures - lines of change 
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6.8 POST-GRAFT CORRECTION 
 
 
Table 6.9 shows the post-graft correction prescribed for grafts that have survived for less 
than 2 years; between 2 and 5 years; between 5 and 10 years and over 10 years.   
 
 
Table 6.9 Post-graft correction dependent on survival time 
 
 Survival time of graft 
Method of correction <2 years 2 – 5 years 5 – 10 years >10 years 
 No. % No. % No. % No. % 
None or none advised 1197 28% 696 19% 278 16% 103 14%
Glasses only 876 20% 1011 28% 583 33% 290 40%
Contact lens only 188 4% 219 6% 141 8% 76 10%
IOL only 1097 26% 547 15% 252 14% 57 8%
Glasses & contact lens 37 <1% 80 2% 52 3% 20 3%
Glasses and IOL 873 20% 1054 29% 454 25% 170 23%
Contact lens and IOL 17 <1% 34 <1% 20 1% 7 <1%
Glasses, contact lens 
and IOL 
9 <1% 12 <1% 3 <1% 3 <1%
Sub-total 4294 100% 3653 100% 1783 100% 726 100%
TOTAL 10456 surviving penetrating grafts 
 
 
The data suggest that visual rehabilitation following corneal transplantation may take 
several years, and that adjustments continue to be made for as long as 10 years. 
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6.9 SUMMARY OF VISUAL OUTCOME AFTER 
CORNEAL TRANSPLANTATION 
 Information on the desired outcome after corneal transplantation was 
available for 79% of the cohort.  In 70% of cases, the major reason for 
transplantation was improved vision and in a further 14%, the reasons were 
improved vision plus relief of pain. 
 A best-corrected Snellen acuity of 6/12 or better at the time of most recent 
follow-up was achieved in 45% of grafted eyes, of 6/18 or better by 55% of 
grafted eyes, and of less than 6/60 by 26% of grafted eyes.  No information 
was available in 17% of cases. 
 Where information was available, Snellen acuity improved after corneal 
transplantation in 74% of cases, remained the same in 13% of cases and 
worsened in 13% of cases. 
 Visual outcome after corneal transplantation depends to some extent on  
indication for graft, lens status and on co-morbidities. 
 
Indication for graft Percent achieving 6/18 or 
better in the grafted eye * 
Keratoconus 84% 
Fuchs' dystrophy 68% 
History of HSV infection 46% 
Previous failed graft 39% 
Pseudophakic bullous keratopathy 32% 
Aphakic bullous keratopathy 24% 
 
*  unknowns excluded from calculations 
 
 
 The most important factors with a negative influence on the visual outcome 
of the grafted eye were:  >5D astigmatism, graft failure, and retinal disease.   
 A refractive surgical procedure was performed on 12% of grafts. 
 By 10 years post-graft, 14% of grafted eyes either required no form of 
correction or had been prescribed none, while a further 8% of eyes had an 
IOL in situ but were otherwise uncorrected. 
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7. LAMELLAR AND LIMBAL GRAFTS 
 
 
7.1 SURVIVAL OF LAMELLAR AND LIMBAL 
GRAFTS 
We have had many recent registrations of lamellar procedures but no significant follow-up 
as yet.  We will produce an interim report to examine the outcome of these procedures in 
2008.  The majority of lamellar procedures analysed in this chapter were performed some 
years ago.  Survival of lamellar and limbal corneal grafts are presented in Figure 7.1 (Log 
Rank Statistic=20.24; df=1; p<0.00001). At ten years post graft all limbal grafts have failed, 
although there are some limbal grafts surviving at periods less than ten years. 
 
Figure 7.1  Survival of lamellar and limbal corneal grafts 
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Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Lamellar 720 162 56 26 11 4 1 n/a 
Limbal 88 21 4 2 n/a n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Lamellar 720 .799 .693 .555 n/a n/a 
Limbal 88 .608 .419 .000 n/a n/a 
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LAMELLAR AND LIMBAL CORNEAL GRAFT SURVIVAL 
TYPE OF GRAFT 
Lamellar grafts:     80% at 1 year 
 Mean Survival 11.36 years   69% at 5 years 
 (SE=0.64; 95% CI 10.12, 12.61)  55% at 10 years 
 Median Survival 14 years    
Limbal grafts:      60% at 1 year 
 Mean Survival 4.96 years   42% at 5 years 
 (SE=0.60; 95% CI: 3.79, 6.12)  0% at 10 years 
 Median Survival 4 years    
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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7.2 DESIRED OUTCOME 
 
The Australian Corneal Graft Registry has recorded a desired outcome for 824 (74%) of the 
1115 lamellar and limbal grafts entered.  These outcomes are shown in Figure 7.2 and 
Table 7.1. 
 
Figure 7.2 Reason for graft 
 
Table 7.1  Reasons for graft 
 
Reason for Graft Number % 
Structural repair 361 45% 
Improvement in visual acuity 223 27% 
Mixture of reasons 81 10% 
Improved visual acuity and 
structural/tectonic repair 
 
37 
 
4% 
Pain relief 35 4% 
Pain relief and structural repair 34 4% 
Cosmesis 34 4% 
Pain and visual acuity 19 2% 
TOTAL 824 100% 
 
Visual acuity and tectonic
4% 
Pain 
4% 
Cosmesis
4% 
Pain and tectonic
4% 
Pain and visual acuity
2% 
Tectonic graft
45%
Improved visual acuity
 27% 
Mixture
10%
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7.3 OVERALL VISUAL ACUITY 
 
 
Figure 7.3 shows the best corrected visual acuity in the grafted eye at the time of the most 
recent follow-up. Post graft visual acuity has been recorded for 606 lamellar and limbal 
grafts. A best corrected Snellen acuity of 6/12 or better was achieved in 55% of cases at 
most recent follow-up; 62% achieved 6/18 or better, and 22% recorded a visual acuity of 
less than 6/60 at last follow-up. Follow-up visual acuities were not advised in 25% of cases. 
 
 
Figure 7.3 Best corrected visual acuity in grafted eye at last follow-up 
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7.4 EFFECT OF SURGEON WORKLOAD  
 
7.4.1 Outcome: number of grafts performed 
 
Figure 7.4 shows the survival of lamellar and limbal grafts (considered together), performed 
by surgeons who have grafted 15 or more, compared with surgeons who have performed 
fewer than 15 grafts (Log Rank Statistic=2.75; df=1; p=.098) the difference is not 
significant. 
 
Figure 7.4  Outcome according to number of grafts performed 
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Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Less than 15 grafts 299 64 18 9 5 2 1 n/a 
More than 15 grafts 509 119 42 19 6 2 0 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially  at risk 1 5 10 15 20 
Less than 15 grafts 299 .759 .589 .423 n/a n/a 
More than 15 grafts 509 .787 .697 .552 n/a n/a 
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7.4.2 Outcome: follow-up surgeon  
 
Figure 7.5 shows survival of grafts followed by the surgeon who performed the graft, 
compared with grafts followed by a surgeon or practitioner who did not perform the graft 
(Log Rank Statistic=27.27; df=1; p<.00001). 
 
Figure 7.5  Follow up surgeon/practitioner 
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Number at Risk 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Surgeon 647 135 45 20 7 1 n/a n/a 
Followed elsewhere 161 48 15 8 4 n/a n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially  at risk 1 5 10 15 20 
Surgeon 647 .742 .604 .439 n/a n/a 
Followed elsewhere 161 .916 .873 n/a n/a n/a 
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LAMELLAR AND LIMBAL CORNEAL GRAFT SURVIVAL 
EFFECT OF CASE LOAD 
Less than 15 grafts:    76% at 1 year 
 Mean Survival 9.77 years   59% at 5 years 
 (SE=0.98; 95% CI 7.86, 11.69)  42% at 10 years 
 Median Survival 9 years    
More than 15 grafts:     79% at 1 year 
 Mean Survival 10.67 years   70% at 5 years 
 (SE=0.71; 95% CI: 9.28, 12.05)  55% at 10 years 
 Median Survival 14 years    
 
 
 
 
 
 
 
LAMELLAR AND LIMBAL CORNEAL GRAFT SURVIVAL 
FOLLOWUP SURGEON 
Surgeon:      74% at 1 year 
 Mean Survival 9.62 years   60% at 5 years 
 (SE=0.69; 95% CI 8.27, 10.97)  44% at 10 years 
 Median Survival 10 years    
Followed elsewhere:     91% at 1 year 
 Mean Survival 14.16 years   87% at 5 years 
 (SE=0.98; 95% CI: 12.24, 16.08)   
 Median Survival approx 16 years   
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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7.5 LAMELLAR GRAFTS  
 
Table 7.2 Main indications for lamellar grafts 
 
Indication for graft Sub-total Total % 
Pterygium  195 19% 
Recurrent  171   
Unspecified 21   
Peripheral  1   
Pseudopterygium 2   
Corneal Ulcers  143 14% 
Unspecified 21   
Marginal 2   
Central 7   
Mycotic  1   
Perforated 110   
Mooren’s ulcer 2   
Disorders of sclera  138 14% 
Scleromalacia perforans 11   
Scleral abscess 11   
Scleral ectasia 5   
Other degeneration of sclera 111   
Previous failed graft 131 134 13% 
Primary graft failure 3   
Keratoconus  123 12% 
Uncomplicated 117   
Keratoglobus 5   
With hydrops 1   
Neoplasia  68 7% 
Limbal dermoid 34   
Malignancy, unspecified 21   
Squamous cell carcinoma 9   
Conjunctival SCC 3   
Benign  1   
Scars and Opacities 57 57 6% 
Corneal degenerations  28 3% 
Corneal melt 15   
Terrien’s degeneration 5   
Salzmann’s nodular dystrophy 3   
Keratomalacia 1   
Recurrent erosions 1   
Band shaped keratopathy 1   
Unspecified 2   
Effects of radiation therapy 25 25 2% 
Dystrophies  15 1% 
Fuchs’ endothelial dystrophy 4   
Macular dystrophy 3   
Granular dystrophy 3   
Lattice corneal dystrophy 1   
Unspecified corneal dystrophy 4   
Corneal oedema/PBK 13 13 1% 
Burns 3 3 <1% 
Other* 57 57 6% 
Unknown to ACGR 4 4 <1% 
TOTAL 1013  100% 
 
* other: corneal ectasia (14); wound dehiscence (9); HSV (5); interstitial keratitis (4); trauma (3); astigmatism (2); corneal 
abscess (2); corneal deposits (2); endophthalmitis (2); lipid keratopathy (2); scleral fistula (2); vascularization (2); 
amyloidosis (1); aniridia (1); aphakia (1); corneal membrane change (1); Goldenhaar’s bilateral dermoids (1); 
measles conjunctivitis (1); pseudomonas (1); Sjogren’s syndrome (1). 
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Figure 7.6 shows the survival curves for the main indication for lamellar grafts, as shown in 
Table 7.2 (Log Rank Statistic= 76.09; df=8; p<0.00001). 
 
Figure 7.6 Main indications for lamellar grafts 
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Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Keratoconus 60 8 2 n/a n/a n/a n/a n/a 
Previous failed graft 94 18 8 6 1 n/a n/a n/a 
Neoplasia 50 11 3 n/a n/a n/a n/a n/a 
Disorders of sclera 98 30 6 2 n/a n/a n/a n/a 
Pterygium 156 44 21 8 4 1 n/a n/a 
Corneal degeneration 22 3 0 n/a n/a n/a n/a n/a 
Scars and opacities 47 12 4 1 n/a n/a n/a n/a 
Ulcers 98 13 5 2 n/a n/a n/a n/a 
Other 92 22 7 5 3 1 n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Keratoconus 60 .832 n/a n/a n/a n/a 
Previous failed graft 94 .634 .460 n/a n/a n/a 
Neoplasia 50 .891 .792 n/a n/a n/a 
Disorders of sclera 98 .912 .791 .330 n/a n/a 
Pterygium 156 .911 .828 .552 n/a n/a 
Corneal degeneration 22 .606 n/a n/a n/a n/a 
Scars and opacities 47 .766 .670 n/a n/a n/a 
Ulcers 98 .601 .456 n/a n/a n/a 
Other 92 .772 .664 .531 n/a n/a 
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LAMELLAR CORNEAL GRAFT SURVIVAL 
MAIN INDICATION FOR GRAFT 
Keratoconus:      83% at 1 year 
 Mean Survival 9.16 years    
 (SE=0.81; 95% CI: 7.57, 10.75)   
 Median Survival approx. 11 years    
Previous failed graft:     63% at 1 year 
 Mean Survival 5.91 years   46% at 5 years 
 (SE=0.73; 95% CI: 4.47, 7.35)   
 Median Survival 5 years    
Neoplasia:      89% at 1 year 
 Mean Survival 5.39 years   79% at 5 years 
 (SE=0.31; 95% CI 4.77, 6.00)   
 Median Survival approx. 6 years    
Disorders of sclera:     91% at 1 year 
 Mean Survival 9.64 years   79% at 5 years 
 (SE= 1.55; 95% CI: 6.62, 12.67)  33% at 10 years 
 Median Survival 10 years    
Pterygium:      91% at 1 year 
 Mean Survival 13.94 years   83% at 5 years 
 (SE=1.00; 95% CI 11.99, 15.90)  55% at 10 years 
 Median Survival approx. 14 years   
Corneal degeneration:    61% at 1 year 
 Mean Survival 3.94 years    
 (SE=0.56; 95% CI: 2.84, 5.04)   
 Median Survival approx. 5 years   
Scars and opacities:     77% at 1 year 
 Mean Survival 7.84 years   67% at 5 years 
 (SE=0.90; 95% CI: 6.08, 9.60)   
 Median Survival approx. 11 years   
Ulcers:      60% at 1 year 
 Mean Survival 7.04 years   46% at 5 years 
 (SE=1.27; 95% CI 4.56, 9.53)   
 Median Survival 5 years   
Other:      77% at 1 year 
 Mean Survival 11.28 years   66% at 5 years 
 (SE= 1.40; 95% CI 8.53, 14.02)  53% at 10 years 
 Median Survival approx.10 years   
 
 
KEY: n/a  =  not applicable   Cl = confidence interval 
 SE = standard error   p = probability 
 df = degrees of freedom 
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Table 7.3 Reason for failure of lamellar grafts 
 
Reason Sub-total Total % 
Corneal scleral melt  29 18% 
Graft failure (not specified)  23 14% 
Perforated ulcers  12 8% 
Infection  12 8% 
Endophthalmitis 4   
HSV 4   
HZO 1   
Mycotic ulcers  2   
Pseudomonas 1   
Recurrent pterygium  9 6% 
Pseudopterygium 1   
Astigmatism  8 5% 
Abscess  8 5% 
Primary non function  8 5% 
Rejection  6 4% 
not specified 4   
with pterygium 1   
with trauma 1   
Neoplasia  6 4% 
Scars and opacities  5 3% 
Wound dehiscence  5 3% 
Corneal degeneration  5 3% 
Ulcers  4 3% 
Other  18 11% 
Scleral necrosis 3  
Vascularisation 2  
Implantation cysts 2  
Glaucoma 1  
Advance in keratoconus 1  
Keratoglobus 1  
Aniridia 1  
Cataract 1  
Ocular cicatrial pemphigoid 1  
Wegener’s syndrome 1  
Symblepharon 1  
Anisometropia 1  
Sclerosing keratitis 1  
Corneal membrane change 1  
TOTAL  159 100%
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Figure 7.7 shows lamellar graft survival for patients grafted for pterygium or keratoconus, 
compared with survival in patients with any other indication (Log Rank Statistic= 22.10;   
df=2; p<0.0001). Lamellar graft survival is significantly better in patients grafted for 
pterygium than any other category. 
 
Figure 7.7  Effect of pterygium and keratoconus (lamellar grafts only) 
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Number at Risk 
Identity Initially 3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Keratoconus 58 7 1 n/a n/a n/a n/a n/a 
Pterygium  156 44 21 8 4 1 n/a n/a 
Other 506 111 33 16 6 3 n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Keratoconus 58 .828 n/a n/a n/a n/a 
Pterygium  156 .911 n/a .828 .552 n/a 
Other 506 .764 .624 .450 n/a n/a 
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LAMELLAR CORNEAL GRAFT SURVIVAL 
PTERYGIUM AND KERATOCONUS 
Keratoconus:     83% at 1 year 
 Mean Survival 9.06 years    
 (SE=0.84; 95% CI 7.41, 10.71)   
 Median Survival 9 years    
Pterygium:       91% at 1 year 
 Mean Survival 13.94 years    
 (SE=1.00; 95% CI: 11.99, 15.90)  83% at 10 years 
 Median Survival approx. 14 years  55% at 15 years 
Other:       76% at 1 year 
 Mean Survival 10.23 years   62% at 5 years 
 (SE=0.78; 95% CI: 8.70, 11.75)  45% at 10 years 
 Median Survival 10 years   
 
 
 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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7.6 LIMBAL GRAFTS  
 
 
Table 7.4 Main indications for limbal grafts 
 
 
Indication for graft Sub-total Total % 
Previous failed graft  18 18% 
Disorders of sclera  16 16% 
    Scleromalacia perforans 2   
    Scleral abscess 3   
    Other degeneration of sclera 11   
Burns  10 10% 
Scars and Opacities  9 9% 
Corneal ulcers  6 6% 
    Unspecified 2   
    Perforated 4   
Neoplasia  5 5% 
    Limbal dermoid 1   
    Malignancy, unspecified 3   
    Squamous cell carcinoma 1   
Pterygium  4 4% 
    Recurrent  2   
    Unspecified 1   
    Peripheral  1   
Corneal oedema/PBK 4 4 4% 
Corneal degenerations  3 3% 
    Corneal melt 1   
    Terrien’s degeneration 1   
    Band-shaped keratopathy 1   
Keratoconus  1 <1% 
Other* 26 26 25% 
TOTAL  102 100% 
 
 
* other: epithelial defect (4); endophthalmitis (3); pannus (3); vascularisation (3); aniridia (2); astigmatism (2); 
trachoma (2); conjunctival ocular surface (1); eyelid ankyloblepharon (1); limbal dysplasia (1); herpes zoster (1); 
iris prolapse (1); ocular pemphigus (1); Stevens-Johnson syndrome (1).
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Table 7.5 Reason for failure of limbal grafts 
 
 
Reason Sub-total Total % 
Graft failure (not specified)  9 22% 
Rejection  7 17% 
otherwise specified 4   
with epithelial defects 1   
with perforation 1   
with oedema 1   
Epithelial defect  4 10% 
Neoplasia  3 7% 
Infection  2 5% 
HSV 1   
HZO 1   
Corneal scleral melt  1 3% 
Astigmatism  1 3% 
Abscess  1 3% 
Scars and opacities  1 3% 
Ulcers  1 3% 
Other  10 25% 
Vascularisation 3  
Implantation cysts 1  
Glaucoma 1  
Band shaped keratopathy 1  
Ankyloblepharon                   1  
Dysplasia 1  
Scleral necrosis 1  
Stromal thickening 1  
TOTAL  40 100%
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7.7 SUMMARY OF FACTORS RELATING TO 
LAMELLAR AND LIMBAL GRAFTS 
 
 Limbal grafts do not fare as well as lamellar grafts in terms of graft 
survival. 
 
 A best corrected Snellen acuity of 6/12 or better was achieved in 55% of 
cases at most recent follow-up, 62% of cases achieved a follow-up visual 
acuity of 6/18 or better, and 22% recorded a visual acuity of less than 
6/60 at last follow-up.  Follow-up visual acuities were not advised in 25% 
of cases. 
 
 No significant difference in graft survival is apparent amongst surgeons 
who have performed a larger number of lamellar and limbal grafts (over 
15 grafts) and surgeons who have performed fewer grafts. 
 
 Grafts followed by a surgeon or practitioner who did not perform the graft 
fare better than grafts that are followed by the surgeon who performed 
the graft.  A likely explanation for this difference is that surgeons are likely 
to continue to follow patients with a higher risk of failure. 
 
 The main indications for lamellar graft are pterygium (19%), corneal 
ulcers (14%), disorders of the sclera (14%), failed previous graft (13%), 
keratoconus (12%) and neoplasia (7%). These broad categories account 
for 79% of lamellar grafts.  
 
 The main reasons for failure of lamellar grafts are corneal scleral melt 
(18%), unspecified graft failure (14%), perforated ulcers (8%) and 
infection (8%). 
 
 The main indications for limbal graft are “other” (26%), failed previous 
graft (18%), disorders of the sclera (16%), burns (10%), scars and 
opacities (9%), corneal ulcers (6%), and neoplasia (5%).  These broad 
categories account for 90% of limbal grafts.  
 
 The main reasons for failure of limbal grafts are unspecified graft failure 
(23%), rejection of a previous corneal graft (17%), epithelial defect (10%) 
and neoplasia (8%).  
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8. COX PROPORTIONAL HAZARDS 
REGRESSION ANALYSIS 
 
8.1 METHODS 
 
A multivariate model was used to investigate the combined effect of variables of 
penetrating graft survival, adjusted for all the other variables in the model. Further analysis 
of the data was undertaken using Stata version 9. 
 
In the preceding univariate analyses, each registered penetrating graft together with its 
archival follow-up records was treated as a separate and independent entity. Some 
patients had a history of more than one ipsilateral corneal graft and some had a record of 
one or more grafts in the contralateral eye (Table 8.1).  
 
Table 8.1 Number of grafts and patients in the cohort with penetrating corneal 
grafts 
 
Group Number Percentage of 
total  
Registered penetrating grafts 
Number of patients with penetrating grafts 
17090 
13879 
94%    
93% 
Patients with one registered graft 11194 81% 
Patients with more than one registered graft 2685 19% 
 
Following on from the results of the Kaplan-Meier analyses, which were used to indicate 
variables of interest, Cox Proportional Hazards regression models were used to investigate 
the joint effects of a subset of variables on penetrating corneal graft failure. To control for 
potential inter-graft and/or inter-eye dependence in the multivariate analyses, the Cox 
models were adjusted to allow for clustering by individual patient [see reference 5, Chapter 
10.8]. Limbal and lamellar grafts were excluded from consideration. Some variables which 
were indicated as significant in the univariate analysis were omitted due to non-
convergence of the model or collinearity. 
 
The selected variables were: surgeons with more than 25 grafts per year on average, state, 
donor age, recipient age, indicator for graft, number of previous ipsilateral grafts, graft era, 
lens status, corneal vascularisation at time of graft, history of inflammation in the grafted 
eye, history of raised IOP, graft diameter*, time to removal of graft sutures (transformed)*, 
post-operative neovascularisation of the graft, post-operative rise in IOP, post-operative 
episodes of immunological rejection, post-operative synechiae,  microbial keratitis, uveitis 
or stitch abscess, refractive surgery in follow-up, where follow-up occurred, vitrectomy at 
time of graft, multi-organ donor, cause of donor death, corneal storage medium, donor-
recipient gender match, eye bank. 
 
The best model was found by a backward elimination process, removing variables not 
appearing to be predictors of graft failure. The assumption of proportional hazards 
appeared reasonable as assessed by Kaplan-Meier plots. 
 
* see page 180. 
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8.2 FINAL MODEL 
 
Two models were used, depending on the rejection criteria for the variables. The first 
model excluded variables with a p-value of p>0.05 (or global p-value of p>0.5 for variables 
with more than two categories) in a stepwise manner, beginning with the least significant 
variable. The second model excluded variables with a p- value or global p-value of p>0.1.  
The second model is more comprehensive but has the potential to increase confidence 
intervals for the model parameters. The variables retained in the final Cox proportional 
hazards regression models are presented in Table 8.2. 
 
Table 8.2 Variables retained in final models 
 
 Surgeons with more than 25 grafts per year (model 2 only) 
 State 
 Indication for graft 
 Number of previous ipsilateral grafts 
 Lens status (phakic, pseudophakic or aphakic) 
 Corneal neovascularization at the time of graft 
 History of inflammation in the grafted eye 
 History of raised intraocular pressure in the grafted eye 
 Graft diameter 
 Time of removal of graft sutures 
 Post-operative microbial keratitis 
 Post-operative neovascularization of the graft 
 Corneal storage medium 
 Refractive surgery in follow-up 
 Post-operative episodes of immunological rejection 
 Arrangements for follow-up 
 
 
 
Tables 8.3 and 8.4 tabulate the parameter estimates resulting from the fit of the best 
clustered Cox models. The tables show the variable, the hazard ratio, the standard error of 
the regression coefficient, the corresponding probability value and the 95% confidence 
interval for the hazard ratio. The first level of each categorical variable was taken as the 
referent. The hazard ratios for a given variable are adjusted for all other variables in the 
model. 
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8.2.1 Model 1 
 
This model includes variables with a p-value of p<0.05, with variables eliminated in a 
stepwise manner, beginning with the leat significant variable. For categorical variables, a 
global test was applied to calculate the overall p-value. 
 
Table 8.3 Parameter estimates from final Cox regression model 1: factors 
influencing the survival of penetrating corneal grafts 
 
Variable Hazard 
ratio 
Standard 
error 
P global 
P 
95% 
confidence 
intervals 
State 
State 1 1.00   0.01  
State 2 0.91 0.11 0.40  0.72 - 1.14 
State 3 1.06 0.12 0.58  0.85 - 1.32 
State 4 1.44 0.22 0.02  1.07 - 1.94 
State 5 1.25 0.12 0.03  1.02 - 1.52 
State 6 0.95 0.15 0.74  0.69 - 1.30 
 
Indication for graft 
Keratoconus 1.00   <0.001  
Failed graft 2.40 0.49 <0.001  1.61 - 3.58 
Corneal dystrophy 2.84 0.50 <0.001  2.01 - 4.02 
Bullous keratopathy 3.73 0.74 <0.001  2.53 - 5.51 
Herpetic eye disease 2.18 0.40 <0.001  1.52 - 3.11 
Corneal scars and 
opacities 
2.04 0.46 0.001  1.32 - 3.16 
Other 2.65 0.56 <0.001  1.75 - 4.00 
 
Number failed previous ipsilateral grafts 
Each additional failure 1.16 .08 0.04  1.01 - 1.33 
 
Lens status 
Phakia 1.00   0.002  
Aphakia 1.59 0.21 0.001  1.22 - 2.07 
Pseudophakia 1.37 0.15 0.004  1.11 - 1.68 
     
Corneal vascularization at the time of graft 
Three quadrants or less 1.00     
Four quadrants 1.41 0.15 0.002  1.14 - 1.75 
     
Inflammation in the grafted eye at time of graft 
Eye not inflamed 1.00   <0.001  
Inflamed in past only 1.46 0.22 0.01  1.08 - 1.96 
Inflamed at graft only 2.15 0.47 <0.001  1.40 - 3.31 
Inflamed both in past and 
at graft 
1.67 0.27 0.001  1.23 - 2.29 
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Variable Hazard 
ratio 
Standard 
error 
P Global 
P  
95% 
confidence 
intervals 
History of raised intraocular pressure in grafted eye 
IOP never raised in past 1.00   <0.001  
Raised in past only 1.45 0.12 <0.001 
 
 1.23 - 1.72 
Raised at graft only 3.15 0.98 <0.001  1.72 - 5.79 
Raised in past and at 
graft 
1.44 0.25 0.03  1.03 - 2.01 
 
Graft diameter 
8.0 mm 1.00     
Every square root mm 
change from 8.0 mm 
1.97 0.27 <0.001  1.50 – 2.57 
 
Post-operative microbial keratitis or stitch abscess 
No microbial 
keratitis/stitch abscess 
1.00     
Microbial keratitis/stitch 
abscess 
1.88 0.24 <0.001  1.47 - 2.40 
     
Removal of graft sutures 
Every one unit increase 
in ln(years from graft to 
suture removal) 
0.61 0.03 <0.001  0.56 - 0.67 
     
Neovascularization of the graft 
Avascular graft 1.00     
Vascularized graft 2.20 0.21 <0.001  1.87 - 2.71 
     
Graft era  
1985-1989 1.00   <0.001  
1990-1994 0.98 0.09 0.80  0.68 - 1.41 
1995-1999 0.79 0.08 0.03  0.50 - 0.76 
2000-2006 0.55 0.08 <0.001  0.42 - 0.72 
     
Refractive surgery in follow-up 
No refractive surgery  1.00     
Refractive surgery 0.63 0.07 <0.001  0.49 - 0.79 
     
Rejection episodes 
None 1.00     
One or more episodes 3.45 0.26 <0.001  2.98 - 3.99 
     
Arrangements for follow-up 
Follow-up by surgeon 1.00     
Follow-up elsewhere 0.47 0.07 <0.001  0.35 - 0.64 
Time varying change 
(per year of follow up) 
1.08 0.03 0.002  1.03 - 1.13 
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8.2.2 Model 2 
 
This model excludes variables with a p-value of p>0.1 in a stepwise manner. 
 
Table 8.4 Parameter estimates from final Cox regression model 2 
 
Variable Hazard 
ratio 
Standard 
error 
P Global 
P 
95% 
confidence 
intervals 
Surgeons with a high workload 
All other surgeons 1.00   0.06  
Surgeon 1 1.21 0.30 0.45  0.74 - 1.97 
Surgeon 2 1.03 0.17 0.86  0.74 - 1.42 
Surgeon 3 0.91 0.17 0.62  0.62 - 1.32 
Surgeon 4 2.17 0.85 0.05  1.00 - 4.68 
Surgeon 5 1.43 0.55 0.34  0.68 - 3.02 
Surgeon 6 0.90 0.21 0.66  0.57 - 1.42 
Surgeon 7 0.63 0.21 0.17  0.33 - 1.21 
Surgeon 8 0.87 0.22 0.58  0.53 - 1.43 
Surgeon 9 0.67 0.14 0.07  0.44 - 1.03 
Surgeon 10 2.25 0.89 0.04  1.04 - 4.87 
Surgeon 11 1.22 0.36 0.50  0.68 - 2.19 
State 
State 1 1.00   0.01  
State 2 0.54 0.20 0.10  0.26 - 1.12 
State 3 1.03 0.15 0.84  0.78 - 1.36 
State 4 1.41 0.22 0.03  1.04 - 1.92 
State 5 1.30 0.15 0.02  1.04 - 1.64 
State 6 0.88 0.17 0.50  0.60 - 1.28 
 
Indication for graft 
Keratoconus 1.00   <0.001  
Failed graft 2.32 0.47 <0.001  1.55 - 3.46 
Corneal dystrophy 2.82 0.50 <0.001  2.00 - 3.98 
Bullous keratopathy 3.70 0.73 <0.001  2.51 - 5.46 
Herpetic eye disease 2.15 0.40 <0.001  1.50 - 3.09 
Corneal Scars and Opacities 2.06 0.47 0.001  1.32 - 3.20 
Other 2.53 0.54 <0.001  1.66 - 3.84 
 
Number failed previous ipsilateral grafts 
Each additional failure 1.17 .08 0.03  1.02 - 1.34 
 
Lens status 
Phakia 1.00   <0.001  
Aphakia 1.61 0.22 <0.001  1.24 - 2.10 
Pseudophakia 1.41 0.15 0.001  1.14 - 1.74 
     
Corneal vascularization at the time of graft 
Three quadrants or less 1.00     
Four quadrants 1.39 0.15 0.003  1.12 - 1.72 
     
Inflammation in the grafted eye at time of graft 
Eye not inflamed 1.00   <0.001  
Inflamed in past only 1.45 0.22 0.01  1.08 - 1.95 
Inflamed at graft only 2.20 0.48 <0.001  1.44 - 3.37 
Inflamed in past and at graft 1.65 0.26 0.002  1.21 – 2.26 
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Variable Hazard 
ratio 
Standard 
error 
P Global 
P 
95% 
confidence 
intervals 
History of raised intraocular pressure in grafted eye 
IOP never raised in past 1.00   <0.001  
Raised in past only 1.45 0.12 <0.001  1.22 - 1.71 
Raised at graft only 3.34 0.97 <0.001  1.90 - 5.89 
Raised in past and at graft 1.43 0.25 0.04  1.01 - 2.00 
 
Graft diameter 
8.0 mm 1.00     
Every square root mm 
change from 8.0 mm 
1.96 0.28 <0.001  1.47 – 2.59 
 
Post-operative microbial keratitis  
No microbial keratitis 1.00     
Microbial keratitis 1.88 0.24 <0.001  1.47 - 2.42 
     
Removal of graft sutures 
Every one unit increase in 
ln(years from graft to suture 
removal) 
0.61 0.03 <0.001  0.56 - 0.67 
`     
Neovascularization of the graft 
Avascular graft 1.00     
Vascularized graft 2.20 0.22 <0.001  1.82 - 2.67 
     
Graft era  
1985-1989 1.00   <0.001  
1990-1994 0.96 0.09 0.70  0.80 - 1.16 
1995-1999 0.78 0.08 0.03  0.62 - 0.98 
2000-2006 0.52 0.08 <0.001  0.39 - 0.69 
     
Refractive surgery in follow-up 
No refractive surgery  1.00     
Refractive surgery 0.61 0.07 <0.001  0.48 - 0.77 
     
Rejection episodes 
None 1.00     
One or more episodes 3.47 0.26 <0.001  2.99 - 4.03 
     
Arrangements for follow-up 
Follow-up by surgeon 1.00     
Follow-up elsewhere 0.45 0.07 <0.001  0.34 - 0.61 
Time varying change (per 
year of follow up) 
1.08 0.03 0.002  1.03 - 1.13 
 
When model 1 is compared with model 2, there is no marked change in hazard ratios for 
most of the variables except for certain states (most notably state 2). This suggests that 
there is confounding between state and surgeon, with some of the variation between states 
explained by the performance of individual surgeons in that state. It should be noted that in 
most of the cases of individual surgeons compared with all other surgeons, the hazard 
ratios were not statistically significant. 
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8.3 TRANSFORMATION OF VARIABLES 
 
The final model includes variables that have been transformed to improve the model fit. 
These variables are graft size and time to suture removal, which have  non-linear hazard 
ratios. Graft size has a minimum hazard ratio (or relative risk) at a size of 8.0 mm, with 
increasing risk for grafts both larger and smaller than this. The increase in hazard ratio has 
a square root relationship with the change in diameter of the corneal graft from the optimal 
size of 8.0 mm. 
 
Suture removal has a very skewed distribution, with the mean time to suture removal being 
1.5 years, but with some very large positive values. Suture removal was modelled as a 
continuous variable, but log-transformed to account for the large positive tail. The log-
transformation of suture removal means that the hazard ratio is greater than 1.0 for suture 
removal times of less than 1 year (increased risk), but greater than 1.0 for suture removal 
times greater than 1.0 years (reduced risk). The risk increases sharply for suture removal 
times significantly less than 1 year. Conversely the risk reduces more slowly for suture 
removal times significantly greater than 1 year (see Fig 8.1). 
 
Figure 8.1 Suture removal hazard ratio 
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In addition, the variable for arrangements for follow-up includes a time varying component 
which models a change in hazard ratio between follow-up by surgeon or elsewhere over 
time.  
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8.4  INTERPRETATION OF THE MODEL 
 
 
The hazard ratio can be interpreted in the same manner as a relative risk – the relative 
hazard of a variable compared with the reference. To calculate the hazard ratio for a 
combination of variables, the individual hazard ratios are multiplied together. For example, 
if a graft is aphakic and has had more than one rejection episodes the combined hazard 
ratio using model 2 is:  
 
Relative hazard (combined) = HR (aphakic) x HR (one or more rejection episodes) = 1.61 x 
3.57 = 5.59  
compared with a reference graft (phakic with no rejection episodes). 
 
 
For continuous variables, the hazard ratio is raised to the power of the value of the 
continous variable. For example, for three ipsilateral grafts, the total hazard ratio using 
model 2 is: 
 
Relative hazard (3 ipsilateral grafts) = HR (1 ipslateral graft)3 = 1.173 = 1.60  
compared with a reference graft with no previous ipsilateral grafts. 
 
 
For the transformed variables time to suture removal and graftsize, the transformation 
needs to be taken into account when comparing hazard ratios. 
 
For graftsize, the hazard ratio can be found using the following formula (for model 2): 
 
Relative hazard (graftsize = g mm) =1.96 √(|g-8.0|)    
 
For example for a graftsize of 6.5 mm: 
 
Relative hazard (6.5 mm) =1.96 √(|6.5-8.0|)  = 1.961.22  = 2.28 
 
 
To find the hazard ratio of follow-up elsewhere compared with follow-up by the surgeon, the 
time-varying component should be incorporated:  
 
Relative hazard (after t yrs) = HR (follow-up) x HR (time - varying follow-up)t 
 
For example, at 5 years post-graft the relative hazard using model 2 is: 
 
Relative hazard (after t = 5yrs) = HR (follow-up) x HR (time-varying follow-up)t = 0.47 x 
(1.08)5 = 0.69 
At 5 years post-graft, the hazard ratio increases from 0.47 (in the first year after graft) to 
0.69. 
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9. SUMMARY 
 
9.1 GRAFTS, CONTRIBUTORS AND ERA 
 
Analyses were performed on cumulative data entered into the ACGR from its inception until 
the census date for this report of 01/09/2006.  Data were available on 18,205  
corneal grafts, 94% of which were penetrating, 5.5% of which were lamellar and 0.5% of 
which were limbal.  Of the penetrating corneal grafts, 78% had been followed at least once.  
Of the lamellar grafts, follow-up was available for 71% and for the limbal grafts, follow-up 
was available for 86%. Kaplan-Meier survival of penetrating and lamellar grafts was 73% 
and 69%, respectively, at 5 years.  Kaplan-Meier survival of limbal grafts was 42% at 5 
years. 
 
Grafts were recorded from each Australian state and territory, with about 60%  
of all grafts being entered from two states, New South Wales and Victoria.  A total  
of 623 individuals contributed data to the Registry. Of the contributors, 345 performed 
corneal graft procedures and 278 were involved in patient follow-up.  Approximately 82% of 
all records of graft were registered by 62 ophthalmologists (18% of contributing surgeons). 
 
Examination of penetrating corneal graft survival according to era (four year blocks of time) 
showed that graft survival appears significantly worse for those grafted in the 1993-1996 
period. 
 
 
9.2 CORNEAL DONORS AND EYE BANKING 
 
Historically, corneas were procured privately and from hospital-based banks, but surgeons 
currently procure donor corneas almost exclusively from Therapeutic Goods 
Administration-licensed Eye Banks in NSW, QLD, VIC, SA and WA. 
 
Causes of donor death related to the cardiac/circulatory system in 31% of cases, the 
cerebrovascular system in 17%, to malignancy in 16%, to trauma, accident, poisoning or 
medical misadventure in 11%, to the respiratory system in 6%, to other specified causes in 
13%, and to causes unknown to the ACGR in 6%.  Most corneas were retrieved from 
cadaveric donors, with 6% of all corneas obtained from multi-organ donors.  61% of donors 
were male and 34% were female. Donors ranged in age from infancy to 99 years at the 
time of death, but the majority (65%) were aged from 51-80 years. 
 
The median death-to-enucleation time for corneas used for penetrating keratoplasty was 6 
hours.  Historically, most donor corneas were preserved in McCarey-Kaufman medium but 
for the past 10 years, Australian eye banks have predominantly used Optisol storage.  
Corneas stored in Optisol appear to have significantly better graft survival than those 
stored in other media.  The median time between donor death and penetrating corneal graft 
surgery for corneas stored in Optisol was 98 hours.  
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9.3 CORNEAL GRAFT RECIPIENTS 
 
Recipient age varied from less than one month old to greater than 97 years,  
with peaks at 20-40 years and 60-80 years.  Approximately equal numbers of women and 
men received a corneal graft.  Recipients under 4 years and over 80 years appear to have 
poorer graft survival than other age groups. The main indications for penetrating 
keratoplasty were keratoconus (32%), bullous keratopathy (26%), failed previous graft 
(19%), corneal dystrophy (7%), herpetic eye disease (4%), corneal opacity or scar (3%), 
ulcers (2%), and accidental injury (1.7%). Corneal grafts performed for keratoconus have 
significantly better graft survival than for any other indication. 
 
Approximately one third of recipients displayed evidence of corneal neovascularization at 
the time of graft.  In about 36% of cases where information on past history was available, 
the eye to be grafted had been inflamed in the past or was inflamed at the time of graft.  In 
about 15% of cases, the intraocular pressure in the eye to be grafted had been raised at 
some time in the past or was raised at graft. Raised intraocular pressure at any time prior 
to, or at graft, is a significant risk factor for corneal graft failure.  About one-fifth of recipients 
had previously had a corneal graft in the ipsilateral eye.  Graft survival falls with increasing 
number of ipsilateral grafts performed. 
 
 
9.4 OPERATIVE PROCEDURES 
 
Graft size ranged from 2.0 mm to 16.0 mm in diameter. Grafts within the size range of 
about 7.5 to 8.5 mm in diameter fare best.  In 40% of cases, an additional operative 
procedure was carried out at the time of transplantation. The most common of these 
procedures were manipulations associated with the lens (24%), vitrectomy (10%) and 
peripheral iridectomy (6%). Graft survival is poorer in aphakes than in phakic or 
pseudophakic recipients. 
 
 
9.5 CAUSES OF GRAFT FAILURE 
 
The major causes of failure of penetrating corneal grafts were rejection (31%), endothelial 
cell failure (21%), infection (13%) and glaucoma (8%).  Removal of graft sutures within 6 to 
12 months of the time of transplantation is a risk factor for graft failure.  A penetrating 
corneal graft that never clears and thins in the immediate post-operative period is 
considered to be a primary non-functioning graft. Thus far, 137 such grafts have been 
reported to the ACGR, representing 1% of followed grafts.  
 
 
9.6 VISUAL OUTCOME AFTER CORNEAL 
TRANSPLANTATION 
 
In 70% of cases, the sole desired outcome for corneal transplantation was to improve 
vision in the grafted eye.  In a further 18% of cases, the desired outcome was pain relief, 
with or without the possibility of visual improvement after surgery. 
 
For patients with penetrating grafts, 45% of the cohort achieved a Snellen acuity of 6/12 or 
better at the time of the most recent follow-up and 55% achieved 6/18 or better, but for 
26%, Snellen acuity was less than 6/60.  Where both pre-operative and post-operative 
Snellen acuities were available an improvement in acuity of at least one line on the Snellen 
chart was recorded by 74% of recipients after corneal transplantation.  In 13% there was no 
change, and in 13% the acuity was worse after graft. 
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Factors affecting the visual potential of the grafted eye included astigmatism of more than 5 
dioptres (22%), graft failure (22%) and one or more co-morbidity in the grafted eye.  
Refractive surgery was carried out on 12% of all penetrating grafts with follow-up.  At 10 
years or more after corneal transplantation, 40% of recipients had been prescribed 
spectacles and approximately 10% had a contact lens.  An intraocular lens was in place in 
the grafted eye in about 33% of the cohort. 
 
 
9.7 LAMELLAR AND LIMBAL GRAFTS 
 
Limbal grafts did not fare as well as lamellar grafts. 
 
A best corrected Snellen acuity of 6/12 or better was achieved in 55% of cases at most 
recent follow-up, 62% of cases achieved a follow-up visual acuity of 6/18 or better, and 
22% recorded a visual acuity of less than 6/60 at last follow-up.   
 
The main indications for lamellar and limbal graft were pterygium (18%), disorders of the 
sclera (14%), rejection of a previous graft (14%), corneal ulcers (14%), neoplasia (6%) and 
scars and opacities (6%).  These broad categories accounted for 72% of lamellar and 
limbal grafts.  
 
The main reasons for failure of lamellar and limbal grafts were failure of a previous corneal 
graft (27%), corneal scleral melt (14%) and infection (11%).  
 
 
9.8 RISK FACTORS FOR FAILURE OF 
PENETRATING GRAFTS 
 
The variables best predicting penetrating corneal graft failure in Cox proportional hazards 
regression analysis were surgeons with a high workload (a variable with marginal 
significance), state, indication for graft, number of failed previous ipsilateral corneal grafts, 
lens status, history of inflammation in the grafted eye, history of raised intraocular pressure 
in the grafted eye, graft diameter, time of removal of graft sutures, corneal 
neovascularization at the time of the graft, post-operative corneal vascularization, number 
of corneal graft rejection episodes, post-operative microbial keratitis or stitch abscess, graft 
era and follow-up arrangements.  Further information on these variables, with the 
associated relative risks for graft failure, are presented in Table 9.1. More comprehensive 
information is found in Chapter 8. 
 
 
A number of potential risk factors for graft failure were identified in univariate analyses. The 
factors that did not influence penetrating corneal graft survival significantly in multivariate 
analysis were: cause of donor death, corneal retrieval from a multi-organ donor, identity of 
eye bank, donor age, recipient age, post-operative uveitis, post-operative rise in intra-
ocular pressure, development of synechiae after transplantation, vitrectomy at time of graft, 
corneal storage medium and donor-recipient gender match . 
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Table 9.1 Variables best predicting penetrating corneal graft failure (from    
model 2) 
 
 
Variable 
 
 
Hazard ratios 
 
 
Surgeons with a high workload (11 compared with all others) 
 
State 
 
Failed previous ipsilateral graft (each additional graft) 
 
Indication for graft 
 
Lens status 
 
Corneal vascularization at graft 
 
History of inflammation in the eye to be grafted 
 
History of raised intraocular pressure 
 
Graft diameter, every square root mm change from 8.0mm 
 
Post-operative microbial keratitis or stitch abscess 
 
Removal of graft sutures, every one unit increase in ln(years from 
graft)  (removal before 1 year associated with greater risk) 
 
Graft neovascularization 
 
Graft era 
 
Refractive surgery in follow-up 
 
One or more rejection episodes 
 
Arrangements for follow-up  
(follow-up by transplant surgeon associated with greater risk, 
with the risk decreasing every year after graft) 
 
 
0.33-4.87 
 
0.54-1.41 
 
1.17 
 
1.00-3.70 
 
1.00-1.61 
 
1.00-1.39 
 
1.00-2.20 
 
1.00-3.34 
 
1.96 
 
1.88 
 
0.61 
 
 
2.20 
 
0.52-1.00 
 
0.61 
 
3.47 
 
0.45 
  
1.08 
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10. METHODS AND DEFINITIONS 
 
 
10.1 ENTRY AND FOLLOW-UP 
Data are entered into the Registry by the contributing surgeon as soon as possible after the 
graft and follow-up information is requested at intervals of about 12 months. Information is 
obtained by mail; missing data are routinely sought by follow-up letter. Each graft is 
followed until graft failure or until the death or loss to follow-up of the patient. The study 
period for the present analyses was May 1985 to September 2006 (21 years).  
 
 
10.2 DEFINITION OF RISK FACTORS 
A history of past inflammation is recorded if the individual is specifically reported to have 
had such an episode, if the patient has had one or more previous grafts in the ipsilateral 
eye, if any intraocular surgery has ever been performed on that eye, or if there is a history 
of the use of topical corticosteroids in that eye in the weeks immediately preceding the 
graft. 
 
Vessel ingrowth into the cornea at the time of graft is scored on a scale of 0-4,  
with 0 representing no growth in any quadrant extending to the graft-host junction,  
1 representing such growth in 1 quadrants, 2 representing growth in 2 quadrants,  
3 being vessel ingrowth in 3 quadrants and 4 being vessel ingrowth in 4 quadrants. No 
distinction is made between superficial or deep vessels, patent or ghost vessels, or single 
or multiple vessel leashes.  After corneal transplantation, the presence of even one vessel 
leash extending into the graft is considered enough to classify that graft as vascularized. 
 
The intraocular pressure (IOP) is generally considered to be raised if a reading of  
25 mm of mercury or greater is made by applanation tonometry, but the decision is at the 
discretion of the ophthalmologist. 
 
Presenting diseases, indications for graft, post-operative complications and reasons for 
graft failure are coded using the ICD.9.CM system (US Department of Health and Human 
Services).  
 
Information is collected on both recipient bed size and donor button size, but for the 
purpose of examining the influence of graft size, the former is used. 
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10.3 DEFINITION OF GRAFT FAILURE, 
REJECTION AND COMPLICATIONS 
Primary graft non-functions are defined as grafts that never thin and clear in the post-
operative period.  The trial time for such grafts is arbitrarily adjusted to one day. Any 
existing graft that is replaced by another in the same eye, irrespective of graft clarity and for 
whatever reason, is classified as a failed graft.  An example in this category would be a 
clear graft with an unacceptably high degree of irregular astigmatism, not improved by 
refractive surgery, which is then replaced.  In all other cases, graft failure is defined as 
oedema and irremediable loss of clarity in a previously thin, clear graft.  The day of failure 
is the first day the patient is seen with an oedematous, opaque graft that subsequently fails 
to thin and clear. 
 
Rejection is defined as the development of a rejection line (epithelial or endothelial) or a 
unilateral anterior chamber reaction with corneal infiltrates and spreading corneal oedema 
in a previously thin, clear graft. 
 
Any development with the potential to compromise graft outcome is considered to be a 
complication.  Post-operative complications are collected in two ways.  First, a number of 
specified complications (stitch abscess, microbial keratitis, neovascularization of the graft, 
synechiae, uveitis, rise in IOP, cataract, rejection episode, herpetic recurrence, early 
changes of bullous keratopathy), refractive and related errors (anisometropia, ≥5 dioptres 
astigmatism) and factors potentially affecting visual outcome but unrelated to the graft 
(cataract, amblyopia, retinal detachment, age related macular degeneration and diabetic 
retanopathy) are listed, requiring a yes/no answer.  Second, contributors are asked to 
specify any other relevant complications, information or departures from their preferred 
treatment. 
 
 
10.4 STATISTICAL ANALYSES 
Kaplan-Meier survival functions are constructed to provide a graphical record of  
graft survival.  For surviving grafts, trial time is calculated as the time between the date of 
graft and the date on which the patient was last seen.  For failed grafts, trial time is 
calculated as the time between the date of graft and the date of failure.  For grafts for which 
we have never received follow-up, the default graft survival period is 0.1 day.  Kaplan-Meier 
plots were constructed using SPSS versions 12, 14 and 15. Cox proportional hazards 
regression analysis was performed using Stata version 9. 
 
 
10.5 COMPUTER HARDWARE AND SOFTWARE 
Existing hardware comprises a HP Compaq dc7600 computer with 2 hard drives: 74.5 GB, 
and 149 GB, and HP LaserJet 4 printer.  
 
The database is constructed in Microsoft Access. The Access database was designed by 
Ms Sandra Bobleter and has subsequently been modified by Mrs Helene Holland, Ms 
Ngaere Hornsby, Ms Carmel McCarthy and Mrs Chris Bartlett.  Kaplan-Meier curves 
generated for the 2007 Report were prepared using SPSS versions 12, 14 and 15. The 
report was prepared using Microsoft Office 2003. 
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10.6 CORNEAL GRAFT REGISTRATION FORM 
 
Registry No. 
 
 
Registry use only 
THE AUSTRALIAN CORNEAL GRAFT REGISTRY 
GRAFT REGISTRATION FORM 
SURGEON  STATE 
RECIPIENT IDENTIFICATION  
Patient's name   
  SURNAME FIRST NAME 
Patient's record No.  (if applicable) 
Patient's date of birth              /          /             Patient gender Male Female 
 
Date of graft             /          /                Eye grafted R L 
 
RECIPIENT HISTORY 
Original pathology/past history/underlying diseases (in words) Office 
use only 
  
  
Current pathology/current indications for graft  (in words)  
  
  
Desired outcomes Pain Relief Improved  Visual Acuity 
Cosmesis Tectonic/ 
Structural 
Repair 
           Please circle or tick as many as apply  
Pre-graft visual acuity R L 
No. of previous grafts in grafted 
eye (excluding this graft)  
  Please advise acuity in both eyes 
If this is a repeat graft in the grafted 
eye, please give the reason and 
date of failure of previous graft 
Reason for failure: 
 
 
Date of failure: 
 
           /           /          
Presence of vessels in the recipient cornea 4 Quadrant 3 Quadrant   2 Quadrant 1 Quadrant    
No
ne 
 Please circle/tick the applicable box 
         Yes         No Unknown 
Current inflammation of eye    
Use of topical steroids in 2 weeks prior to graft    
History of intraocular surgery in grafted eye 
(not including a previous graft procedure) 
   
Active HSV infection at time of graft    
Does patient have a history of raised intraocular pressure?    
Was intraocular pressure raised at the time of this graft?    
Immediately prior to graft, was the eye to be grafted Phakic Aphakic Pseudo 
phakic 
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DONOR INFORMATION 
 
 Donor age (in years)  Donor gender Male Female 
 
 Multiple Organ Donor Yes No 
 Eye Bank Source SA NSW 
 QLD VIC 
 WA VIC - Forensic 
 
 Eyebank No. (if applicable) 
Please circle/tick applicable box   
 Cause of donor death  OFFICE USE 
ONLY 
  
  
 
 (Please fill in as many as are known using a 24 hour clock)  
Time and date of donor death  Time  Date 
Time and date of enucleation  Time  Date 
Time and date of storage of cornea  Time  Date 
 
Storage method      
Moist Pot  Organ culture  CSM  Optisol  Other  
      Please state 
Endothelial cell count (per mm²)     
 
OPERATIVE DETAILS 
 
Type of graft Penetrating Lamellar               Limbal or  
stem cell /conjunctival 
 
Size of graft Recipient               mm Donor 
Button 
                mm  
 
 
Time of day graft performed  
ACCOMPANYING PROCEDURES:  (Tick as many as apply) 
Peripheral Iridectomy  Removal of cataract   
Trabeculectomy  Triple procedure   
Vitrectomy    
Other procedures 
    
     
Immediately following the graft, was the eye grafted Phakic Aphakic Pseudophakic 
 
COMMENTS  
 
CONSENT: Please remember that you should gain consent from your patient for data to be forwarded to the 
ACGR 
 
PLEASE RETURN THIS FORM TO: 
Australian Corneal Graft Registry 
Department of Ophthalmology, Flinders Medical Centre 
BEDFORD PARK   S.A.  5042 
PHONE:  (08) 8204 5321  FAX:  (08) 8277 0899 
   Ver Dec 2005 
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10.7 CORNEAL GRAFT FOLLOW-UP FORM 
Registry No. 
 
 
 
Registry use only 
THE AUSTRALIAN 
CORNEAL GRAFT REGISTRY 
FOLLOWUP  
Date Rec'd
 
 
     Ver Dec 
2005 
SURGEON  STATE 
PATIENT IDENTIFICATION AND GRAFT OUTCOME 
 
 
 
 
GRAFT STATUS 
DATE PATIENT LAST SEEN  BY YOU             /          /           
GRAFT SURVIVING ON DATE LAST SEEN Yes No (Please mark correct box)  
     
GRAFT FAILED Yes No DATE GRAFT 
FAILED 
         /           / 
    Office use 
only 
REASONS FOR GRAFT FAILURE 1.    
 2.    
PATIENT STATUS 
     
Status Please tick applicable box Date 
DECEASED/LOST TO FOLLOWUP (please circle) YES NO /           / 
FOLLOW-UP ELSEWHERE? (Please advise the name and address of the follow-up doctor, if known)  
 
 
POST OPERATIVE EVENTS   
 
DATE OF FINAL SUTURE REMOVAL: /           /            
   HAVE ANY OF THE FOLLOWING OCCURRED: 
NEOVASCULARIZATION OF GRAFT  SYNECHIAE  
SIGNIFICANT RISE IN IOP   UVEITIS  
CATARACT DEVELOPED SINCE GRAFT  STITCH ABSCESS  
RECURRENT HERPETIC DISEASE  OEDEMA  
MICROBIAL KERATITIS    
      
NO., AND DATES, OF ANY REJECTION 
EPISODES  SINCE LAST FOLLOWUP 
 
/          / /          / /          / /          / 
 No. of rejections   
   Office use only 
ANY OTHER SIGNIFICANT EVENTS?       
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OPERATIVE PROCEDURES ON THE GRAFTED EYE 
 
HAS AN OPERATIVE PROCEDURE BEEN PERFORMED ON THE GRAFTED EYE SINCE THE 
LAST RECORDED FOLLOW-UP?  
YES NO 
IF "yes", PLEASE TICK AS MANY AS APPLY:    (Please mark which is applicable) 
CATARACT REMOVAL 
INSERTION  IOL 
YAG LASER/MECH. CAPSULOTOMY 
    GLAUCOMA SURGERY  (Please specify)     OTHER OPERATIVE PROCEDURE   (Please specify) 
  
  
 Please mark applicable 
box 
HAS ANY REFRACTIVE SURGERY BEEN PERFORMED?   YES NO 
IF "yes" PLEASE TICK WHERE APPLICABLE:    
            SUTURE ADJUSTMENT              EXCIMER LASER - PRK  
            COMPRESSION SUTURES              EXCIMER LASER - LASIK  
            RELAXING INCISION              OTHER (Please state) 
            WEDGE RESECTION    
POST-GRAFT VISUAL OUTCOME 
SNELLEN ACUITY (with preferred correction and without pinhole) 
GRAFTED EYE  
 Please mark all applicable boxes 
ARE SPECTACLES WORN? YES NO 
ARE CONTACT LENS WORN? YES NO 
DOES PATIENT HAVE AN IOL IN PLACE IN THE GRAFTED EYE? YES NO 
ANISOMETROPIA  
MAJOR DEGREE ASTIGMATISM (>=5D)  
K-READING (if available)  
CENTRAL GRAFT PACHYMETRY  ENDOTHELIAL CELL COUNT (per mm²)  
  FACTORS AFFECTING VISUAL ACUITY IN GRAFTED EYE (Please tick all that apply) 
 
CATARACT  CME  RETINAL DETACHMENT  
AMBLYOPIA  MYOPIA  ARMD  
GLAUCOMA  OPACITY/SCAR  DIABETIC RETINOPATHY  
  OTHER (please specify)     
    
  EYE  HAS NO VISUAL POTENTIAL   IF GRAFTED FOR PAIN, HAS PAIN BEEN RELIEVED? Yes No 
OTHER COMMENTS 
 
             
 
             
PLEASE RETURN THIS FORM TO: 
AUSTRALIAN CORNEAL GRAFT REGISTRY 
Department of Ophthalmology, Flinders Medical Centre 
BEDFORD PARK  S.A.  5042 
PHONE:  (08) 8204 5321  FAX:  (08) 8277 0899 
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